A-1
Š€‚}‹’}av{&
afebgh 3mqsˆw‘In'k
s]2$
n+
?:) 1ji. 2j-* 1,2
(1 V^ /6†v y>@~‘’j^
2
V^ "986V)
Ĝ¯ĝűőƂƇ(Neofinetia falcata)Ĺę|ƒķÉ¥īŇ
ŅŌiję&ĦģŅŌķÁĪğ·<«‹ĤçlŒ8
ĩňIJĥĮĚľĮęíÎ~ķYğÏýŋuıĨĴij
ě
ŋāĪIJĥĮĚĨňľijķęŕƂŞH/ŋÎķ×Ĭý
—fŋpôķ+±ĩĬ…ĪĮƏƍ ęŭŐſƄķ
ŁĮÎĸŴťũŞŞŶƉŞĸý—fŋ…ĪĮ
Ɛƍ
ęÎģŅmĪĮ¹šŋ…ĪĮƑƍĶĵĤŅňŇĚ
gěĹęűőƂƇĸ¥ÎĤÉķ­vīŇýņŋ…
Īęĭĸº¿îĸP«ŋ–àĪĮĚ
Ĝz›ĝ04ƈ>:ƂƇ5ģŅiĪĮ 8 º¿$ĺÜ}
ÎĥƊģŅiĪĮ 5 º¿ę 11 º¿ĸ N. falcata ķ
ığIJęí΋ĸÎÐģŅèŋ‘ÇØĸÖijğę
ŹŐŗƆ3műōŐŭƉ(Polydimethylsiloxane/
Divinylbenzene)ŋoĪIJ 26Ĕ1ėę2 ~îuÀĪĮ
\ęűōŐŭƉķ+±ĪĮfŋ GC/MS ķMĪIJę
ý—fŋ…ĪĮĚ
Ĝ ¾ † ĝ ý — f ŋ … Ī Į ¾ † Methyl Tiglate ę
(Z)-3-Hexen-1-olęBenzaldehydeęLinaloolęMethyl
ƕenzoateęFarneseneęBenzyl alcohol ĶĵĤ
Kĩň
ĮĚĨňŅĹ N. falcata ĸý—fĴĪIJīijķ9,ĩ
ňIJğŇłĸijĞİĮ̂)DfķığIJĹę\
…ŋåŁŇĚľĮęº¿îĸý—fŮţƉƇķP
«Ĥ
KĩňĮĚ
1)Holman, R.T.,et al.,Amer.Orchid Soc.,Bull.42,678(1973)
2)Ono,T.,et al.,Natural Product Letters,13,53(1999)
3)Miyazawa, M.,et al.,J.Essent.Oil Res.,12,197(2000)
GC/MS +l#mqs…’‰n
]rn+lŒx’\(on"9
A-3
“c V^ "986Vjd V^ /6
†vy>@~‘’_
Ĝ¯ĝŬƉŲ 6 µùĸ¥Ñĸýņĸ¡^ŋcĴ
GC/MS …ķńİIJŽÙĪęŬƉŲĸýņĸÌĪbĪ
ŋ™DīŇý— ķığIJ…ŋÕİĮĚĩŅķŬ
ƉŲĸýņŋ¥ģĪĮûyĴĪIJęŤƉş¦ ĸŷŒ
ƉţƇŮŗŋ§ĪĮûyĸí­ŋĿĮĚ
Ĝz›ĝŬƉŲĹƅŽƇŭƉŵŪęƅŽƇƁƉŔƃęűƄ
ƉŦƈŠƉŝęƆƉşƈšƂūőŻęÞęĢńĺö¼Óŋ
%ņħĮ̅yĹŭŐŎƄ¤ķ¥ÑňIJŖž
ťųijJŠ\ęŐƇŖƀŵƉţƉij8üĪĮĚý— Ĺ HS ›ĴŹŐŗƆ3m›ŋ§ğIJęGC/MS …
ŋÕİĮĚýņĸcĹ 2 ”òŎƇřƉŨۈķń
ņÕİĮĚŬƉŲŒŖŞĸmĹęÒª˜ƌpH2.6 Ûxƍ
ij 72 ė ę 10 î Õ İ Į Ě ŷ Œ Ɖ ţ Ƈ Ů ŗ Ĺ
WPI(whey protein isolate)ŋ§ğĮĚ
Ĝ¾†ĝ6 µùĸŬƉŲ¥ÑĤuīŇý— ŋ
GC/MS ij)DĪęý—ųƆűōŐƄŋfĪĮĚƅŽƇ
ŭƉŵŪĴűƄƉŦƈŠƉŝĸýņĤ@ľňęĕ
-PineneęĖ-PineneęLimonene ĶĵĤÏýķIĪIJ
ğŇĴÃġŅňĮĚƆƉşƈšƂūŗŻĤBŊňĮĸĹę
ĕ-CubebeneęIsomenthoneęCitronellol ĶĵĤZ÷Īę
ƖöÊĩƗĸ2ķĶİIJğŇĴÃġŅňĮĚĨňŅĸŬ
ƉŲķ–ĽIJÞęö¼Óĸý—ĹXĦęHS ›ijŎ
cUĤ!ĶĮŁŹŐŗƆ3m›ijžDĚ
ŬƉŲĸýņĤīŇŷŒƉûyĸí­ijĹęûyĴĪ
IJ@ľňŇŬƉŲĴmz›ŋŽÙijĞŇĚƅŽƇ
ŭƉŵŪęűƄƉŦƈŠƉŝęÞęö¼ÓĤ@ľňĮĚ
¥ŬƉŲĸýņĴûyģŅŽĩňĮý— Ĵĸï
ęĢńĺûyĸ-ĸ.øķığIJÃK
ŋÕİĮĚ
^
„~uz|umpts|uƒŽ‚^
ƒ}n=mpts‡<L;BF
1%6^
A-2
A-4
iMZj,SDj:4j
T[j0!W•“WY^ 8Pj
•W^ N”
Ĝ¯ĝŪŞƌŪŞ´ŪŞO ďƍĹę
|ƒĸGVķĢğIJ|R¯ķúĩňŇþ‡Ŀğú
-ĸƏıijĞŇĚĭĸ>"ŘijĞņËķ‰ü¯
ĹğĴĩňIJğŇĚĪģĪzijęŪŞķ*ľň
ŇŎƇŨŜŎūƇĤĀğké ÆŋnıĨĴĤ9,ĩň
IJğŇĚĩŅķęáTęŎƇŨŜŎūƇķŕƇðĸ†
Ĥ[ĩňIJğŇĚĭĨij1ĹęŎƇŨŜŎūƇŋ*
ŀŪŞĸ°ķůŨ®Ô¬½Å;“j ŋīĨ
Ĵŋ¯ĴĪIJ²¶ŋíAĪĮĚ
Ĝz›ĝŪŞĸ°ŋ ąĄĆƋĒčĊăĎć Đ ijmĪęĨĸm
ŋ ēĊČăĉ œƉųƇŔƂŻij¨ĪĮĚ]ŅňĮ¨
ĸĠįęâĸ% Ďđďċ ķńİIJĩŅķ¹ØĪĮĚľ
ĮęůŨ®Ô¬½ÅƓƔĘƒƎŋ§ğę½Å;“ķığIJ
½ÅwŋwġŇĨĴijŽÙŋĪĮĚ
Ĝ¾†ĝ ĨňŅĸ¨ŋâ Ďđďċ ķńņ…ĪĮĴĨ
ʼnęÍ»Ĵ_ŊňŇ#ŰƉŗĤ³ÚĩňĮĚĨĸ ŋŪŞūƇĴ)DĪĮĚľĮę]ŅňĮŪŞūƇŋ
§ğIJůŨ®Ô¬½Å ĎďăĈą ķLīŇ;“j
ÿŋÕİĮĴĨʼnę;“jĸœaĤĿŅňĮĚĂ ľ
Įę;“jĸjĹŎŸŨƉŜŞķńŇĨĴĤ}
ĪĮĚŪŞūƇĸèäŋ§ğIJęäœaï
ŋķığIJŽÙĪĮĴĨʼnę¡ķœaķĹŎŘƃŚƇ
ijĞŇŧƄűŏūŝƇèĤïĪIJğŇĨĴĤ}Ņ
ģķĶİĮĚ
iX cj?:) dj-* c`d^
iRKH 1jJC 1jOA 2 j
GU 2jKE* 2j :5 1“1 Qj2 Q7>”
Ĝ¯ĝŜŎŪźũ(NH2CN)Ĺ?ķĹC6ĪĶğĴÃ
ġŅňIJğĮĤ, áTŢƂŹżOĸŴŎƃƉŵťŤ(Vicia
villosa subsp. varia)ģŅ#õĩňĮĚĀ¸ 452 µ
ĸÑŋLÝķÕİĮŜŎŪźũQۈĸ¾†ģŅ,
ŜŎŪźũĹŢƂŹżOĸŗśűŝ(V. cracca)ĴŬƃŒƇ
ŝƀOĸūŠŎŔŜŎ(Robinia pseudo-acacia)ķł*ľ
ňIJğŇĨĴĤ}ŅģķĶİĮĚŜŎŪźũĸæt%
Ĺ°ÈŸŃĒÆóF, `aŎƄŚƉƄ•ŋWĥ
ßĨīĚìêijĹūŠŎŔŜŎĸÎĤú„ĴĪIJ
§ğŅňIJğŇĮŁ, ƒ²¶ijĹūŠŎŔŜŎĸÎĸ
ŜŎŪźũ*ëŋDëĪ, ú„ĴĪIJĸt%Ĥ
ķ€
FijĞŇģŋÛĽŇĨĴŋ¯ĴĪĮĚ
Ĝz›ĝūŠŎŔŜŎĸÎĸÛ£›Ģńĺt%ëķı
ğIJúÂeĸĞŇ
ŋLÝķĪĮŎƇřƉŨۈŋE
{ĪĮĚūŠŎŔŜŎĸÎĸê=qôŋÕğ, m ĸŜŎŪźũ*ëŋ GC-MS …ĸńņDëĪĮĚ
Ĝ¾†ĝŎƇřƉŨۈĸ¾†ģŅ, łË¯ĶÛ£
›ĹÎĸ?ĻŅij, 1 UĸúijS7 3 hĤúĩňIJ
ğŇĨĴĤŊģİĮĚ¥ĸūŠŎŔŜŎĸÎ(2.6Ĕ0.6
gFW/h)ķĹ 58Ĕ30 μg/gFW ĸŜŎŪźũĤ*ľňIJ
ğĮĚŜŎŪźũĸ LD50 Ĺ 125 mg/kg ijĞŇĨĴģŅ, ã
Rĸt%ëijĹ¥ĸ¢dijĞİIJł
ļĸZ÷Ĺ
ĥŊŁIJğĨĴĤržĩňĮĚ»sħķīŇĴ, ŜŎ
Ūźũ*ëĹDëñ©(1 μg/gFW)ķĪĮĨĴ
ģŅ, ?ĻŅķĪĮ:(ł¥ĸ¢dńņNĶĦĶŇĴr
žĩňŇĚūŠŎŔŜŎĸÎĸt%Ĥ
ķFŋġ
Ň'ÆaŏŁIJğĴÃġŅňŇĚ
- 41 -
A-5
Streptomyces sp. USF-6280 1h78e
j DPPH €qo+*6 \
]H _ ^, 2-pyrone 6hW
`5 \ , -, /!X4,
':\ T\ (Y" G…Z0[)
A-7
è
ď
®Đè àRTä”%Į7BĺļßĝĤ
Streptomyces sp. USF-6280 ‡ į
s Į DPPH
( 1,1-diphenyl- 2-picrylhydrazyl)ůőʼnűml¢Ł¨
© ğ Ľ č ‚ V W D ĭ ĕ Ē ĩ Č 1 Ŷ germicidin ŷ Č 2
Ŷ 3-(2,5-dihydro-2-oxofuran-4-yl) propinoic acid ŷ Č 3
Ŷgermicidin BŷĮ&ßČ#IŠÓĭĨĒĩ?1ĝĤč
‚°µįČUSF-6280 ‡ė¨©ğĽ DPPH ůőʼnű—
aŁğĽv
2-pyrone #-¢Į&ßȊÓ
…Ł
®īĝĩĒĽčè
ďw•(İ¿†Đè USF-6280 ‡ŁŧşřŜ=9è (10L)Ī
30ĊČ4 yÝk =ãĝĤč=ã¾ [ČĿÕĝĩ]Ļ
ľĤ=ãĿ™ŁAÙĪ pH3 ĭÑtĝĤčĢĮ[ČØÙ
ņŘűĪhĝČ Ùa¬Ł]ĤčěĮ Ùa¬
ŁŐŰʼnōűè ên-ŦŊŏŴè ïè ØÙņŘűëČSephadex
LH-20 ʼnůūêŬŖŠŵűëè ŋųŪŜŌůŤŃŵČÀĒĩÒ
HPLCèê‘è ïè łœŜŞŜŰűè ïèTFAëŁªĒĩºÍĝČ
DPPH ůőʼnűml¢īĝĩČ4 (49.1 mg)Č5 (5.3
mg)Č6 (1.4 mg)Ł]Ĥč
4ȟÊÛ¤¿~Čmp 191-193ĊČĮGXį
C9H12O3è
êæ
Ç FABMSëĪđħĤč1HČ13C-ÿþĀ ŒŨŋŜűČ
Ž NMR Œ Ũ ŋ Ŝ ű Į … Ė Ļ Č 4 Ł
4-hydroxy-6-isopropyl-3-methyl-2H-pyrane-2-one ī ’
LĝĤčèè 5Čèè (C9H14O3)Čĸ.‹ĭŠÓ
…ĝĤīěĿČ
phomapyrone C ī. Į 4-hydroxy-3-methyl-6-( 1methylpropyl )-2H-pyran-2-one ĪđħĤč6 ĸ 2-pyrone
#-¢ĪđĽīpLĜľČ¦8ŠÓ
…ŁÌħĩĒĽč
4 Į DPPH ůőʼnűml—aįČED50 4260ĉM (0.5
hr)ĪđħĤčè
è
A-6
O
N
N
O
O
O
O
N
N
H
N
1
O
N
N
O
N
H
4
N
H
O
N
N
N
H
N
2
O
N
N
H
3
O
O
O
N
H
6
5
ď¿†Đ#-¢ 1Č4Č5 ĭį—aėÏķĻľĬĖħĤ
ėČ#-¢ 2Č3Č6 ĭÞĝĩį—aėÏķĻľČüøõð įĢľģľ 0.32 þČ0.20è þČ10è þ ĪđħĤîè
`? =aArthit Makarasena
V3*aAN\ E
†S7Ka*6 Us‡
è
ď ®Đ5/»œŲŅŰŝįČóö 4§§¤śťŐŨť
ŘŝĪđļČʼnŰŅūńňŴĹłŴŭŞŅūńňŴī ñ O ñ
ĮÜŁYdğĽ×g®ĬńňŠŤŇł—aŁĝĩ
ĒĽčeĎįěĮ£aĭ– ĝČœŲŅŰŝĭ 3aŁ
iĨłŴŭŞŅū>īłőŝ>Ł0Ķ#-¢Ł-dĝČ
œŲŅŰŝīÜŁYdĜġĤ[Č PĭĺļœŲŅŰ
ŝĭ oKÇ>ŁQğĽěīŁ ®īĝĤčĢěĪČ
œŲŅŰŝīłőŝ#-¢ĮÜŁYdğĽƒĭĨĒ
ĩ‰ÎğĽěīīĝĤčè
ďw•ī¿†ĐĴĠČŢŝųŊŐűłŴŭŞŅū>Ł0Ķ
ŭśű#-¢ŁªĒĩ -YdĭĨĒĩƒ‰Î
ĝĤčxĭ?1ĜľĩĒĽłűŊűłŴŭŞŅūīœŲ
ŅŰŝīĮÜYdĮƒŁ'ÅĭĝČÙŁ ĔĽěī
ĪŀĠĖĬÜYdŁ ÿþĀ ĭĺļ±ÏĝĤčĜĻĭČń
ŴŊŮŧŵŜğĽ›WŁM›ĖĻ õðè ĊĴĪ\Ďĭ
ĚČM›ĭfĝĩĖĻ ÿþĀ œLĝĤīěĿČÜĮY
dėÔĜľĽěīŁ ĝĤčĢěĪȝFŁÚŋųų
ũűūĖĻÚőŋųųņŖŴĭCĔČ÷ðè ĊĪ } ¡
ĝČM›ĭfĝĩĖĻ ÿþĀ œLĝĤīěĿČõðé³WÜ
ėYdĜľĽěīŁ±ÏĝĤčĢĝĩÉ2šĒěīĭČ
æ›Ŷ÷ðè ĊŷĪńŴŊŮŧŵŜĝĤ[ĭ›Ŷõè ĊŷĪń
ŴŊŮŧŵŜğĽīČÜė
ßğĽěīĬęČāĄćąĂăĄĈè
ýûíòð ŋųŪŜŌůŤŃŵĭĺļ ñððéÜīĝĩķĩ
&ßğĽěīĭdĝĤčè
, I<~„lpyrwhJg
dfq}„tmzx€q„cih2
L Pè
ċ . a: &a #(a\
%Ba%)\
† OSK@FC‡
ď ®ĐzËĮȯŸCcįȯũűŭŴĪđĽ 20-Ţŝ
ųŊŐņŋŗńŔŴĭĺħĩ^ĜľĩĒĽčȯũű
ŭŴĮGŲŧűĪĮªŠė½ĭÑIJĻľČĢ
Į+NĭOğĽÈ¯ũűŭŴĕĺİĢĮłŎŞŒŜ
ĪđĽőŧŴŕńűŢŝůőŴ(DBH)Į¿-‹Xė{Ļ
ĖīĬħĤŹ‚°µĪįČ+NĭOğĽ¿-‹XŁ
ĸīĭĝĩČ!¥®ĭȯũűŭŴĮłŎŞŒŜŁn¼
ğĽěīŁ ®īĝĤŹ
ďw•ĐxHĮ DBH ĮåˆŁrCĝĤ#-¢Ł×
ĝČĢľĻĮ€JLŠÓŁGI•ŁªĒĩŠ¹ĝ
ĤŹDBH īĮâaŁU:
SŶRMSDŷŁjŒī
ĝĩ¸ĝČâaĮæĒ#-¢Įĵ-dŁÌħĤŹ
-dĝĤ Į#-¢ĭĨĒĩČçÄ zË«„Į
½Æ Sf-9 ıĮ[3H]ponasterone Į*ļĵĭĕĺijğ
žW`·ÁĖĻ 50%!†žW(üøõð룸ĝČĢĮ
Ł—aĮjŒīĝĤŹ
A-8
q|nƒvzxƒs‚„u€q„k9
bfw{mo>;
Q gRe
jG MD
` $T a
V3*aAN\ E
†S7Ka*6
Us‡
ď ®Đ“Â˜<ĭ¨bğĽŜţńʼnĮ­ŖŴšŋŶŐ
ŴťŲŋŘŴŷĮ—a _Ł­»GśŢŝųœŲŴŚ
ůőŴêùøýëŏńŝĖĻ"®
…ĝČĢĮ¨¢­Į
GŠŁ
{ğĽěīŁ ®īĝĤčěľĴĪĭČeĎ
įŭŠŤř»# ùøý ė—a _ī ,Ò®ĭ¿-ğĽ
ěīŁ Ēĥĝȗa _ĮŐŒŚńŴ>ĮpLĭd
ĝĩĒĽčĢěĪ
6ČŤř»>ŁĜĻĭĸē ĨQ
ĝĤőŤř»# ùøý Ł#I-dĝČĢĮ#I®aī
¨¢­—aĭĨĒĩ‰ÎĝĤčè
ďw•ī¿†ĐŤř»>ĮÃq‹Xīĝĩ òìôíăĆúíùøý
ī òìöíăĆúíùøý Į ò ´âĮ­»GŁ#I-dĝČŐ
ŴťŲŋŘŴ¨¢­—aœLŁÌħĤčĢĮ¿†Č
òìôíăĆúíùøý įE ; ùøý ĭ$uğĽ­—aŁ²
ğěīė{ĻĖīĬħĤč wČòìöíăĆúíùøý įŘňŵ
ű>ıĮ)`aėæĒĭĸĖĖŀĻĠE ;Į òðé³
WĮ­—aĝĖ²ĜĬĒ ėĖħĩĘĤčĝĖĝČ
ĒĠľĮ#-¢ĸŘňŵű>ī¿-ĝŋųŭŤŇłŁ
YdĝĤ@-Č#I­!¥ĭSį¨ĞĬĒěīĸ±
ÏĪĘĤčĢěĪČòìôíăĆúíùøý ī òìöíăĆúíùøý ĮJ
LŠÓĮÖĒėČŋųŭŤŇłYd|Į—a _Į¶
#IĭZáğĽěīėÅĔĻľĤčğĬŀĦȗa;
ī —a;ŋųŭŤŇłĪįȗa _Į¶#Iė
ÒĝĩĒĽĮĪįĬĒĖīĒē ĨĮÐŁ¶ĩĽě
īėĪĘĤč
- 42 -
um{ ' *b7\^ F
hf{tk|5_@ ),
SWT
ZP83O[@/B[;JR >R
}N6IR *76=~R
A-9
A-11
Z-A2E 1[0J+" 2,3[ MH 4[
<. 1R }1 #NI[2 # SVBL[3
#ND$[ 4 K&~
è šéR›¤EþĄåӎ eÃH…þêĐĶĩń
T#*Z㛤ĔÁûýëĐæñă*ZþĄåƒ
w
¿ïá¥Î`šĂT#óåòĎÔôùģ
łĸŅĜłİėĮěŅĔ–ëù‰¬ã‰¬¯-S]ï
,·þêĐæiĂ^çĄåĸĿėŁłĂ‚Ñ6Ĕa
ü 1 ĂGóýåĶĩńT#Ĕ6 ÿõĐġĞńĴħ
Ņăgùā-]…Ĕ70óù 1)æ 2åòĎĂ9B·6
%òđùġĞńĴħŅă¥X*ZĆÿIÔõĐñÿ
Ĕ šÿóùæ
èh…íčą¯ÄéėŁłĂ‚Ñ6Ĕaü 2 ĂGó
ýåĸĿėŁłėłĠŇł 1 þnÍ%óù*ZsĔÍ
–óåġĞńĴħŅ-]ĔyÂóùæėĥĨŁĬĔƒw
¿ÿóùĶĩńT#*ZĔÁëå”ôùģłĸŅĜ
łİėĮěŅÿĚĺĝġĬĂčĐʱšā“%*Zï
ËÁóå÷ă¯v9B·6%òđùġĞńĴħŅ 3, 4 Ĕ
-]õĐñÿĂ]"óùæĉùåX ²¯mzÉ uĂč
ďåġĞńĴħŅ 3 ă G¥%@Ĕ„Cóùæ
òĎĂå*Z|ză lĔ šÿóýåsyn, anti ăĚĺ
ĝġĬĔaü6Ĕ÷đøđ-]óý.{ă*ZĔÁ
ûùăþåöý70õĐæ
TMS
OTBS
PhMe2Si
O
1(R=CH2OH)
2(R=OH)
MeLi•LiBr
dĂVëåcK þ@†[āĚĺĝġėłĠŇł Ĕ]óå2 ķŅĢłÇåSharpless
eĢIJĬńĝġł%åÑ
’ĂčГ%åėĥīĮĬÇĔÁë bis-THF “Ïă-]
ĔÁûùæ‘3åbis-THF “ÏîĎėŁłĚģĩłÒ Õ
Ĕ-]óå2 ıŀĢęĽĔ =ÿóù¥Î`šā THP “
S]*ZăyÂĔÁûýëĐæ
1. Fall, D.; Duval, R. A.; Gleye, C.; Laurens, A.; Hocquemiller, R. J.
Nat. Prod. 2004, 67, 1041-1043.
2. Hoye, T. R.; Ye, Z. J. Am. Chem. Soc. 1996, 118, 1801-1802.
H
PhMe2Si
PhO2S H
3
OTBS
OH
+
PhO2S
šé
İŅŃĘġŸėĥīğĮŅĄå‹Lņ ‹L•ăİŅŃĘġŸ
xŒčď&Ùòđå‘3ĉþĂ 400 ¢ ă%-Œï&Ùò
đýëĐ攌†[Ą_º åÀāĀNPë†[ï70ò
đýíďå†[™‘ăľĜĮĤĽă 1 üÿóýļīĠŅĬŁėÚ
>Ì«ă complexäĔQ!Ă×FõĐñÿï70òđýë
Đær›¤ă š%-ŒþêĐ chamuvarinin Ąå2004 OĂ
İŅŃĘġŸxŒ Uvaria chamae čď&ÙņzɄCòđùg
ėĥīğĮŅþêĐæ 1 VtăėĥīğĮŅþĄăāëå
¯5 THP-bis-THF “zÉĔoõĐñÿïYþêďå÷ă
G¥Ð³íčą°G¥Ð³Ą lþêĐær›¤þ
Ąåchamuvarinin ă-]®ăœ¥ĔÁìÿĂå°GzÉ
ă„CĔÁìñÿĔ šÿóùæ
èh…ÿ¯vé
OH
OH
R
è
TMS
TMS
PhO2S
r|zdh=cjngp| chamuvarinin _
,:?
OTBS
H
OSiMe2Ph
4
1)J¾å⠝Ïâ ¡â jrȽ%@ 2006 O:ň £Øâ
3A04a01 p.173.â â ߗ~Ýåâ A¥kªå⠝Ïâ ¡â jrȽ%
@ 2007 O:ň £Øâ 3A26a03 p.251.
A-10
r|zdh=cjngp| pyranicin _,
:?
1
Z9
[0J+" 2,3[ MH 4[(
G 3[ <. 1,3}1 #NI[2 #
SVBL[3
#ND$[4
K&
~
è šé‹Lņ ‹L4hÔ\õĐİŅŃĘġŸxŒ
îϔ•òđĐİŅŃĘġŸėĥīğĮŅÜĄå_º
Č­¶€[āĀÛMĂP¨ā”Œ†[ï70òđý
ëĐ%-Œ´þêĐæĉùå÷đĎă†[™‘ľĜĮĤ
Ľă üÿóýåļīĠŅĬŁėÚ>Ì«ă complex I
ăQ!ā×Fï70òđýëĐæ jĉþ{çā THF
5ėĥīğĮŅþåñă complex I ×F†[
àïÁ
ēđåzɆ[ ÖïlĎîĂòđýëĐæóîóå
THP 5ėĥīğĮŅþĄqúĂ÷ă70ïāëæ÷ñ
þ 2åTHP 5ėĥīğĮŅă ¢þêĐ pyranicin ă
THP “ÏĔ Pd(II)
=Ĕ–ëù¥Î`šā“%
*ZĂčďz©óåpyranicin ă-]ĔÁëåTHP 5
ėĥīğĮŅþĄqúĂÁēđýëāë complex I ×
F†[
àĔÁìñÿĔ šÿóùæ
èh…ÿ¯véAcrolain )ą laurylmagnesium bromide
Ĕ™ŒÿóåSharplessâ eĢIJĬńĝġł%*Z
¦Ĕ®ý“%*ZÞÿāĐėŁłĚģĩłĔWùæ
WĎđùėŁłĚģĩłĂGó Pd(II)
=Ĕ–ëù¥
Î`šā THP “S]*ZĔÁëåpĊ¥Ĕoõ
Đ 2,6-ġģÿ÷ăĢėģĩŃěĻŇþêĐ 2,6-īŀŅģ
Ĕ 93 : 7 ÿëì¼;ā¥Î`[þWĐñÿĂ]"ó
ùæ UåcK þ pyranicin ă-]ĔÌ]óåWĎ
đù pyranicin Ĕ–ëý complex I ×F†[
àĔÁ
ì CþêĐæ
A-12
XU]a` YUvivqxlyoskz|UR
VUeyw|L_,R
R
Z41Q%[8 ![ C[
} JR *765J~
è šéĥŁŅ/ģŃěĮŅĵńĩĘŅĸģijĖħŇĦ 2C
ʼnPP2CŊĄ­¶Ă?3õĐ
āĵńĩĘŅĸģijĖ
ħŇĦ(PP)ăŋ¢þêďå¸ÆČģīŃģZ§¦Ă
Ö óýëĐæPP2C Ąo$ā×F ă70ïĈÿ
ĕĀŠðå
ă PP Áćý¿’@šėĵńŇĨĂčĐ
›¤ïËĕþëāëæ÷ñþ
r›¤þĄå2003 OĂĸģ
COOH
ij Ė ħŇĦ× F ÿó ý7
0òđù 7-ĸģĸįľĨłĭ
ijħŃŅ-1-ĜłĹŅÑ(1)ă
PO3H2
-]Ĕ(µĂ 6-ĸģĸį
ľĨ łĭij ħŃŅ-1- ĜłĹ
2
ŅÑʼn2Ŋíčą 1 ă%@]ĔÁûù 1)æ
èh…éīłĚŅÿ -ĴĨńŀĞīŅĔ™'fÿóýå6ľĨł- -ĩīŀńŅʼn3Ŋíčą 7-ľĨł- -ĩīŀńŅ(4)
Ĕ-]óùUå1 ĔĮīŁł%õĐÿĂ 2å3å4 ă
‚¬Ĕ¹ÙòöýĭijħŃŅ“ĔS]óåĮīŁł6Ĕ
ėłĜŁ#‚ ĂčûýĜłĹŅÑĂóùæ}Ăå6
íčą 7 ăľĨł6Ĕ»¬%óýîĎĜłĹŅÑĔ
t-Bu 6þÇóùU廬ĔĢĚīĝġŁŅÑ6Ă³b
óùæ8ÑĔ–ëý¹ÇĔÁëå2 íčą 1 Ĕ-]ó
ùæ
è¯védĔ(µĂ 4 ă-]DàĔ<ċùÿñĒå7
0ÿĄ˜āď 3 ï ”]ŒÿóýWĎđå3 íčą 4 ă
+Ą÷đøđ 60ňå15ňÿāûù 2)æ4 îĎ 1 Ćă]ĂVëå3 îĎ 2 Ĕ-]óùæ÷ă¯vå2 Ĕ/ċ 5
üăg %-ŒĔWĐñÿïtùæ1 ă NMR ĪŇħ
čďi7ă 1 Ą‡-ŒþêĐñÿïž1òđùæ
1) K. Swireczek et al., J. Med. Chem., 46, 3703 (2003).
2) M. Pal et al., Indian J. Chem., 42B, 593 (2003).
- 43 -
Ld0Y^f{on|yDb
P
A-13
Øcyٍ„
õń-ĩĽBX˼Ń
Ń Ć¹øÕ:%Ġč
ħĻò*Væé¼:%„ń
ń õçìÖäăõ-”ĬĥĹĘ
Ņ õFÛìÖRĀăìŅ
Ņ Ć¿
ľĆ*Væé¼ĬĥĹĘĥŅ
>ƊÛì?ĊĻıľ6ĎġĮĺľĒõÿāˆæ
éìòäĄÕŽòèĂĉľğĝŀĻ®Fà 31ʼn62Ł
ö+†ñRĀăìÖ
X
SOCl2
OH
X=I, Br
X
R
HN
H2N-NH-R
NH
Cl
O
1
A-15
W 'XE#<&X
2=}N
O .-84:8~
؎ÙĉľğĝŀĻ®F÷Õ[àć"Õ[ņŇň"Õ
[Üï"ôóÕ'©3Íö½ôunòôĂ,¦
WàÍÛes%.„¤öŃïñÚĂÖçßçêö.Y
y÷ÕÍôīĹĘĊijĆçìāÕ<tÄþ)çÛ*
ViĆUòèĂôóÕĕęĤÇþ”×ö®F.
Yõ¸çðÛôÛ9.ý<ÛÖêäñh•÷ÕB
ô¿>ƊÛì?ĊĻıľ6ĎġĮĺľĒ*V
ĆÀ*VõÕ~2ôi՚ßïm²WöÚĂ.
YyöÃĆªôÛÕêăƊÛìbĉľğĝŀĻ
®Fö.YĆªôÜäòõçìÖ
X
(/+pvyqx{b4:
O
O
2
3
R
CuI (20 mol%)
L-proline (40 mol%)
dry DMSO
K2CO3
rt-70, 3 h
N
NH
O
indazole
Ø lÙ¿>ƊÛĂ?ĊĻıľ6 C-N ĎġĮĺ
ľĒ*VõÿāÕĉľğĝŀĻ®Föšô.Yy
ĆÍñáìÖ*V÷ÕĸĊ%„ÿāý*VWàÛ§
%„ĆŠÛì9.õÞÛðýÕD~ñµþßõ·ªç
ìÖPըˈõr×ô£`7àFæăìńłĩ
ĽĎĻİľ¼ò”×öĬĥĹĘľöžû.ąéõÿø
Šö]=Õ>ö}%ÕRĀăìĉľğĝŀĻ
ßĀöæĀôĂ®F%Չ‡zWöp¬ôóöGÃ
àfúăĂÖ
Ô
؎ÙChartelline AÕBÕC ÷&{õoXèĂĕēijė
Chartella papyracea ÿā(ÆæăìĉľĥŀĻĈĻĎĽ
ĉĥñÚĂÖh%.„÷ÍJõĩĽĔľ%æăìĉľĥ
ļħľ spiro--ĹđĞijòĉIJğĝŀĻà 10 4ˆĆçð
¢àîì=;ķħŀđôq¶Ć^îðÛĂր¥Ā÷ä
ăúñõ chartelline ö spiro--ĹđĞij»öq™yĆ
—çðáìÖh•ñ÷ chartelline C ö.Yõ/
ãðÕspiro--ĹđĞij!ÌòôĂ 12 4ˆĹđĞijö.
YĆp¬çìÖÎ
Î
Øcyò lÙÐÑ 4ˆĹđĞijö ÏĬĥĽĐėČĦIJĥ»
ĆčĐėijö–òĎĻİľ¼òö¡.ˆ%*Võ
ÿîð.YèÌƗðìÖçßçÕäöÿÜôMKö
¡.*V÷81àùòćóôÛìü՚(ôĵģĻ
7
ƊÛÕ*VöÍòd¸%ĆªîìÖĭċħĻĈ
ĚĤĈĻģĬĥ‹jöčĐėijĆĵģĻ7
òçðŠ
ÛÕzWČęĢĻƊæéðÕčĐėij–ñö¡
.*Và±äĂßƐ­çìÖèĂòčĐėijĆĈĚĠ
ĻđĽĺĥòĘđĽĽĴĞľñ$ƒèĂògOçì´āö
¡.*Và±äāÕ ÏĬĥĽĐėČĦIJĥàRĀăìÖú
ìäö*V÷¼đĽĺĥõĉľĥŀĻÕčĐėijõĉ
IJğĝŀĻĆêăëă^ï9.ñý·ªèĂäòà
ßîìÖ
QRVUST f{t|yaZY_;el
pz{[7]>HaM]c4:P
A-14
A-16
W K?XX6IP 9
P P (OP .F)
؎٠1991 IÕLarock Ā÷īĹĘĊij>@5ÕoĸŀĥĈħĺľò»ĈĚĠļľßĀ_õ 2,3-
£`
ĉľĥŀĻĆ.YèĂcyĆ81çìÖäö*Vñ÷Ĉ
ĚĠļľö£`7öÜíÕÿāßæÍÛcàĉľĥ
ŀĻńõFæăĂÖQjöVŠñ÷ÕßæÍÛė
ĺĻœö£`7Ć^ïĈĚĠļľĆŠÛð£¹\W
Ć SçðÛĂýöàùòćóñÚîìÖêäñÕÿā
Åô£`7ƊÛì9.ö£¹\WõïÛðp¬
èĂäòòçìÖ
Øcyò lÙ ßæÍâÕßïÅô£`7òçð›Ć
ŠÛĂäòòçÕ-C-ĒĻĕėĻĈĚĠļľÕ -C-ıľ
ĨėĻĈĚĠļľĆêăëă¯«çìÖĸŀĥĈħĺľ÷
ĈIJĨ7à‚°öýöò Ts 7ñ°æăìýöƊ
ÛÕêăëăƞû.ąéð£¹\WĆp¬çìÖ
êö lՂ°öĸŀĥĈħĺľòıľĨėĻĈĚĠ
ļľòö*Vñ÷ÕÍÛ¹\WñıľĨŀęàĉľĥŀ
ĻńõFæăìÖcÕTs %æăìĸŀĥĈħĺľò
ń”ö›ĈĚĠļľòö*Vñ÷Õêăëă›»à
ĉľĥŀĻńõFæăì%.„à‰Y„òçð
RĀăìàÕêö¹\W÷ßîìÖ
ö lÿā՛ĈĚĠļľà’裹\W÷›
ö”Éõ@èĂäòàąßîìÖæĀõÕĸŀĥĈħĺ
ľö°7ࣹ\WõNÈĆÝðÛĂäòàą
ßîìÖ
"J1XX6IP 9}
O.F~
wtjhgyb%mqisik{b$G
5Cd3`\^ury+b
4:
W*B 1X 2X2K 2,3X
)A 2,3 1X6IP 9 1 P
(1 O.FP 2 ,4P 3 !O@)
؎ÙÎ ěĢĐĤĐėľ(ZTX)÷ĶĥđďČĻ Atelopus
zeteki ÿā(ÆæăìL#ô“ŸvñÚāÕêöq¶÷
2004 IõHĀöĒĻŀĮõÿîð NMRÕMS ęįđ
ĤĻĆÌçðxCæăì 1ÖÎ çßçkõŠÛĀăì
ĖľĮĻ÷åâT¾ñÚîììüՀ¥Ā÷õ’
è ZTX ö 2 ĿZö»q¶õïÛðEVèĂĵģ
Ļ%.„Ć.YçÕêöq¶Ć­èĂäòòçìÖ
Ò10 4ˆõ0úăĂ N-ĈėĻĉĜčĐĖĝĺľq¶
ÓĒĈħĘľÁö N-ĬĥĽĐėĎĻĪĴŀĤq¶
Øcyò lÙÎ N-ĈėĻĉĜčĐĖĝĺľöĵģĻ%.
„÷a…³öcy 2 õÿîðFßăĂ
ˆW%.„
öÊ2 .Ć Adams >õÿĂw|$*Võ
ÿāºçð.YçìÖÎ .YçìĵģĻ%.„ö 13C
NMR ĆCçìòäĄÕĎĻİħĻö%AėĭĤ
÷¾?%A˜õÿîðæăìýöÿāý‘9
ėĭĤçðÛìÖÎ úì N-ĬĥĽĐėĎĻĪĴŀĤöĵģ
Ļ%.„ö.Y•ïÛðý81èĂÖ
1
2
- 44 -
Yamashita, M. et al. PNAS 2004, 101, 4346.
Blanchard, N. et al. Org. Lett. 2007, 9, 1485.
€Šƒ~jF<?@&ikonqu
†qˆ|uqˆj
)
f!# Yg%> Zg3= [g
A-17
HC'N ZP[O ‹"O Y 08
M5:vˆxŠgZ (85:8g[
1G5:8Œ
ªj«€uÕąîâÕñąÇ§Œċvċœ€Ô"¸
ўf€uÁ¬Ð§;”fÄÃÆo©Æd^T~
Ô>¿9·À*²Ä›Ô>¿¨·°·§ÕąîâÕ
ñąÆ`jÄ9CXǧJ½mq·À¯Ï¹§
ÁÍÕâĂÕąîâÕñąÆ9dz±Ä­¨
$:©Ç§ÕâĂõĀùòćÓt°ÏÕąîâÕ
ñąÉÆ(?ÅÎÑ 3 Æ9Ԑ9·¼ ¤¢¨¡
ªCX«ĆªxO«¡ õĄĄßĂâòćĂ°Ïˆ2·¼Õåî
õÙòąˆ2ŧÕåîñîāĂ\,ÁøąãĂß
ĂáâĂ×ûíćîÔf­À§ßĂáâĂ7ԃ
­§1 Ô ‘<jÅ6¼¨¶Ïŧ1  2 Ô EDCI ÁÚ
äìĂ·¼5§Baker-Venkataraman 7ÅÎÐc
·À C cÔQr·¼¨6ÏÒ¼“tõĀùòćĂÔ§
'Vu£ýèòćĂÁ Zn-Hg Ôf¶ºÀ’¸Ñ
µÂÅÎЧŒv€Æóćøð4€uÁ¬Ñ 3 ÆG
Æ9Ԑ9·¼¨¡ ¡
¡
¡
¡
¡
¡
¡
¡
¡
¡
1) Tetrahedron Lett. 2007, 48, 6005-6009.
UQ{stuz|‡}|tuˆj)5:O
A-18
f;.gB+O g%g6
IO 9‹L1GŒ
ªj«õßU·ÀkÏÒÑìîĄïîÝâąĈTTXĉÅ
ǧ)@Æ+z±-%·À­Ñ¨µÒϝz
ǧTTX Æd9ŸÊ¼ÇŠe^Â|®ÏÒÀ
­Ñ±§»ÆDmÄ=Çn¶ÒÀ­Ä­¨»µÁ]}
ÏǧTTX Æd9wʼNJwÔD¸Ñ¼
̧TTX ÅG͎­+zÆĊ¿Á¬Ñ 5-íÛÝ
â TTX ÆS‹Ô.9¸ÑµÂÅ·¼¨
ªCXÂxO«Ê¹ 5-íÛÝâ TTX ½´Áij§Æ
TTX zÍ`jÅ9¸ÑµÂ±Á²Ñ˜
ÔöĄþăùßĂáåòąÂ×ç÷ăòćÈ2Æ
Diels-Alder 7°Ï*•Å9¸ÑhÔqÀ¼¨
¡ Diels-Alder 7ÆãÚąÁ¬Ñ×ç÷ăòćĂƉ…
ř·À§×ç÷ăąÛÝâïƗcÔA_Æ LDA
°Ï LiHMDS Å(F¸ÑµÂÁ§`Ô ¶º¼¨–
7Æ Diels-Alder 7ů­ÀǧãÞĄĄýèąÁ
BF3 ¥OEt2 Ôf¶ºÑµÂÁ§ ­{‘<8Â`
ÁIËcÔ6¼¨¶ÏÅ Overman ÅÎÑ
Õûò&Æ2ÔwÀ§˜Ô 100 g äàćĂÁ
9¸ÑµÂÅ9·¼¨
¡ a%§µÆ˜°Ï 5-íÛÝâ TTX ÆS‹Æ
9Å ´ÀP†Á¬Ñ¨
w‚… r yu „4, XSRRVS i m n
W]e^_ba_]OY`_abc]ce_\Yd]T jK O
B-1
fD/g$3g1 7#g3
*g3/gAN‹JL‰
1E‰101g1 phlk2-Œ
ªj«Methionine aminopeptidase2(MetAP2)Çèąô
Þ
Æ N KýêÛñąÔB¸Ñ÷ĄìÕćæÆ
oÁ¬Ð§N-ûāäî×ĂÄÃR©ÄdbjT~ř
¸Ñ¨ÜĂâØüxèąôÞ
Á¬Ñ S100A1 Ç
MetAP2 ÆY8Ԛ0¸ÑµÂ±n#¶ÒÀ­Ñ¨Ll
pÁǧæöĀõÖëâÿgNÆ MetAP2§S100A1 Ôs
…·§MetAP2 ÆY8¯ÎÈ S100A1 ƚ0Y8Ô/
•jÅ[/¸ÑµÂÔj·¼¨
ªCXÂxO« æö Āõ Öëâÿ ° ÏÞ Ąćñąß· ¼
MetAP2 Ô*‚Áia¶º§ÕõÖñìÖćÞĄúîß
ĀõÖć§×Ûą?ÞĄúîßĀõÖćÅÎÐs…·¼¨
µÒÔf­À methionin p-nitroanilide (Met-pNA)Ô&
·À§Tris-HCl y„Z pH7.5§ 37¦ÆM
ÁĊE
˜7¶º 405nm Æ!3ÅÎÐY8Ô·¼Âµ
Ó§Y8ÔH¸ÑµÂ±m‡¶Ò¼¨Km Ç 0.24mM ÂW
ÌÏÒ¼¨
CÁ§*‚Áia¶ºs…·¼æöĀõÖëâÿg
N GST-S100A1 Ôf­À GST ÷ĂéØąÕëå×ԃ
¾¼ÂµÓ§MetAP2  S100A1 ±x¸ÑµÂ±m‡¶
Ò¼¨S100A1 Ô-¶ºÀ MetAP2 ÆY8[/ԃ
­§MetAP2 Å1¸Ñ S100A1 ƚ0Y8Ô[/·¼Â
µÓ§S100A1 ± MetAP2 Å1·ÀY8Ԛ0¸ÑµÂ
±n¶Ò¼¨Ki ǯλ 0.1mM ÂWÌÏÒ¼¨
Cloning, Expression and Biochemical
Characterization of Novel
Dihydrolipoamide Dehydrogenase Gene
from Clostridium kluyveri
fSaikat Chakraborty, Hiroshi Nonaka*,
B-2
Masayuki Inui*, Hideaki Yukawa*,
Makiko Sakka, TetsuyaKimura, and
Kazuo Sakka (Grad. Sch. Bioresources,
Mie Univ., *RITE)
D ih y d r o lip o a m id e
d eh y d r o g en as e
o f t en
ter m ed a s “D i ap h o r a se ” f o r i t s ch ar a c te r i st i c
f lav in m o ie ty an d N A D H o x id as e ac t iv i t y.
D ih y d r o lip o a mid e d eh y d r o g en as e catalyzes the
oxidation
of dihydrolipoamide: dihydrolipoamide +
NAD+ -> lipoamide + NADH + H+. In case of bacteria
and eucarya, this enzyme normally functions as an
integral component of the pyruvate, 2-oxoglutarate, and
branched chain 2-oxoacid dehydrogenase multienzyme
complex or the glycine cleavage system. A novel
1368-bp Clostridium kluyveri gene codes for ~ 50 kDa
protein was cloned and over expressed in E.coli system
and further biochemical and spectral studies were sought
to investigate its identity. The recombinant protein
showed very strong dihydrolipoamide dehydrogenase
and diaphorase activity. Non-covalantly attached FAD
was released at boiling temperature and quantified
(7.2M). UV-visible absorption spectra showed two
peaks at 453nm and 270nm and the ratio of A280/450 =
4.98. Although the optimum temperature was 40ºC at pH
7.0, the protein showed some stability as high as 70ºC
and 6.0-9.0 pH range. Fluorescent spectral study
revealed the formation of NADH in forward reaction in
presence of reduced lipoamide, in turn confirmed
dihydrolipoamide dehydrogenase activity. Unlike other
anaerobic bacterial dihydrolipoamide dehydrogenase
enzyme, this enzyme had specificity to only NADH as
coenzyme, where NADPH did not react at all.
- 45 -
q E3 z{tx eOc
Œ™®±¥¯šq
B-3
Ċ—ċńœűĩ äĽŎœŮŇŮʼnŊŨűáëûöïéöâĒ
ăåãæ ŇŭʼnŋŘ«-ĘĞ<¢ÜģČĵ涒ħJLĔ
@3ĘĢčĶĈńœűĺęĶńœřųŏħġčĢı
<ĔĨŽ‰đĴ–ėķĢĐĵćĜĨĽŨŜÑÏĨË
čđĴć¢"~ЧšļŨŭųĨ åç Ĥ åèáëìåç Ĥ
ëìåèâħÜėķĢčĶĈTŽ‰ ëìåç ńœřųŏĩ
ĄòāõÿĀþôĀøà ôÿÿúÿĀø÷à öôĀôûĂÿúÿąĤčĎ7Ĩ¿#ĺ+ĕ
Ģ"~ĺ>ĘĢčĶĖĤĒjĴđħėķĢēĞĈ
ĤĖĸĒćTŽ‰ ëìåç ńœřųŏĤ}ÄĘĢćTŽ‰
ëìåè ńœřųŏĨ)VzxħØęĶX8ĩĭĤĻĥ
SĴķĢēĢčĦđĠĞĈà
à
p™ģĩćëìåè ńœřųŏĨ)Vzxĺję
ĶĞİħć
‘q ëìåè ńœřųŏ
Ì?ĨņŰųŚűŇĤ©įlďЧĨ=ԖŒ¤
嚞ęĶĈà
à
Ċg€Ĥ«sċÆKćyĉĦ HĨňŜũÏĒ
rėķĞĨģćĜķĴĨÏħ@3ĘĞ ëìåè Ì?
Ŵ åèŵĨaBĽŨŜÑÏĺ(±ħĘĢ@Û5ĺʼn
ųŘĘĞ®ÒţŬĿŧųĺ
ĘĞĈ
ĘĞ®ÒţŬ
ĿŧųĤ ĨňŜũĺÖ4ħčĢć
åè Ì?fĺ ðêñ €ħijĵ:JĘĞĈSĴķĞ
åè Ì ? f Ĩ 9 7 Ï ĺ 7 ħ Ę Ģ ć
óéíîáóùøþüôûàôÿĂüüøĀþúöàúýĀøþûôöø÷àâäðêñ €ĺčĢ
à åè Ì?×Ĩ97ÏĺBĘĞĈŒ3ćà åè
Ì?Ĩ©įlďЧĺSĶĞİħć=´ºĺD
ĤĘĞ=ԖŒ¤ĺx ĘĢčĶĈà
B-4
B-5
2\‚]S‚!2*
²K# C>^Bd‚
*
`L87°nPL³
Ċ—ċ
H+-ŠŰťōšļőųŏ (H+-PPase) ĩć'ŦŭŤţœ
ŘđĴZĵć7ŠŰŭűÑ (PPi) ĨxÉı'¦ģ
Č
ĶĈPPi "~ĤĜķħPĘĞ H +ĨÅÇħġčĢ
+
¨Ħ%zxĺjęĶĎďģćķĞ H ŦűţĨ
ūŖŮ?Ĥ±ďĴķĶĈp™ģĩćd­º‘qĨ
H+-PPase (ScPP) ĺ ĘЬ°—Ħ;“rħij
ĠĢćH+-PPase z³ĨĎğćŠħć˜ĨGĦč H+Å
ÇĐijĪŁśŮŅųPħØĹĶĽŨŜÑ|7Ĩ.B
ĺ`ĘĞĈ
Ċg€ċ
17 2µÃÈÛ5ĺ_ğ 794 |7đĴZĶ ScPP Ĩ×
ĺ 4 !Ęć,Û5ħġčĢŬűŒũ;“FŬĿŢŬ
ŭųĺÀĘĞĈĜĨĎğć7«-Î
ĺ/İĞßM
@Û5ĺ_ġ 2 ġĨŬĿŢŬŭųÛ5 (183ź586)
ħġčĢć‚WĐijĪP$‹ĺ›ę;“
ĺōņŭųŚűŇĘĞĈėĴħćÎ
Š“—;“F
ħijĶrı¾čć‚WIJP$‹īĨOÚđĴćz
³|7ĺ.BĘĞĈ
Ċ«sċ
ŬűŒũ;“ĨIđĴć7«-Î
ĺ_ġ¨²
Ůųţ e ĺcďĶµÃÈŘŪĿű TM5 ĒŠħÒ
ģČĶĖĤĒ›ėķĞĈėĴħć7«-Î
ÆħŁ
śŮŅųPħØĹĶ|7Ē
¯ęĶĖĤĒ ›ėķ
ĞĈ2 ġİĨßM@Û5ħĐčĢĩćTM12 ħP
$‹ĒięĶőĿţĨ;“ĒĠĢ@3ĘĞĈĮ
ĞćŮųŪűŮųţĨz³Øı›1ėķĞĈ¬°
—rħijĵćĨĽŨŜÑ|7Ĩz³ĨįĦĴĚć
,ŘŪĿűĨz³ħġčĢa…ģēĶ«sĒSĴķĞĈ
¤¬›E3¡®œ¤±žŒU
Z‹’I?
)²K#³‚XY²
g³‚,[M&²K#³‚D
²K#6³‚i10F²g³
Ċ—ċœŰŋřųŏŴEC 1.14.18.1ŵĩćūŜšŀŜųŮ
ĺ~Ñ&ĘĢ o-ŌšŀŜųŮĺŽZĘćėĴħ o-ŌšŀŜ
ųŮĺÑ&ĘĢ o-ńŜűĺŽZęĶ)Vĺ>ęĶÐ
§ģćuՂWUĺıġĈřŪʼn?CĨœŰŋř
ųŏÌ?ĩ 625 ĽŨŜÑ|7ĺʼnųŘĘĢčĶĒć?
CđĴ¡ÀĘĞœŰŋřųŏĩŸo 238 ĽŨŜÑ
|7Ēĵ*ĴķĢčĞĈĖĨŸo|7ĨP!ĺ
jĴđħęĶ—ģćœŰŋřųŏÌ?(TYR67)Ĥć
Ÿo 238 |7ĺ{ĔÌ?(TYR42)ĺ=´ºģ–
ŒėěĞĈ
Ċg€ċĜķĝķĨÌ?ĩćŹoħœłůŘńŋ
űĤ His őŇĺ_ġ½-őűŞņŴTrxŲTYR67ćTrxŲ
TYR42ŵĤĘĢ–ŒėěćSDS-PAGE Qħć^ His őŇ
^ČĶčĩ^œŰŋřųŏ^ŴIgGŵĺčĞ•
t¸ĤœŬŨűĺ7ĤĘĞ‚Wt¸ħijĵwĘĞĈ
Ċ«sċ TrxŲTYR67 Ĥ TrxŲTYR42 ĩćĜķĝķ 85
kDa Ĥ 60 kDa ĨőűŞņĤĘĢ–ŒėķĞĈčĚķı
œŰŋřųŏ‚Wĺ_ĞĦđĠĞĒćÕĿłűĺƒ"Ę
Ģ=´ºĺ6ÝęĶĤćTrxŲTYR67 ģĩ‚Wĺ›ęij
Ď ħ Ħ Ġ Ğ Ĉ Trx Ų TYR67 ĺ ˆ ; W  ě Ě ħ
SDS-PAGE ħđĕĶĤć‚Wĩć85 kDa Ĩ
¯ħ%
ėķĶőűŞņģĩĦĔć66 kDa ĨőűŞņħw
ėķĞĈĖĨ 66 kDa ĨŝűŘĩćˆ;WĘĞ TrxŲ
TYR67 Ĩ SDS-PAGE ģ ĩ Á İ Ĵ ķ Ħ đ Ġ Ğ Ĉ
SDS-PAGE Ĩ%
¯ĩć?CĨœŰŋřųŏĤ
6ݺ£ĨœŰŋřųŏģĩćˆ;WĨn‡ħij
ĵ;&ĘĦđĠĞĈRĠĢ斌ĘĞ TrxŲTYR67 ĨĎ
ğćʼnűŞņŗĦxÉĺNZĘĢčĶıĨĒ‚WĺıġĤ
›1ėķĶĈ
{rs¨®ª©” ±žŒ8TJ-m
‹„†’G5‹‘‡ˆ
{r _b„–¦­˜±+‹k“’
•«§f:q
 ' h  … Ž ‚ < ‚ " 9Qq
²l°C`³
B-6
Ÿ£¢E3 y|}~€z{stw —¡¤±žŒ
Wo/•«§f:‹‰ƒŠ
[p$ t´ E t´6q ;
u
´Rj* u´%V4N u ´D(% v´
=q .²t aH°`´u A@°`´v 4
°`³
Ċ—ċmÆć[ĉĩŐŕŔ»đĴņŬōĆħHęĶ
Family GH-18 ńœřųŏ(CrChiA)ĺ'ÙĘćĜĨxÉ
Ĥ)VŠWĺjĴđħĘĞĈpЧĩv‰ńœřųŏ
ĤĘĢĩİĚĴĘĔć¢œ)Vĺ>ĘćĜĨxÉĤ
z³ħ·0ĒıĞķĢčĶĈgćĽŨŜÑÏħĐč
Ģ CrChiA ĤnYĦ.W(¥ 35%)ĺıġşŗńŗŗŭł
ŋŒųŏĩĜĨ>Î
ÆħčĔġđĨ¹ÞhĽŨ
ŜÑ|7Ē@3ĘĢĐĵćĖķĴĩ CrChiA ħĐčĢı
@ėķĢčĶĈp™ģĩćCrChiA Ĩ‚WÎ
ħ@
3ęĶ¹ÞhĽŨŜÑ|7ĨÒWĺjĴđħęĶĖĤ
ĺ—ĤĘćĜķĴĨ¹ÞhĽŨŜÑ|7ĨĎğ
Trp197ćPhe166 ĺ Ala ħ¯bĘĞ;“ŴW197Ać
F166AŵĺZĘć;“ħĎxÉĤz³Ĩ;&ĺÂĬ
ĞĈ
Ċg€ċӎ4Ĥ;“4Чĺ=´ºĨ–Œ¤ģŽ
Ęć”~WņŰŧŗŇŬšľųĐijĪňنÊħijĠĢ¡
ÀĘĞĈĖķĴĨЧĤ(GlcNAc)n (n=3-6)ĺ)Vėěć
ĜĨŽZ‰ĺ TSK-gel G2000PW ĐijĪ Amide-80 ŃŬ
ũĺčĞ HPLC ħijĠĢrĘćӎ4Ĥ;“ģ
ĨŽZ‰©ZĨËčĺÂĬĞĈĮĞć¸We
ŴCDŵħijĠĢˆABWĺÂĬĞĈ
Ċ«sċӎ4ĤġĨ;“ŴW197AćF166Aŵģ)
VĨªk;&ĺ}ÄĘĞĤĖĸć;“ħijĠĢ‚WĒ
„GĘćĮĞ¢œ)V‚WĒ¼ĘĔ]ďĴķĢčĞĈ
ĮĞćŽZ‰ĨĽŜŧų4ĺrĘĞĤĖĸć;“ģ
ĩӎ4ħ}ĬĢćfŸ\ĒÍoīœ%Ę
ĢĐĵć Trp197ćPhe166 ĩŶŷŊĿŗģĨ¢|7ĤĨ
«-ħØĘĢčĶĖĤĒĹđĠĞĈĮĞć;“ħijĠ
ĢˆABWı„GĘĢĐĵćĖķĴĨĽŨŜÑ|7ĩx
ÉĨAB&ħıEĘĢčĶĖĤĒđĠĞĈ
- 46 -
hjG7,-1,3-1,4-bi_fld[
138
B-7
B-9
WF+! 1, . 1, 6E'
1
, * 2, 2# 1 m1 K9kJ, 2
SA<n
âãńʼn° Synechocystis PCC6803 ŒjāĠņĜIJ
Ŋĩ(SsGlc)Ă C gĀ Family GH-9 ĀMòďD
ıłĘʼný N gĀúāĨņňŊħ£+ıłĘʼnē
-ĉÑDÔ8ēeðûåďàîĐćüā’™ĀČĎß
hƟĂ-1,3-1,4-ĠņĜIJŊĩüäĎß-1,4 £+ā
Äü_ïĐďîýêbčéĀïĐûåďàðéðßh
Ɵā:£+ğŇĹİāþāÄü-1,3 £+ê
¶¹ïĐûåď é Ă bčé ü Ă ÿåàh’™ü Ă ß
SsGlc è Č ă Ñ D Ô 8 ē t ^ ï ô ÷ @  ŋSsGlcCBDŌē‹åûß-1,3 £+ý-1,4 £+ā—á
āÅéčÿďĠņĢĥņěŅģœē:ýðû&Xē
³åß y„Zē·ą÷à
â`zãSsGlc èČă SsGlcCBD Ă pET3a ē‹å E.coli
Origami(DE3)pLysS āŽ‡žĀČùûT÷àŽ‡ð÷
SßDEAE ĜńŁē‹åß0.2Mŏ0.4M ā NaCl āĠńĦ
ęʼnİĀČϛ´ð÷à-1,3 £+ý-1,4 £+ā—áā
ÅéčÿďĠņĢĥņěŅģœē:ýðûßdÂi
üƟ&Xē³åßõā&X‰[ƒē ICS-3000
ē‹å÷ HPAEC-PAD zĀČùûkð÷à
â £ l ã , q ā £ + ¢ [ é č ÿ ď œ ß Glc-1,3
Glc-1,4Glc (G3G4G)ý Glc-1,4Glc-1,3Glc (G4G3G)
ĂbčéĀÿď¦ĀïĐ HPAEC-PAD zĂß
îāČæÿ£+ÒPāÿďěŅģœāÏĀÂðûå
ďîýêĒéù÷àSsGlc ý SsGlcCBD Ă`ýċĀß
G4G4G4G3G ý G3G4G4G4G øíē yð÷à
G4G4G4G3G Ă G4G ý G4G3G äďåĂ G4G4G ý G3G
ĀïĐßG3G4G4GŎG Ă G3G4G4G ý G Āï
Đ÷àČĎ:ā-1,3 £+ĂßhƟā:£+
ğŇĹİāDVéčÏĐ÷¦ü¶¹ïĐďċāý
YĒĐ÷à
âã łĬňİňŊĹ¡®ēłĪĵŊņē‚Ÿýðû
9Öð÷<+ßłĪĵŊņ©yŸÆŸ (MDH) ēŽ
Ɵýð÷0.ÌÐEÁžêŽ‡ïĐďîýê‘č
ĐûèĎßPQQ Ɵüäď MDH Āúåûۏÿ
’™êLÍïĐûë÷à`ß­{Oā4?ČĎ$Ïï
Đ ÷ ł Ĭ ň İ ň Ŋ Ĺ ¡ ® ü ä ď Methylobacterium
extorquens No. 19 mēłĪĵŊņ-e96ü9Öð÷
£lßîĐćüĀ;/êÿåĖņįķıÇ#ÃƟ
ÿčăĀĞÇ©yŸÆŸêŽ‡ïĐûåďîýē”¶
ð÷àh’™üĂßM. extorquens No. 19 mŒjĞÇ©
yŸÆŸē›´ðßhƟā„Z
ē³ù÷à
â`z%ă£l㠛´r1ýðûTčĐ÷ĞÇ©yŸ
ƟĂßÐE(Jýðû NAD+ øíüÿì PES+ ÿ
þā
NÐE(JĀċ!†ªìÐE–"ē³ù÷à
ć÷ßÐEā:„ZĂØìßĞÇAā
ĜņľʼnÇĀKðûĂs¨ðÿéù÷àhƟĂ
SDS-PAGE ýġņđÀğňĿİĠńĹėŊā£lČĎß
()2 āļĮňěğĪĿŊāĤĺŃijĭİp¾ēeòď
îýêbčéýÿù÷à*ĤĺŃijĭİā¡ÿE
ÉĀúåûĂßMALDITOF MS ĀČďkē³ù÷à
hƟ}éčÄUÿ A).'ħĽğİņê
ïĐßĹńĸʼnÿčăĀ˓ÙğńħĪŊāF5ê
•2ïĐ÷à‡5ßhƟĀF5òďÊMĘěʼnýe
sĢĹĕğĪŊā,Iē³æý,cĀßhƟD&X
ā&X½QĶńłŊĪŊĀúåûnµē³ùûåďà
Bacillus circulans KA-304 7,V
Family19 `efld[/LZ0BV
B-8
Methylobacterium extorquens 7,aP
C1@O@[?HY]\3 V
V
W6 =X:Q $XU) X
D X>) R
m>Tk4nV
B-10
W:QV $X*V (XDV XV
>)V Rm>TV 4Nn
Achromobacter xylosoxidans 7,^gj
C1@O@[PM&
-V
V
W6IXKF 1 X:Q$XU)X
>)RXD
m>T 4NX 1 ";5%<S%cn
Ú
âãBacillus circulans KA-304 ê‰[òďĝĬIJŊ
ĩ I ý -1,3-ĠņĜIJŊĩĂßSchizophyllum commune
āĻňİĻńħ݉[ĀWÓüäďŋ1ŌàĝĬIJŊĩ I ā
C gÔ8ĂßĠŅĢĥīŊĩ Family19 7āDıłĘ
ʼn ý Ø å , Z ē • ò à ` ß N g Ô 8 Ă ß B.
circulans WL-12 ĝĬIJŊĩ A āŅʼnĜŊıłĘʼnýĒó
éĀÕðûåďêßõās¨Ăbüäďŋ2Ōàh;
üĂßĝĬIJŊĩ Û āp¾ýs¨ēkð÷àÚ
Ú
â ` zã ĝ Ĭ IJ Ŋ ĩ I ā N g Ô 8 t C @  ŋCatCHIŌē´ð÷àć÷ßĝĬIJŊĩ I ā N gÔ
8ý¥«±ĪʼnĶğŋGFPŌê²+ð÷ĝłńĪʼnĶ
ğŋNtermCHI-GFPŌċ·´ð÷à
Ú
â£lã ĝĬIJŊĩ I ý*@ÆŸā¸Zēwºðß
ā£lēT÷à Ü ĝĬIJŊĩ I ĂßĢňĘīņĝ
ĬʼnĀKðûßØå£+|Zē•ð÷êßCatCHI ĂĆ
ýĔþĢňĘīņĝĬʼnĀ£+ðÿéù÷à Ý
NtermCHI-GFP ĂßĢňĘīņĝĬʼnĀ£+ð÷àîā
£lĂßĝĬIJŊĩ I ā N gÔ8êßĝĬʼn£+Ā
ÎĒďîýē•2ðûåďàÚ ÞÚ NtermCHI-GFP ā
S. commune ®Ąā£+|Zē·ą÷à
Ú
ŋ1ŌÈčßBiosci. Biotechnol. Biochem., 68, 1299-1305, 2004
ŋ2ŌÈčßBiosci. Biotechnol. Biochem. 69, 602-609, 2005
âã Achromobacter xylosoxidans ꉊòďĖŀʼn©yŸÆŸ
(AmDH) Ăß|ZVĀİŅĻİĹĕʼnİŅĻİĹėņĝĵʼn (TTQ) Ģ
ĹĕğĪŊēeòďý§çčĐûåďàTTQ ƟýðûĂßłĬņĖŀʼn
©yŸÆŸ (MADH)߬×aĖŀʼn©yŸÆŸ (AADH) Āúå
û›ÿ’™êLÍïĐûåďêßõĐčā TTQ Ɵýwºð÷
<+ßAmDH Ăß(1) *ĤĺŃijĭİā N-gĖŀĵÇÅā,Z
êÿåß(2) =:ZĪʼnĶğüäďß(3) E…ÇŸĀKðûoĊ
ûHIüäďßýåù÷„Uēeð ûåďàõîüßh’™üĂß
AmDH āĢĹĕğĪŊāÇ#Ã]"ēVĀßGäďåĂ
Ðx#G\zē‹åû„Z
ē³æýĀßAmDH ā3up¾
ĀČďÇ#Ã]"ā·šĀúåûnµð÷à
â`zã f@Z AmDH }ß%ăßĠĖijĦʼn@ZS$Ïð÷
AmDH āĢĹĕğĪŊ-eĤĺŃijĭİŋ ĤĺŃijĭİŌāĈā}ē
‹åōĢĹĕğĪŊāÇ#Ã]"ĀúåûßÐEÁłįėĚŊĪ
Ŋē‹å÷ĜńŁÐzĀČĎkē³ù÷àžāÐēĥĹİ
ïôďîýĀČĎ TTQ „eā.'ħĽğİņ@#ēð÷à
â£lã f@Z AmDH %ă ĤĺŃijĭİĀúåûߞāÐĀK
òďĢĹĕğĪŊā UV-vis .'ħĽğİņ@#ēkð÷£lß2 Ð
EÇ#Ã&XĀKòďĴņʼnħİRĀĹėĭİðßr€Ç#ÃÐ
êõĐöĐß+0.15 Vß+0.11 V vs NHE üäďý˜ċďîýêüë
÷àAmDH ā|ZVĀF5òď TTQ Ăßā TTQ ƟāõĐČ
Ďċr€Ç#ÃÐêvĀĥĹİðûå÷à`ßĜņľijņ
¯üäďĹęijņķıńĦʼnēf@Z AmDH }Ā~ ð÷<+ß~
ÉĀXñ÷¿¤ÿ UV-vis .'ħĽğİņ@#êïĐßĹę
ijņķıńĦʼnê)¼ĀĢĹĕğĪŊĀ£+ðûåďqEê
ïĐ÷àðéðßTčĐ÷ħĽğİņ@#Ă MADH ē‹å÷<+āċ
āýĂBëìÿĎßĢĹĕğĪŊ»āˆ>êBëìÿďîýê•
2ïĐ÷à
- 47 -
)3BCOA|{wk|ls
v€}j‚oh*M,DQ
B-11
c7$… dE;… d#
†
d+%W 0… d&7 …ƒ …SK
U5<d†SK 5<„
ðñ­¼ċĘěvŒ­³:Ččí­¼÷vŒ
ċJÿě™(Zėµ”Zğ¡ÿĈČqY¨Č
ąĈòěîûĜęY¨yxČ­ğmęöċÿěĂĕí
vŒ­³:ČċÛĞěÒ¬±ČxËĉy´ċÛ
ÿěs÷ÔĈòěîûĜēĈċívŒ­³:<«
ňŅĻħňĩĴŌĹō(RG) –I ČċÛĞěu»¼Č
ÏBĩňĮİŏğ0FýíRG-I Øğÿě RG ʼn
Ġŏį YesW Čy´*ϦxËğmęöċýćø
Ăîrž¥ĈčíRG ʼnĠŏįČ+Yyxğmęöċÿ
ěĂĕíYesW ȃZÐğx\ÿěĠńĻÓ|8Č0
Fğ¿ĄĂî
ðkñSPring-8 ČeKğ–óćíYesW ĉĠĹŌĪ
8(ħňĩĴŌĹō 2 «)ĉČ/Č¯oDĶŏİ
ğ,ÞýíĀȦxËğ€FýĂî¦xËöę
A+Yĉ8ÂÆċÛĞěĠńĻÓ|8ğbFýíĀĜ
ęČЍ˜;˜ČÊSŝsğ¿ĄĂî
ð¯tñ/ČxËċąóćí2.5 Å ´ēĈČĶ
ŏİğ,Þý R = 16.6 %ēĈªI'ýĂîĠĹŌĪ8
číYesW Č -ĿŌŀňxËČ>ċ°ÿěĩŋľķ
ċ¯/ýćóĂî8ĉ–ÿěĠńĻÓ|8ċą
óć;˜ğÀýíÊSÅļňņŏİŏğ€FýĂĉ
ûĝíLys-535 *Ď Arg-452 ÷8ČĦŊłĨĬŊ8Č
ÂÆċÔĈòěûĉ÷męöċĊĄĂîƒZÐÈ
ċ°ÿěĦŊĬģŅĢĥōČÑċÔĊĠńĻÓ
|8ċõúě;˜číĀȃZ÷ã½ċ†MýĂû
ĉöęíĦŊĬģŅĢĥō÷ƒZċXâĈòěûĉ÷¡
4üĜĂîNírž¥čg¢İŏīijķİōļĩž¥
ĿŌĪňŅȒĉýć¿ĞĜĂî
N=4"jvmRi6ef Zm
~pz~u|€nyxrq‚ohG
H,*h$
B-12
c W V?dTW >d@W 1
W ƒ9„
ðñê -ĪŊİńŊķňōĮŀĿIJıŏįê (GGT) č
ĪŊİIJĥōê (-L-Glu-L-Cys-Gly) ėĪŊİIJĥō&
/ğ8ĉýí -ĪŊİńŊ¯/ğiÿěÒ¬Ĉ
òěîûĜēĈċí]ïč GGT ğ+YyxCċ
ÜGÿěÍ£Ž[ĠĹŌĪÜG"íĪŊİńōÓ -Ł
ĮŁōÓĭĤĮĵŊÃLğٛýírÒ¬ċJÿě
–ğÄĐćøĂîrž¥Ĉčí8ĪŊİIJĥōČ
ĬĮĵĢōØČxËõĘϦ'Dċ‚ýíjĂ
ĊÜG"ğ
ýí GGT Č8ÂÆyxČ­ğ
męöċÿěûĉğĉýĂîê
ðkñê Cys-Gly ċJYýĂxËğpÿěÜG" 1–3
ğ¦Î^ċ/\ýĂîûĜęÜG"ȃZğ=¶
¼ GGT ğ–óćýĂîê
ð¯tñê Øğ_ĂĊóÜG" 1 ĉ L ĠńĻÓxËğ
ĖąÜG" 2 čTóÜGƒZğ¡ýĂ÷í D ĠńĻÓ
xËğ_ąÜG" 3 Ĉčí
COO
O
ƒZ ÷½ý ù ýĂ ûĉö
O
H N
P
N
CO
ęí GGT čĬĮ ĵĢ ōÐ
H
O O
Ȧ'Dğ)IċÂÆÿě
Ph
ûĉ÷ĞöĄĂîēĂíÜG"
1
2, 3 číʼnō(BȦ'
COO
O
Dċ8ĆùĀĜāĜ¤Č¦
O S
H N
P
N
CO
˜Zċßÿěûĉ÷Ĉ
H
O O
øĂîkȘZċčÜG
Ph
ƒZ÷òĚíkċčÜGƒ
2
Z÷Ċóûĉöęíʼnō(B
COO
O
O R
ȍFČ¦Ñ°÷í GGT
H N
P
N
CO
H
ȃZWĉČ+YċXâĈ
O O
Ph
òěûĉ÷ĞöĄĂî
3
2
3
2
3
2
B-13
[^a L
OAg ^^]a L
OA
h2!h-JW
c(%IdW /dƒ
SKU5<„W
ê
ðñÉÒ¬ő RTŒčíB”ŒDž¥ė·
RiċõóćX.zĊÒ¬Ĉòěî+Y%í
²‹ZíČ{ Zĉóôöęíķʼnç躐š
ģĢŊĮőAMV RTŒĉŇŌĺŏŃģĮœ¾™ģĢŊĮ
őMMLV RTŒ÷Ęù–üĜćóě÷í+Y%ė²
‹ZČd¹÷ĕęĜćóěîrž¥ĈčíAMV RT
ĉ MMLV RT Č+YÊSȇSCZí‹EFZíõ
ĘĎ×6ĿňĢŃŏőTPŒČ‹EFZċJÿě%tċ
ą ó ć } Ç w Á ý Ă î ð k  ñ TP ĉ ý ć
poly(rA)•p(dT)12-18 ğ– ó Ă î É + Y č í 5 nM
RTí25 ëMê TP őŠSč p(dT)12-18 ČŇŊc©Œí0.4
mM [3H]dTTP Ĉ¿óí®nċ+Y„ğa-ýíÓ
‰Z—ďČeK´Č-ĔöęÊSğĕĂî
‹EFZčí100 nM RT ğ 28 ëM TP C5òěó
čàC5ċí40œ55ìĈFnڋ‘ğ¿ĄĂ
Vċí37ìĈÉ+Yğ¿ĄĂîð¯tñ+Y¸Ì‡
SčíAMV RT ÷ 48œ52ìíMMLV RT ÷ 42œ46ì
ĈòĄĂîAMV RT Č T50ő10 Úȋ‘ċĘ̃Z
÷ 50Őċÿě‡SŒčíTP àC5Ĉč 47ìí
TP C5Ĉč 52ìĈòĄĂîMMLV RT Č T50 číTP
àC5Ĉč 44ìíTP C5Ĉč 47ìĈòĄĂî
Č¯töęíAMV RT č MMLV RT ĘĚĖ‹EFZ
÷éùíTP ċĘ̋EFZ÷ĘĚ1ÿěûĉ÷¡üĜ
Ăî‹#DsČ¯tíAMV RT õĘĎ MMLV RT
ȋ?ƒċčí‹?ƒČƒZ'ĤōķŌĽŏČH÷
=øóûĉ÷¡üĜĂîê
B-14
!Px
tj ‚oX\b_`YhOA8! h
'W
c:Fd+7.d (
SKU5<)
ê
ðñBacillus ȕ”ÿě¤ïČZ
ÖĿŌĵĠŏ
įčä3$P§ċQù –üĜćóěîĀĜęČôăĈ
@‹ZŎ@9ZÒ¬ thermolysin (TLN)č$~Č
É+YċĘĚŀĿIJĸ/\+YğAýíP“2h
ĠĮļŊĵŏŅČ!æ/\ċ –üĜćóěîrž
¥Ĉč TLN ĉéó0Zğ_ą B. amyloliquefaciens
ZÕOĿŌĵĠŏį(BaNP)ČÒ¬'DZğw
ÁýíTLN ĉ}ÇýĂî
ðkñ ŸE—íÝĢ ĥ ōcĩ ŌŃķĪňľ ġŏí
Affinity ĩŌŃķĪňľġŏċĘĚ B. amyloliquefaciens Č
7å„öę BaNP ğªÀýĂîFA-Gly-L-Leu amide ğ
8ĉýćÒ¬ƒZğˆFýíÒ¬ƒZċJÿě‡
SípH ČUáĉ NaCl ȅ$%tğÄĐĂî
ð¯tñBaNP Č 25ìċõúěÒ¬ƒZ (kcat/Km)č
TLN ĉ}Đěĉ 25%ĉóĖČČíNaCl ċĘĄćƒZ
÷`fÛfċlýí4 M NaCl C5Ĉč 13 ċ
ƒZ'ýĂîĀȃZ'Sč TLN ĉ0§ĈòĄĂîē
ĂíBaNP Č¸Ì‡Sč 55ìí30 ڋ‘ċĘĚ
50%?ƒÿě‡S T50 č 65ìĈòĚíTLN ċ}Đć
10ìóî¸Ì pH č 6.5 ĈòĚíkcat/Km Č pH CZ
ĘĚ pKe1 č 4.9ípKe2 č 8.0 ĉĕęĜĂîûĜęč TLN
ĉđĒ0þĈòĄĂîûČûĉöęíBaNP ȃZß8
č Glu ēĂč Zn(H2O)õĘĎ His Ĉòě.´Z÷éóî
3
- 48 -
k~xyfl|b9&P
cbE!
ade9&cb3Y
B-15
^KR6W$Y ;
UO}XBI€
ò ¤ ó į Ŕ Ō Ŏ ģ İ Œ (TLN) Đ ® [ L – ¿
Bacillus thermoproteolyticus ú¿GϜĂĜL–
ddÛŃőķģĻŔijĊôĜřw¥ªĊĐ؊d
ď pH Ndú×dĎİłĹĀ؊dú4ĀąF = TLN Ġ/bĂĜþċĠ¤ċĀĉõĜřğĝğĝĐþ
ĝĔĊĎ؊dÔĎ¹ĂĜ Asn112 Ġ Asp Ď¹n
ĂĜþċĎęě؊dĐĂĜúŘ×dď pKa ú 5.3
ùĚ 5.7 ĎF-ĂĜþċĠA6Āąř9؊dÔĎ
¹ĂĜďġʼnĽ×‚@Ġ¾ãdġʼnĽ×‚@øęđ
Ala Ď¹nĀ؊dĒď,zĠÉēąřòpˆó-ĒŏĶ
ī IJ (Asn159-Ala180) Ď ¹ Ă Ĝ Ile168 ŘSer169 Ř
Asp170 øęđŠdÔÝáď C vĺŋģŒďå
>Ď¹ĂĜ Tyr157ŘVal230ŘSer234 Ġ AspŘGluŘ
HisŘLysŘArgŘAla Ď¹nĀąře=Õ&ċŃőÕ&
Ġ!£šÿăĜþċĎęěI¼¿ĊF = TLN Ġœ
ĀŘ?èùĚ°ÆĀąřF = TLN ď FA-Gly-Leu
amide (FAGLA) ø ę đ Z-Asp-Phe methyl ester
(ZDFM) *„$ŠdĠ’PĀąřò µzóIle168 Ř
Ser169ŘAsp170 ďF = TLN17 ©ďöĆŘ14 ©úĨ
ijģŒøęđ FAGLA *„$ŠdĠŒKĀŘ3 ©
(I168A Ř I168H Ř S169A) ú þ ĝ Ě ď Š d Ġ u Ā ą ř
Tyr157ŘVal230ŘSer234 ďF = TLN18 ©ďöĆŘ12
©úĨijģŒ*„$ŠdĠuĀŘĄďöĆ 3 ©
(V230RŘS234AŘS234E) ďĕú FAGLA *„$Šd
ĠuĀąřI168A ď FAGLA øęđ ZDFM *„$Š
dúٜ= TLN ď 2 Ď4ĀąřòºTó-ĒŏĶī
IJ (Asn159-Ala180) úŠdĎØ
Ċôě؊dÔ
Ýáď C vĺŋģŒďå>ú@ÇËĎØ
Ċô
Ĝþċú¦ÿĝąřIle168 ďÜĐÖ²$M"ÔĠ4
õĉõĜřIle168 Ġ Ala Ď¹nĂĜþċĎęěŘþďå>
ďS[úĀ؊dcÐď{Ídú4Ā؊
dú4Āąċº÷ĚĝĜř
B-16
B-17
ïXï;
ŖIàϜ眧ŗ
ò¤óMMP-7 ď kcat/Km ď pH NdĐYďZõńŐ
=s·Ġ¦Āï×dď pKe ú 4.0ïC@dď pKe ú
9.8 ĊôĜþċùĚïŠdâ@Đ×dú Glu198 Ĕą
ĐÛՄïC@dú Tyr219 ċº÷Ěĝąðfñ
Đ MMP-7 ďĵőİŒ‚@ďļĹő-ċԘ ¤F ĎęěïC@dŠdâ@Đ Tyr219 ĊčõþċĠ¦
ĀïMMP-7 ϵ2Āą„$Mď0»dĠkoĀąŚŗ ð
9ï–)O¤yċԘ ¤F ĎęěïMMP-7
ďŠdâ@ĠmPĀąð
òpˆóI¼¿ŸxŏĮŒŀĻŒĹĿĹ MMP-7 ĎęĜÂ
@ MOCAc-PLGL(Dpa)AR *„$ŠdŖkcat/Kmŗď
pH NdĠ 15ï25ï35ï45íĊ’PĀąðvan’t Hoff
plot ŖpKe ď‘[F-ŗù̊dâ@ďŃőĹŒâ
ĎöĥŒĴŐŁŔF-ŖHoŗĠ…Ėąð
òµzóHo Đ×dú-20.6 kJ/molïC@dú 89.9
kJ/mol ĊôćąðġʼnĽ×ĘıŅŃĵĺďâ–ďA6
ċďƒÎĎęěï×dŠdâ@Đ COOH Ċô
ěïGlu198 ĊôĜċº÷ĚĝąðpïC@dŠd
â@Đ NH3+ ĔąĐ (NH2)2+ ċº÷ĚĝąúïŠdÔ
ĎĐ Lys ĔąĐ Arg úN<ĀčõðĄþĊïMMP-7
ċĿĺőĪįŊ×ď2ď¬ÑŖ1MMQŗùĚïC
@dŠdâ@ďÅċĀĉïAla162 ďÜď«
².MĎÕĀą„$Mċ Pro217 ďÜďײ.M
ĎÕĀą„$MωĀąðF =Ö² E198A ď
ŠdЌKĀïA162G øęđ P217G ď kcat/Km Đٜ
=Ö²ď 50ŕôĜõĐ 70%ϐVĀąðA162G ďC
@d pKe Đ 10.3 Ċïٜ=Ö²ęě 0.6 ëùćąð
òµÊóMMP-7 ďŠdâ@Đï×dú Glu198ïC
@dú Ala162 ĎÕĀą„$MċmPÿĝĜð
1. Y. Muta et al., Biochem. J. 386, 263 (2005)
hqi|`trvrzpjmwo{u{qf
s~n 7MMP-7€bCbL
> ade2
^._$;_
UO}XBI€
ò¤
MMP-7 ĐI¼čČĊÒ(£šúÇĖĚĝĉõĜňĹ
ŏĶīIJŋĴőŃőķģĻŔijĊôěïď¨ċ‹”Ď
UĂĜÞú¦8ÿĝĉõĜðfñĐþĝĔĊĎï10
©æď¶½ĨķĪŒæď MMP-7 ĎUĂĜßR,zĠ
Éēï(-)-epicatechin-3-gallateŖECGŗútė^õßR
ŠdŖKi Ŝ0.47μMŗĠuĀïßR€\Đäjh=Ċô
ĜþċĠA6Āą 1ó ð9ïĨķĪŒď˜dĠk
ċĀĉïECG ċ MMP-7 ď
žĠyĀąð
òpˆó
ĿĹe= MMP-7Ŗ$MÚ 19,000ŗĠI¼¿ĊģŒī
ŐŔıōŒņĸĢŔċĀĉ£šÿăï0“-`ŏłĦŔ
ŐĸĢŒĬÿăąð
òµzó
ECGŖ$MÚ 442ŗĠ 325 nm Ċ+ÌĂĜċ 398 nm Ď~
IĠėĈÂIJŅīĹŐúœāąðECG ď 398 nm ďÂ
^[ŖFI398ŗĐĥĴĽŔՕ[ďqĎęě·¤Ď
E*Āï20ŕĥĴĽŔŐN<ĊĐäN<ď 1.4 ĎÓĀąðĔąï1 μM ECG ď FI398 Đï1 μM MMP-7 N
<ĊĐäN<ďB2ċƒēĉ 12ŕE*Āąðþď
ċû MMP-7 ϵ2ĀĉõĜ ECG ĐïECG ď MMP-7
ĎUĂĜ Ki ęěï51ŕċ¯ÿĝąðĀąúćĉïĂē
ĉď ECG ú MMP-7 ϵ2ĂĜċïECG ď FI398 Đ
MMP-7 äN<ċƒēĉ 24ŕE*ĂĜėďċº÷Ě
ĝĜðþĝĐï12.4ŕĥĴĽŔŐN<Ċď ECG ď
FI398 ďE*™Ď_ĂĜðĂčğĆïMMP-7 ĎøýĜ
ECG µ2ÔĐÈ㙠62 ď¡„d›DĊôĜþċú
¦8ÿĝąð
1řH. Oneda et al., J. Biochem. 133, 571Ŗ2003ŗ
trvrzpjmwo{u{qfs~n [
\\]Z[€b9&Vb* Y
C-1
O@bQfg|Qfg|
0SM4`Qfg|=@
b)JY
^'F1:#D+?",
(GTN$58H<8A/
-7P%CB@P€
ò¤óì çĎ5ĔĝĜ×ģħŒĐŘ"Ċ
×ģħŒċčěŘ×ģħŒĐĩŒĘ±W¢Ġ]ûÌ
þĂċõğĝĉõĜřĀùĀčúĚŘfú:ĎøõĉÙ
Àď5u×CÚĎÞĂĜ'ĐčõðÙÀď×
ģħŒ5ÚÉ|ĠÃöċ!ĎŘ×Ġ-ĂĜ—
Ġl³ĂĜþċĠ¤ċĀąř
òpˆóì ÙÀď×ģħŒŘ×ģħŒď$yĐ
Ĝ鈉 2000 Ďaćąřç7e$ďi#ĐŘ
1įŒŃŐĠĄďĔĔŘôĜõĐ´%`؆ê„ôĜõ
ĐĥĴĽŔŐĎęěi#ؕ¸Ā؄ôĜõĐŋĴĽŔŐ
ϓ`Řא-Šd’PéĎĀąř
א-Šdď’PĐŘì 100M דċŇŏ
łĤĽŔŐĘÙÀi#—Ġ®ÚŽ2ŘPÚĠÃõ؂
NÚĠŕĊ¦Āąř
òµzóì IJŔľŔňŔĭĶĹĊgĎ ĜÙÀď×
øęđ×ģħŒ•[Ġ’PĀąċþĞŘ}ÀæĊĐ
ŝ2,100 mg/kg FWŘzÀæĊĐŝ1,280 mg/kg FW Ċ
ôćąďσēĉŘÁÀæĊĐŝ7,000 mg/kg FW ė5
ĔĝĉøěŘÁÀæĎ×øęđ×ģħŒúHü
5ĔĝĉõĜþċúrĚùċčćąřĄďIÔ$Đ×
ģħŒĊŘ×ģħŒ•[ĐŘ5mg/kg FW Ċô
ćąřĔąŘJ—Ÿxďi#—ùĚא-Š
dĠl³ĂĜĎôąćĉŘĂĊĎø½e$úužĊô
ĜþċúrĚùĎčćĉõĜďĊŘø½°Æ7Ġž
õŘא-ŠdĠ’PĀąřĄďµzŘġIJĮŐ
ŀŒ×Đ 71.4ŕĎŘø½ďŇŏłĤĽŔŐś©ďB2
ĐŘ90.992.7ŕϐVĀąřš<ŘJ—Ÿxi#
—ĎĈõĉ3€ďQéĠøþčćĉŘ×ģħŒĠ
VÿăĜ—Ġl³ĊôĜř
- 49 -
>THb‚…|XhFo
C-2
Okz|-/{}Vn
€Ž„‘ qrto so p |Yj8QB
.|1
C-4
w e 4 = Z – I ' x ~ – W ) # < –o
5!`o ”( ’^ a•
ć¤ĈÇùŐŭŚŇĨ[ðļŤŘßĢĉķũŌŭųřũ
ŭųŬľŋŭĦNĻĢĊķĕģĎĵøU#žďwįĸķŴ
oĢÇùĨà®ĥļūŪņůĺ_ÔĘķó²{ĢIJ
ĉķŴz§¬ĢĨÇùħøU#žĦÓĘķĝıĦ
ļūŪʼnŭĢĉķ Fag e 1 ĦųçLŦľŨůŖ.\ĺžĊ
ġH°õėųH°õď Fag e 1 ħ!KËíƒÀĦ
-ĮĘXîĦĠĊġÎėĝŴ
ćo‹ĈFag e 1 ģ 20kDa ħļŨŜŘńŨŇŐŭűAGŲųįĝ
Ĩ 1.4kDa ħŅŋŬňŪŃŭűXGŲħ‘3ĺµ
ėųZĵĸĝ¯yĺ 60ÿųRH65ŰĢ 1 ×ãŖŨľśůœ
ĽŭňĘķĕģĦĴğġH°õėĝŴŊľŎièŇŬţ
ŕňŨŝĽůĦĴĶH°õĖĸĝIJħģxõħIJħĺ
!ëėųH°õĖĸĝ Fag e 1 ħļūŪņů]ų–
]-Ī*]ĦĠĊġÑĬĝŴļūŪņů]Ĩ 6 ħ
ÇùļūŪņů^¼ħȒĺžĊųŖŒŕŞŬŒœĽŭň
‹ģ ELISA ĦĴğġÑĬĝŴ
ćµĈŖŒŕŞŬŒœĽŭňħµųH°õĦĴğġ
Fag e 1 ħļūŪņů]ďÆėĒėġĊķĕģďÏı
ĵĸĝŴĕħĕģĨ ELISA ĦĴğġųAG õĢĨ 3.6Ź
10.9ŰųXG õĢĨ 1.9Ź10.7ŰįĢ“SėġĊķĕģ
ď¨ÏĖĸĝŴo 50mMPBSűŸH7.0ŲĢħ Fag e 1
ħ–
]ĨųH°õĦĴğġŹ3.5 ĦE(ėġĊķ
ĕģďsĵĎĦĖĸĝŴ*]IJÆėĒm;ĖĸĝŴ
*Œ]ĨųAG õĢĨTÒħ*'ħ 59.9ŰųXG
õĢĨ 39.7ŰĦįĢE(ėĝŴħĕģĎĵųH°
áĺžĊĝçLŦľŨůŖ.\ĦĴķH°õĨ Fag e
1 ħļūŪʼnŭħ“*ĺ5İ!KËíƒÀš]ħm
;ĺÐQėųó9²{ģėġħø(*ĺIJĝĵ
Ę1À]ď©:ĖĸĝŴ
uCo v*%o Kv3aPmv]d0
— –U4Sv7'_v”ci
E\v—o ”6•:[•
[¤]ü ÃĦĨœŒºa¡ħäĦ)ħĉķƒÀ
]™ďHĒ5įĸķĕģď¦ĵĸġĊķďĂ³¿FĦ
ĴĶ*6/ďJĔĵĸġĊķădĄĨ ļŤŘÝß
űGABAŲ圝ĘķßÅ Lactobacillus brevis ĺžĊ
ġÃĺ£ÞĖĚĂGABA ĺø5vĘķÃ£ÞŁŅ
ōĺZĝăzŁŅōĨ GABA Ħ(ČġÃÂÕďhĠ
‚ĄĥƒÀĺvėġĊķģ»ČĵĸķăěĕĢ=Ăz
ŁŅōħƒÀ]ĺsĵĎĦĘķ¤ĢĂøÈ?£
¢ŨŒŕűSHRŲħÈ?ĦPĘķ XîĦĠĊġÎė
ĝă
[o‹Ůµ]ü įę 9 ×úħ SHR/IzmĂê]ŨŒŕĂ1
¹ 7 +ĺö*ėĝăÃ£ÞŁŅōĺ,=´0f
ėĂìȤÈ?̸ĺžĊġ SHR ħÈ?ĺ´t¤
Ħ•LėĝģĕĹØUű2 mg/kg of bodyŲĢñÆĥ
æ?)ďÏıĵĸĝă„ĦĂ5 ×úħ SHR/IzmĂê
]ŨŒŕű1 ¹ 7 +Ųĺ¯yôn SP Ħġŵ×ãô½ėĝ
YĂÃ£ÞŁŅōĺ‘3ėĝônĺ 35 qãČĂÈ
?ĺ´q¤Ħ•LėĝģĕĹĂzŁŅōĺ 0.003%f
ėĝ¹Ģv`ĥÈ?re$žďÏıĵĸĝăô½
YĂ
&Ħġ2Á<ĺl ėĂļŭŌłœŭŋŭ I
GjÞ²űACEŲħŒ]ĺ•LėĝģĕĹĂ¾čĴĪÈ
’ħ ACE Œ]ĦĠĊġv`ĥďÏıĵĸĝăĖĵ
ĦĂuøÈ?ď 190 mmHg ĺ©Ę 36 ×ûħ
SHR/Izm ĦPėġ4‚ħkó÷ĺÉğĝģĕĹĂŁ
Ņōf¹ĦĠĊġv`ĥÈ?æģ¾ħ ACE Œ]
ďÏıĵĸĝă
ħĕģĎĵĂzŁŅōĨÈ?æžĺ©Ęc!
ģėġĂGABA Ħ(ČġĵĎħ ACE åM™ĺ5Ļ
ĢĊķĕģď©:Ėĸĝă
C-3
‡‘‹‘.ŒˆŠ|F{fy
JM
ƒŽ‰‘|Œ‰€“†9{}
A,|2
C-5
u":Rv'?v
”
i^’lEL•
ć¤ĈRùňŪœŭ (S) ħşŬœļůŏ (E) ĦĴķ
(ˆ!
Ħčēķ–
UħrĦĠĊġÎėĝă
ćo‹ĈĀ2«şŬœļůŏħ‡Öŷ S ĺ 37ÿĢ pH
8.0 ħũ ŭß Na ·Ê  Ħ b —ė ĂŎ Ş ő ũ ŋ ŭ
űSUBŲĂŊůŧŨľŋŭűTLNŲĂŝĽŋŭĂŕũşŋŭĂ
þŅŧŕũşŋŭĦĴĶ!
ėĝű[S]=1.0 mg/mlĂ[E]=27
units/mlĂ1 unit ĨŃŏľŭ(ˆ!
Ģŵ!ãĦĂß1
–] !ĦőŬŋŭ 1 μg ĦWĘķ A275 ĺČķŒ
]Ųă āpH čĴĪ”UħXîŷ S ĺĂ(i) 37ÿĢ pH
6.0Ź8.0 ħũŭß Na ·ÊĂ9.0Ă10.0 ħšĿß Na ·
ʐĦĂűiiŲ37Ź60ÿĢ pH 8.0 ħũŭß Na ·Ê
Ħb—ėĝă¶ĊġĂpH čĴĪ”UĺĞĂSUBĂ
TLN ĦĴĶ!
ėĝű[S]=1.0 mg/mlĂ[E]=27 units/mlŲăü
ćµĈĀS ħ–
UĨĂ.\%Ĩ 50 μg/ml Ģĉğĝ
ďĂE ĦĴķ!
Ģ´t¤ĦEIėĂ60 !ãħ.\Ģ
ĭĮuIűSUBĂTLN Ģ 350 μg/mlĂŝĽŋŭĂŕũş
ŋŭĂþŅŧŕũşŋŭĢ 200-250 μg/mlŲĦÙėĝă!
تĺÚ|ħ SDS-PAGE ĢOėĝģĕĹĂ
.\%ħ S Ħ5įĸķ 30 kDa ħc!űňũļŌŭĂ
ňŪœŗŭŲĨĂŶ!ãħ.\Ģ 14 kDa Ħ!
ė
ĝăĕħĕģĨĂňŪœŭħ–
ĦĨH…éħ!
ď[
Ģĉķĕģĺ©:ĘķăāS ħ–
UĨĂpH 10.0 Ģ
uIJIĐĎğĝű50 μg/mlŲďĂSUB įĝĨ TLN ĦĴķ
!
ĦĴĶ pH 8.0 ĢuIJIĐĒrėĝăįĝĂS ħ–
UĨĂ37Ź60ÿĢĭĮLĢĉğĝďĂSUB ĦĴķ
!
ĢĨ 45ÿĢĂTLN ĦĴķ!
ĢĨ 50ÿĢuIJIĐ
ĒrėĂuIĨģIJĦ 400 μg/ml Ģĉğĝă
u;<v&G@vN$
”g+i EDL •
ć¤Ĉü ŐŭŗŭĨŐŭŚŇģħ6¥‰†žijÞ
²īħ6¥åMžĺhĠĕģď¦ĵĸġčĶĂW§
¬ňŪůşĢĨĕĸįĢĦ±ÄŸ}Őŭŗŭģŕũşŋ
ŭģħžĦĠĊġÎėġĐĝăěħµĂC
A]ļŤŘßijěħŠşőŖģ±ÄŸ}ŐŭŗŭģďV
Ċ8]ĺhĠĕģĺ ėĂpĦB7ėġĐĝăĕĸ
ĵħ8]ĺ#žĘĸĩÀ™ħŐŭŗŭòħ!~
ijŐŭŚŇļŝĽŗœĽůīħ\žĥĤď»Čĵĸ
ķăěĕĢz§¬ĢĨ Arg ŐňĺžĊġĂŐŭŗŭŮŐŭ
ŚŇļŝĽŗœĽůĦĠĊġÎėĝăü
ćo‹Ĉü Glutathion S-Transferase (GST)ü ħ C yÛĦü
ąý(Gly)5ý(His)6Ćü ħŠşőŖÜ"ĺQĖĚĝ His Ő
ň(ŐŭŚŇĂ-Ī GST įĝĨ Green Fluorescent
Protein (GFP)ü ħ C yÛĦü ąý(Gly)5ý(Arg)9Ćü ħŠ
şőŖÜ"ĺQĖĚĝ Arg Őň(ŐŭŚŇĺěĸ
ĜĸcėĂŧŔŪŐŭŚŇģėĝăŐŭŗŭħŢũŝŀ
ŘůŪۖ*ŧŔŪģėġĨŠóKßòij±ÄŸ
}ŐŭŗŭĥĤħ–*gĺÍėĂĕĸĵħļŝĽ
ŗœĽůĦĠĊġ HPLCĂLCĂSDS-PAGE ĥĤĺžĊ
ġÎėĝăü
ćµĈü gģĥķʼnŪijĂěħōŠůŊůĦ>LĘ
ķŠóKßòij±ÄŸ}Őŭŗŭ­ħũńŭŖĦĠĊ
ġ2«ÎėĝģĕĹĂSephadex LH-20 ģŠóKßŖ
ŔŋŪģĺ‘3ėġ5ŽĖĚĝgĦ Arg Őň(Ő
ŭŚŇģħ8]ĺhĠ1À]ď©ĖĸĝăįĝĂ4
‚ĦėġcėĝgĺŃŨťĦDĖĚġ HPLC Ħ
Ġĥđ ArgĂArg-ArgĂArg-Arg-Arg ĺŬůŖĖĚĝģĕ
ĹĂà3UďEČķĦĠĸġhtãďâĒĥķģĊċ
µIJZĵĸĝă›@Ăĕĸĵħ6¥š]ۚ]Ă
-Ī6¥ėĝŐŭŚŇħ– o‹ĥĤĦĠĊġï„
ÎĢĉķăü
- 50 -
xpg{l-gqhzM8^ryujz
P]abmzszR^`
C-6
Ē
ń·ŅÑ0ƏƯƗƯšŦŁ‚LţŢŤ[ŎXŔŁƟƪ
ƛƯėĜėƁƱƬĉŠņŵƂƓƃƯűſƞƂƓƃƯŹ@
ƩƗƒƕšŔşù0ŔŚďIƣƫƟžƙƱƬśš×ʼnų
ŶşŇŵłďIeťÑ0ƏƯƗƯŦƏƯƜƄţŢš
0Ź_iŕŵƏƯƗƯ—eŹ¼ŕšœŶşŇŵŌŁƂ
ƓƃƯť)ûŁě ûŠŦƏƯƗƯ—eŹ¼œŖŁŢ
ť¾]ťù0]ŠƏƯƗƯ—eŹmŞŲňŤţŵŋŦ
y»ŤœŶşŇţŇłŘőŠºÁŠŦŁƪƒƂƱƍŤ
ŲŝşƂƓƃƯŹù0œŗŚƂƓƃƯù0ŌmŞƕƫ
ơƉƯĀM—eŁäŻƬƠƥƯ4¹¯ŁĪĽļ ű
ġĻĵ ÔŴðŔƢơƑƖšť¯Ź¯ŔŚƏƯƗƯ
ŹŭŚłĒ
ńw”šÌ‚ŅƂƓƃƯĔęĘĝĜēĕŦ T°€ťƪƒ
ƂƱƍŹ¯Ňş Ě zþù0ŹåŇƴęĘĚīĒ ĺĨĞĘęĒ öø
ƛƒƟźƱƵŁ+cťËzE(ŹŵŚů Ěę ŒšŤ+
cšŹo,ŔŚł+czþŤŲŴù0ŌòŭŁù0]
ŌGōŇŪŢ³‘eŹmŞšdŸŶŚŚůŁĭĤį Ƃƪ
ƦŹ¯Ňş ĨĮĪģ ŹåŝŚłŬŚŁƂƓƃƯù0
ŦƕƫơƉƯŤOŔ4¹ŕŵőšŠĀM—eŹ¼ŕš×
ʼnųŶŚŚůŁƂƍżƯưƟƀƱƫƯ”Ź¯ŇşƕƫơƉƯ
ĀM—eŹ KŔŚłŘťÌ‚ŁĀM—eŦ+czþ
ŒšŤC%ŔŘťaŦù0ťššŰŤžRŔŚł
ĨĮĪģ šƕƫơƉƯĀM—êťŽîŋųŁƂƓ
ƃƯù0ťƕƫơƉƯĀM—eŦņŵāųŶŚù0
ŌGōŎ`ĆŔşŇŵ.ÚeŌ¼7œŶŚłőťù0
ŹŕŵŚůŤŁ{ŤƣƫƟžƙƱƬ4¹eŠÛ
ű įĤįėĮġħĥ Ą–'ţŢŤŲŵ¿Ńť‡èŹÊŭ
0ŸŗŔŚł
Ē
C-7
C-8
U< 2V- /V@ |
QS :9>}
ń·ŅQĐŨŕŬŦQĐÅť¸õŤņŚŵõŠŁ
æÄó¾Šť#®§ŠņŴ¡eċ§ÒÏŌFŇł
ª<ŠŦűëţŢN²ťČuť
ŁƜƯűƄƒƃƱ
ţŢťQĐÄ%Uċ6Ť¯œŶşŇŵłQĐŨŕŬ
3}iť‹ÚeŤÿŕŵºÁŦFŎåŸŶşŇŵ
ŌŁ§«(J·«aťiŤŞŇşťŁvŔҋÚ
eŤÿŕŵºÁŦRţŇťŌª¨ŠņŵłŘőŠº
ÁŠŦQĐŨŕŬ %¦«ŊŲŧ÷È
§Ť ľ
ėĔĚėĝĕĖĔĚėĜĕƅƬƂƯŌ3ŬŶşŇŚőšŋųŁƪƒƕť
‘™ƋƕƭƋ£¶­Ť*ūŕ`ĆŤŞŇş‡èŔ
Śł
ńw”Ņ%¦«ŔŚ‘¡e±Ź ġŁŘťŸŤƌƬ
ƪƱƍ«ŔŚ‘¡e±Ź Ģ šŔŚłLĎŤŦ Ğ ñđ
įĤ ÇĂƪƒƕŹ¯ŇŁƇƯƕƮƱƬÖš ġ ŊŲŧ Ģ œ%
ÖĔƈƯơƬ ġŁĢ ŹƇƯƕƮƱƬČuťľƋƏƱƑ ĞƳ
šÕqĕŤŏŚł/ŃĚĝ xþČØa ěĝ zþÍċŔŁ
ƋƕƭƋƆƱƊŤŶ ěĜŀť‘‰ŤćõŬŠ‘™Ŕ
ƋƕƭƋìâaŁÙÞõŤ¶­ŔşŇŵÙÆßrą
Àŋų£tŹ’ůŁœųŤƇƯƕƮƱƬÖŤOŕŵ
/ƈƯơƬÖť£tť$0Ź Ěęę ŋųVŔ^Ňş
£j ©šŔŚł
ń̂ŅƈƯơƬ ġ ŊŲŧ Ģ ťľėĔĚėĝĕĖĔĚėĜĕƅƬƂƯ
3}ûŦŁĚĘęƳš ĜĘĜƳŠņŝŚł/֚ۍŁus
,ûŁùC%ûšŰŤ}gVŦéůųŶţŋŝŚł
£tŦƇƯƕƮƱƬÖŤOŔŁƈƯơƬ ġŁĢ šŰŤ
}gŤŹ¼ŔŁ£j &‚ŌéůųŶŚłőť
őšŦƈƯơƬ ġŁĢ Ť3}œŶŵľėĔĚėĝĕĖĔĚėĜĕƅƬƂ
ƯŤŲŵ&‚Šņŵš×ʼnųŶŵł
MNE?Dc&Zbtpg+8^
#^
^`S
dwx^hizozfhjn{lP
0!Xa_vek]XYbG5L
;][W\S
C-9
UJFS H~=S 6 T~)'~74A~
F<%|QI~T I}S
S
ń·ŅµĊť¶´ŦƶäťSøťC%Ō9š×ʼnų
ŶşŇŵłwƶ¦Yeť‚LŻƦƪƴEmblica officinalisƵŤ
ŦƶµĊŹjʼnŵ&‚ŌņŵšçŸŶşŇŵłŔŋŔƶőť
ŤÿŔş½J·ţƔƱƏŹ¼ŔŚA5ŦţŇłŘőŠºÁ
ŠŦƶŻƦƪl§ťƃƈƯƑƯƁƃƉƐƱƍĀM—ešƤ
ŽƋťä¢SøŤʼnŵ`ĆŤŞŇş‡èŔŚł
ńw”ŅƘƜƱƬ®ť‚LŹ EtOHƶ70%¦ EtOH ŊŲŧ
¦‘ŤŲŴlŔŚťŜƶbųŶŚ/ſƃƋŹ¤ÑaƶÌ
ŔƶLĎŤ¯ŇŚłIn vitro ŠťƃƈƯƑƯƁƃƉƐƱƍ
—eŦƶ@šŔşƃƈƯƑƯŹ¯Ňş 30 þ+cœŗƶ®
­ŔŚSøûŹ 290nm ť4]Š KŔŚłőťÇŤ/l
§Ź%ʼnşƶ¥œ%ťƇƯƕƮƱƬšŽîŔşĀM©ŹÃ
ŔŚłä¢Søť¯ť‡ŤŦƶICR ÇĂeƤŽ
Ƌƴ6~7 ñđƵŹ¯ŇƶĎ~þƶWí:>ČuƴxƄƭ
ŻƶCE-2ƵŹà°s,œŗŚłČØaƶŻƦƪkÖŤ
Ŧù 1 ƲņŚŴ 100ƶ200ƶ500mg ť EtOH l§Ź 3 x
þË-kŔƶnormal Öš control ÖƴďSøƨƔƬƵŤŦ¡
HŹkŔŚłcontrol ÖšŻƦƪkÖŤŦ 3 xťƈƯơ
Ƭk 1 zþ"ŤƶƁƃƎƗƯøƂƫŽƦŹkŔŚłoäŦ
ƈƯơƬťË-k 2 zþaŤÝõG'ÜŲŴåŇƶbųŶ
Śä¢ťSøûŹ HPLC ŤŲŴ KŔŚł
ń̂ŅŻƦƪť EtOH l§ƶ70%¦ EtOH l§ŊŲŧ¦
‘l§ŤŲŵƃƈƯƑƯƁƃƉƐƱƍŤOŕŵĀM—eŦ
ɤ] 100μg/ml ŤŊŇşƶŘŶřŶ 46ƶ30ƶ30%ŠņŝŚł
|ŰĀM—eŌďŋŝŚ EtOH l§Ź¯ŇşƤŽƋũťk
LĎŹåŝŚšőŷƶä¢SøŹœŗŵ2Ōéů
ųŶŚł
/R#BDCKJ
C?;@6!$8
&A, 90< 7>- 1) % =3 LM S +5":Q.O +N4+O
F'E* G2I+P(H.T
U (1 BV."VO,V
* CV<3S $S
| IKS ;:}
ń·ŅïZƶùüTŤŲŵ;Dű‘ť“ƒŦ›!ţ¬B
8ĈšţŝşŇŵłŘőŠ•ŹăůşŇŵťŌ†§Ź¯Ŕ
Ś¬B˜(ŠņŵłºÁŦƶďŇùüTãÀÚŹŰŜƶŕ
ŠŤ­ÇŌ»ÂœŶşŇŵ ĔxƚƒƂĕ
ŤƶƝƕťƧƏƮƑƁƘżƯôIŹPŔƶŲŴď¤]Ťùü
TŹãÀŕŵ_qŹŕŵőšŹ·šŔşŇŵłĒ
ńw”ŅŬŖƶƝƕťƧƏƮƑƁƘżƯôIŠņŵ Ź ĶĸĒ
ĴĻıķij ŠƶƸŞÓŐŚôIŠņŵ ŹơƪƋƥƖ ĺĢĩĚěĚ
ũnŔƶĺĢĩĚěĚė ŹæŔŚł1ˆŤƶ Ź ĺĢĩĚěƷ
ũnŔƶĺĢĩĚěĚė ŹæŔŚłŒŤƶőŶųťơƪƋƥ
ƖŹ Ē īġĦĦĒ ęĜĿęĚĠěĝ „ũPŔ
Śaƶpp¿”ŤŲŴƶ ũhƒœŗƶ¨…ť
êPŹŭŚłŬŚƶƇƯƕƮƱƬšŔşƶ ú­
„ťŭƶŧŤƶĺĢĩĚěĚ Źmŕŵ ŹŰhƒœ
ŗƶ¨…ťêPŹŭŚłœųŤƶőŶų¨…ŋųťƂƬ
ƋêPŤ^ōÎŇşƶKáťêPŹŭŚł
ń̂Ņpp¿”ŤŲŴƶ/ ŹhƒœŗŚÌ
‚ƶŘŶřŶŋųtťýŕŵ¨…ŹbŚłœųŤƶőŶ
ųť¨…Ź ħıķIJĹĻĵėĢĞ ?=ƴĚĒμīĒĬġġƶĚęĒμīĒĝėģĮĮİ
Ź3ŮƵũÕ\ŔƶěğŀƶĚğ zþy~Š?čŔŚÌ‚ƶÐ(
ŔŚƂƬƋŹbŚłœųŤőťƂƬƋŹ1Êiť?=ũÕ\
Ŕƶ?čŔŚÌ‚ƶ ŌPœŶşŇŵšfœŶŵƂƬ
ƋŋųKáŹbŚłĒ
- 51 -
C-10
M9‘,
1¡’ŒŽ–h=P“
8
‰k'C 1 ŠPutu Suparthana1 ŠEBr
2Šk6p 1Š#&%o 1§1 ( Y
W iŠ 2 š£—˜ );9*J
S RU/¨
ý“þ*¤_ĂěħĪÀ={“ŗgene targetingŘĝÀ=Ĝ|
«
qěQÐĜZėÿĪûČĄČúԞw‰ėĝzüĚģěĦĄ
ĄĭĨĎú@&«ĚÀ={“ĝĢēȒċīĖĀĚĀûn”
ėĝYüąÍČĒ T-DNA Ĝw‰ĶńŎğĜ]½šě}ËĮĦĕ
Agrobacterium tumefaciens Ĝ 2 8®Ę LBA4404 ®ė in planta K
_ČĒĽŅ(Fagopyrum esculentum, T1 )ěăĈĪÀ={“Į
qČĒû
ý d  þ { “ À = Ę Č Ė Ľ Ņ Ĝ 1 À = (acc No. AB327276,
U-gene Ę
˜)Į¿Ğútargeting vector ĝ U-gene Ĝ<ě pBluescript
Ĝ multi-cloning site Į.Ĥ 445 bp ĜbĮ]ČúpIG121-Hm binary
vector Ĝ GUS À=Áʨ_čĪĉĘěħĩy ČĒûĉĜ targeting
vector Į A. tumefaciens ŚřĘ M-31 8®%Ğ LBA4404 ®ěDČ
ĒûĉĜ A. tumefaciens ®ĮĀúYüĜȒČĒ in planta K_
ėĽŅŗ† 1 'ŘĮK_Čú‡ě¿įē T1 w‰ěăĈĪ
À={“ĜX-Įú´‹KúSouthern q%Ğ PCR ė–¶ČĒû
ý¥rþ3 ®tĜ A. tumefaciens ėK_ČĒĐīđīĜ T1 Ĝ
transformants Ĝ´‹Kĝ2ėúĀĒ®těħĩĚĔĖĀĒûĉ
Ĝ¥rĝ®těħĩ targeting construct Ĝ genome Ĝ]ÁąĚ
ĔĖĀĪĉĘĮ—0ČĖĀĪûSouthern qěeĀĖúM-1 Ę M-31 8
®ěħĪ transformants ė1 U-gene Ĝ band Ĝ¨ą™#ČĒûĉĜ
¥rĝ targeting construct ą1 U-gene ĜÁĄĐĜĊć¹ě]
ċīĒĉĘĮJć—0ČĒûTargeting construct Ĝ54ÂĘ U-gene
ĜÌ^ÁĜ54ÂĮ primers ĘČĖĀĒ PCR Į²ĔĒĘĉĬú
M-1 ®ěħĪ transformants ėĝmMºĩĜ 3’-end flanking DNA ą
M-31 ®ěħĪ transformants ėĝmMºĩĜ 5’-end flanking DNA ąÔ
ÑIė6HċīĒûĜ¥rħĩúM-1 Ę M-31 ®ėK_čĪĘ
ÔÑIė”non-precise”Õ gene targeting ą·ĆĪĉĘą—0ċīĒû
C-12
Research purposeCold stress-related Mitogen-Activated
Protein Kinase (MAPK) pathway has been extensively studied
in Arabidopsis, tobacco and maize. We have shown that
OsMEK1 (OsMKK1) and OsMAP1 (OsMPK3) are induced
during a moderate chilling (12°C) stress in rice. Here report
identification of rice MAPK components specifically interact
with OsMEK1, and possible involvement of thioredoxin h in
the regulation of this MAPK signaling pathway.
MethodsYeast Two-hybrid system and PXG and ONPG
methods were used in evaluating the physical interaction. In
vitro kinase assay was carried out with myelin basic protein
(MBP) as a substrate. Northern blots were done with plants
treated for 12°C stress.
ResultsTwo-hybrid screening identified specific and strong
interactions of OsMEK1 with OsMPK3 and OsMPK6,
respectively. In vitro, OsMEK1 directly phosphorylated
OsMPK3. A constitutive active OsMEK1 (OsMEK1DD)
strongly enhanced kinase activity of OsMPK3. These data
indicated that OsMEK1 and OsMPK3 are the components of
the same signaling pathway for moderate chilling stress. Two
hybrid assay also identified thioredoxin h as an interactor of
OsMPK3. Thioredoxin h inhibited MBP kinase activities of
OsMPK3 and OsMPK6 in vitro. Interestingly, thioredoxin h is
up-regulated in response to moderate chilling stress. Therefore
it was suggested that thoredoxin h is a negative regulator of
OsMEK1-OsMPK3 and OsMEK1-OsMPK6 pathways.
›¤˜ ŸœŸ“34-Vž¥¢š
xx€|t “hOH8r
C-11
‰oQ ªŠmc‹•«Š&AZ ª
§ªn¦JeŠ«n¦I¨
ý“þn”AėĝúĹœIJŃłļłěăĀĖcĜ
Ca2+ ¥)ľŔņĴĮ’ČúĐĜ£ªE1ĄĨú
CCaP1ŗA. thaliana cytosolic Ca2+-binding proteinŘú
CCaP2úCCaP3 Ę/+ČĒûĉĜ 3 ĕĜľŔņĴÉĜ
İōńÃÂĝÒTąÔĀûn”ĝú( CCaP Ĝ
Œ|«Ĝ
hĮ“ĘčĪû
ýdþ( CCaP Ę GFP Ĝ±)ľŔņĴĮ3Ó£ªė
’‹ċďĪĉĘěħĩú£ªE1Į*?ČĒûĢĒŊœ
ŏŖľŖGUS qăħĞ‘ʼnœĿŀıŔĵěħĩú’
‹ÁĮhĨĄěČĒû~ěúzü̍©oėĹœIJ
ŃłļłĮ©ċďúCCaP1úCCaP2 ĜŒŋőĮŐ
İőľIJŎ PCR ěħĩ?Æ
qČĒûňıŁĴœŖŎăħ
ĞĴŐŊŁĴœŖŎÀ=•7těăĀĖĦ*zěÀ
=’‹
qĮ²ĔĒû
ý¥rþGFP ěħĪ
qĄĨúCCaP ĝ£ªě>1č
Ī&…TľŔņĴėÿĪĉĘąhĨĄěĚĔĒûĢĒ
ŊœŏŖľŖGUS qĜ¥rĝúCCaP1 ĝ¯sŠ
“ěúCCaP2úCCaP3 ĝvŠ“ě’‹°œčĪĉĘ
Į — Č Ē û Ő İ ő ľ IJ Ŏ PCR Ĝ ¥ r Ą Ĩ ú CCaP1 ú
CCaP2 ĝjoėŒŋőą6!ČúċĨějo
Į¦ĈĪĘ 24 iÉNěĝfŒŋőĜ 10 šIĢė
6!čĪĉĘúĢĒŒŋőĝĺŋŒŐŔěħĔĖĦ
6!čĪĉĘąĄĔĒûjoėŒŋőą6!
čĪĉĘě!ĂĖúÇmŗ60 iÉŘĜjoĜNúĮ
ˆCčĪĘaiÉěŒŋőąfŒŋőĢė
S»ěčĪĉĘĮ’ČĒûĢĒ’­NĜ@
ěăĀĖĦúCCaP1úCCaP2 ĝěBČĖú*zĜ’
‹RŸĮ—ČĒû
Molecular characterization of rice
MAPK components that interact with
OsMEK1
‰zˆ†‡ƒ…‚r„sr `\?©
§eR@<¦DgeR¨
C-13
^X
,10b’ ”–.+
:G‘“7ž¥¢šJK
‰L]2! tŠ_La u Šl53
t
Š"F vŠ>L3T w Šj$. tr
§ t fN¦e¦¡˜™Š u q¦e¦JGd
Šv}{~y¦:GJIŠw [¦¡˜™¨
ý“þ¯§K_[³ĝúOpĜuĶńŎK_ě
€ĠĖԒ‹ąmMėĆú¬¡ĮČĒDÀ=\`Ĝ
UīĜĚĀĚęúw‰ėĜ‰ŽĮ²āė:ćĜą
ÿĪûĉĜ[³Įl"ěčĪĒĥěĝúpԆIÕ ×¢
áÝÝÕ òïÜòñÕ ÷øöôòëØÕ ĜľŔņĴą>1čĪ¯§ĻŁœŌ
ěúęĜšIĜ9pľŔņĴĮ°œčĪĉĘąpĪĜ
ĄĮhĨĄěčĪQąÿĪûĢĒúYüĝijőŇŔĸIJĴő
ė|«čĪ æåèÜêåèë÷î Į¯§ěDčĪĉĘėŽT
ą,čĪĉĘĮhĨĄěČĖĀĪąúÊĨīĒ¯§ėĜľ
ŔņĴ’‹ěăĀĖú©6JĜĒĥĜQkÊĜ
æåèÜêåèë÷î ’‹ÆĮhĨĄěčĪĉĘĝÎGěÄėÿ
Īûn”ėĝúĢĎ çæè Į¯§ĶńŎěDČĒK
_ľŅķĮČú¯§ĻŁœŌėĜ çæè °œÆĜxµĮ
²ĔĒûċĨěú›üĜŊœŏŖľŖ Pė æåèÜêåèë÷î
Į’‹ċďĒK_ľŅķĮČú)X|«6;ě
¾ČĒ æåèÜêåèë÷î ’‹ÆĮxµČĒûÕ
ýdŕ¥rþõ÷ìä ŊœŏŖľŖƒě çæè À=Į¼¥
Čú¯§ĶńŎěDČĒK_ľŅķėĝúçæè ą¢
ßÝÝùßâÝÕ òïÜòñÕ ÷øöôòë °œČĖĀĒûK_ěăĈĪ
éðìð÷íô ĚęĜ1T¯§ľŔņĴÆě8$ĝĚćú
©ú)X‚Tĝúōtʀ¸ČĖlWĚFąĨīĚĀ
ĉĘĄĨúԆIĜ9pľŔņĴą¯§ĜŒ|«ěV
LÏĮ%ġċĚĀĉĘą—0ċīĒûdú›üĜŊœŏŖ
ľŖŗèõ÷ìäÙÕ èööóÙÕ èö÷õß %Ğ èö÷õÞßŘě æåèÜêåèë÷î À
=Į¼¥ČĖú¯§ĶńŎěDČĒK_ľŅķĝú
ōtĜ ÞÚàÝ Ĝ æåèë÷î ‚TĮ—ČĒûK_Ĝ
©ăħĞ)X‚TĮ€¸ČĒ¥rúßÚà Ĝ æåèë÷î ‚T
Ĝgěħĩ)X‚TĝgČúw‰ÄÆĝ ÞÛã ě
6!ČĒûĉĜ æåèÜêåèë÷î Æĝ¯§ľŔņĴÆĜ ÞÖě
Ħ„ĒĚĀĉĘĄĨú)XJ$ľŅķėĝ ßÝÝùßâÝÕ òïÜòñÕ
÷øöôòë Ĝ9pľŔņĴĮōtĜ¢ ÞÛ㠍ŽėĆĪĉĘ
ąhĨĄěĚĔĒûÕ
- 52 -
C-14
' , O- « ® ™ Ÿ ² ž * ‚Œ~}tu‚ •F•
 GbN q‘13) q‘i:hS
r‘3 s‘e"/ qorl
µq ^I³f³©™›‘r ^I³]³©
™›‘s b³g7¶
º
ì…íkzĈīĴŎīM‹ē°Kć¯úė5õĈ§
8ô¦U…īŀŋğĩŐħćĔĖZĈzě€
QùĂïėê÷ĘĎăćéĩŏğĸĶĬĶćòïĂéīŀ
ŋğĩŐħK-8ĈāăîėĭŌŐ¼ĝōĥķŐŌIJ
ıœÒÑŔİŐĽĦĈăéDćĔĖ„~Ÿ@øĘė
\ ÒÑ İŐĽĦéÔâÒÑÂÃÔ ě(<ùéýĈ8{N
ě_ĕó ćù þœ ÐÜÔÞ⺠ÊØÜܺ ÐÙäáÚßܽº ÂÆȺ ¿¾Áļ¿¾ÂÇ»º
À¾¾ÅŔêý÷ăd†ŠăĉéīŀŋğĭġįŒņEQć
òöė ÔâÒÑÂÃÔ ĈiþúGě_ĕóćúėþđćé
dİŐĽĦĄĈīŀŋğĩŐħ-8Ĉ‚ě
hùþêº
ì]sőiíÔâÒÑÂÃÔ ĉ¦U…īŀŋğĩŐħćĔĖ Ä
ˆ¶Ĉ ÝÑÏÉœÔâÒÑÂÃÔ¼¿ÔåØ»º¼ÀŔě€Qúėêý÷ăé
ýĘĕĈăQ/İŐĽĦĄXxøĘė
ÔâÒÑÂÃÔ¼¿Ô òĔĊ ÔâÒÑÂÃÔ¼À ĄéýĈĈ ¿Ç ˆ¶Ĉĩ
ŏğĸĶĬĶ ÒÑ İŐĽĦòĔĊ áÞÑÏÐ ĄĈ‚ě
© r âãß¼ÙäÕàÚ× s ć Ĕ Ė h ù þ ê ý Ĉ  i é
ÔâÒÑÂÃÔ¼¿Ô òĔĊ ÔâÒÑÂÃÔ¼À ĉéáÞÑÏÐ Ĉāăî
ĖéÃè¼īŀŋğī¨Ĉž¡ćo–úė Ó¿¼Å¾Í òĔ
Ċ ÒÊÁüÜÚÛغÒÑ İŐĽĦăîė ÔâÒÊÎÀÆ ĄĒ Ê c
Ĉ ÑÒ ĵŇğŐě
ùÂùþêøĕćéĩŏğĸĶ
ĬĶ ÖËÏÉ ŋğĿŋŌŒóĕĈīĦŌŒķŐħćĔĖéÁè¼
īŀŋğī¨ž¡ćo–úė ÓÀÉÌÁà ēīŀŋğĭġ
įŒņEQĈIbć Ãè¼īŀŋğī¨ă o–úė
ÐÑÐÁÆ ĄĒ ÔâÒÑÂÃÔ¼À Ą‚úė÷Ąô‡,øĘ
þêĔĖéÔâÒÑÂÃÔ ĉīŀŋğĭġįŒņEQćòö
ė1dmQ-8ě)đþ5nĆİŐĽĦĄĈ
‚ćĔĖéīŀŋğĩŐħ }ĈKć¯úė÷Ąô
‡,øĘþê
C-15
dK £° ,O-`•JD˜
*’— z‹…wr •?Ÿž¥¯_Q
•0
 B) q‘GR9 q‘=
C-16
+ q‘VGW r‘e"/ qµq ^I
³]³©™›‘r j³]³EC[
¶
ì…ĩŏğĸĶĬĶĈyĩŊ IJĦ-8ă îė
HsfA2 ĉéDē¹őwéH2O2 ĆąĈˆëĈª
"…īĴŎīć?ùĂ¢£ćM‹ùéHSPéAPX2éģŋ
ĦıĺŒō'Q©ŒĆąĈv§8Ĉ„~ěŸ@
úė÷Ąăé”N–Ĉ|JćòïĂ«ĆGěVĀ
ĂïėœPlant J., 48, 535-547, 2006Ŕêd†Šăĉ é
HsfA2 ĈīĴŎīM‹NĈ„~ěKúėĩħĶō
¥ŽĈ_ě
ďþêº
ì]sőiíHsfA2 Ĉª"…īĴŎīM‹ć?úė\
İŐĽĦ'QĈLNělúėþđćéĩŏğĸ
ĶĬĶ0·• T87 ěİŐĽĦ'Q±=ĩĦŏŁ
ĤĩŅĵœCHXŔă 1 `®ùé¹wīĴŎīîėï
ĉ H2O2 ćĔė HsfA2 ĈŸ@ć%čúF´ě
Ŏłōă hù þêýĈiéīĴŎīćòöė
HsfA2 ĈŸ@ĉ CHX ćĔĖ;ćĉTøĘĆ
óĀþô鵚ƤCôžđĕĘþê÷ĘĎăćé!z
Hsf ĈŸ@ćĉ3NİŐĽĦĈ›‰ô¯úė÷Ąé
øĕćĉ HSP90 Ēùõĉ HSP70 ô Hsf Ĉ„~Kć¯
ùĂïė÷Ąô_ĕóĄĆĀĂïėêý÷ăĎûéŀŏ
ijĝįŒņ±=œMG132ŔćĔė HsfA2 „~ě
hùþĄ÷ęé 15 IĔĖ¢£ćŸ@øĘþêùó
ùéCHX ćĔėĉéMG132 ćĔė HsfA2 Ĉ
Ÿ @ ě ; ć ± = ù þ ê ø ĕ ć é HsfA2 Ĉ „ ~ ĉ
HSP90 ±=ăîė geldanamycin ć?ùÚùõŸ@
øĘéýĈŸ@ĉ CHX ćĔĀĂTøĘþêĈ÷Ą
óĕéª"…īĴŎīećòöė HsfA2 ĈīĴŎī
M‹NĈKćĉ\ć'QøĘėİŐĽĦô¯
úėŽĄùĆïŽô9.ùé“ćĉŀŏijĝįŒ
ņĄ HSP90 ě
ùþŽô¯ùĂïė÷Ąô‡,øĘ
þê~.é÷ĘĕĈŽĄ•uNªŒŎłōĄĈ
¯ěhùĂïėê
Ÿ ± ™ § ¥ ¡ ¥ vpˆˆpmƒny|l
‰ŽŠˆ‰†ˆ‹‰†ˆ†ŽƒŠˆ‡‚‹„olwŒ{€xq ”–—
§°›¢¤«´¯•@
C-17
$Z 1‘3 2‘e"l / 1
µ1:^I³]³©™›‘2:b³g7¶
¡SF]EMPWa\6¸tKO]Kd4!
0™„¸ª¥5f3“¡v|23>S
F]EMP5¸ti5b/1> 6
JOJ_-&13%»w5BNR_2³u@ƒ
†*>,9 ¨zŸ!;7 5nDZa
@‚$µ'*‡6'?814J^CSQLQ
VAX[a5b/1> 6¸tSF]EMP
4*>r
—p™„@Œ){®¯ •‰‘5¨zŸ
@ˆq*>'2@¤), +'1¢§16«3 5
œ”­5@±.,
Š˜`¬{®¯ •‰‘@ž 0 5 4;>nDZa5ˆqs4/ 0
’²),+5¬nDZa5 6
5€m4;=Œ…4ˆq(?,(<4
£y‘
@ž 0UZIaOoœ
4;>¸t¡KO]KŽhd4!&>HTY e
5 GBR_º5›}@±.,
1
6·Žhd4!&> GBR_º#¹‘
2–¶)0© k°¦)0 ,(<4 oœ
4;=
5 GBR_º6© k4
81xr),gc;=J^CSQLQ4! 0
6¸tSF]EMPWa\5št4”­
) : @¸tl~"<j´)0 >'2#
‹<"43.,
¨¥Ÿ­šœH4pª¬°²/cP
`•±´¦²ž“;T6
q
"2l
‘
l Y& q‘!#l q‘
r
8l U ‘\Ml . s‘5Gl X s‘
Gl + s‘<l ( s‘Al k
a qµql ^If³]³©™›³rl ^I
f³%³E%³sl A>©™›L¶
ì…íĻĶĩŊĠģ(Zingiber zerumbet Smith)ĉég#
ĝĪĝē#7Bt+ć€OùéýĈj˜ć5õĈˆ
¶ĈijōŃĺğĵě)ĐkzăîėêýĈijōŃĺğĵ
ĈðÿĈïõāóĉéœ:…ć«ĆGěiþúĒ
Ĉô)ĎĘĂïėê{ćĻĶĩŊĠģćùó9.ùĆï
ĮōŐńŐĉ³Ać&MNć>ďéļĦijŌĝĈP2
¥±=ēéýĈˆëĈa‚Ć"'zċĈŌŒĵ
"'zĄùĂbHøĘĂïėêùóùĆôĕé÷ĘĕĈij
ōŃĺğĵĈ€'QŽēé€o–ĉ_ĕóĄĆĀĂ
ïĆïêý÷ăRëĉéĮōŐńՀ'QĈ®Ąù
ĂĒ’ñĕĘėéæ-ľņŎŐ'Q©Œ§8ĈĻĶĩŊ
ĠģóĕĈ$²ě2*úėê
ì]síĪʼnīňŐªĆąéŸ@ě^ùþĻĶĩŊĠ
ģóĕ total RNA ě$²ùéRT-PCRéRACE-PCR ĈS
sě‚ïĂ­ cDNA ě$²ùþêýĘě6—™ă„
~øüé¸zăîėľĜōĹĩōŌŐª(FPP)Ąě
&Møüo–ěhùþêĎþéŌĝōİğņ PCR ćĔĖ
ĪʼnīňŐªćĔėé§8ĈŸ@ iě Čþê
ìií$²øĘþ cDNA ĉé548 ĝŅĺªq1ěĨŒĵ
úė 1644 bp Ĉ ORF ěWÿéX<8¬ĉ 64.5 kDa
ăîĀþê÷Ĉ§8Ĉo–hĈié€QzĄ
ùĂæ-ľņŎŐ(95%)ôé€QzĄùĂç-ĢŌġľĞ
ŎŐ(5%)ô'QøĘþêøĕćRëĉéFPP 'Qć¯Ě
ėY™ƒfĈŇļŏŐªŽ§8‘ě@ùþ6
—™ă zss1 ě„~øüþêýĈiéin vivo ćòïĂ
æ-ľņŎŐô 51.9 mg/ 50 mL culture ă'QøĘþêĎ
þézss1 Ĉĉj˜ćµšćĕĘéĪʼnīňŐªć
ĔĀĂpćKøĘĂïė÷Ąô_ĕóĄĆĀþê÷Ĉ÷
ĄĉéĻĶĩŊĠģćòöė zss1 Ĉ4[óĕĈ°KĄù
ĂĈo–ě‡,ùĂïėê
- 53 -
+u|t…E{…€v \b_]a_Y
iOA3I-W
C-18
c5M@6d)d
ˆU†;N‰
C-20
4FW
ďŸĐAtPCaP1 ĮŋŨłŗŕŎŕĨžěļĢt
ĭ
ŅŐńũ³+ŏũřŇĨđĻĎĚĭAĮ¿ÌÎâ
6ĿgĢīĒ\AĨđĺīėř—Ĩ±
¼¿Ĭ³+ĜħĒĻĎIJĢ”EĭÖ¯ĭŒˆÏĩĭ
ä\ĮĹļīĒĎěĹĬ*§ōŔŧō—ĬĸĻťŁ
Ŧŏłš PCR ĸĺčÛLķ$ōŔŧōĬ[ªĜħ
ž–ŧŝŦĭxėĹļĢĎĸĺčAtPCaP1 Į
±¼ĭ]9ÒĬßĜħĒĻ(½\ė¹ĔĹļĢė
ġĭ±ī™—Š½ĮyĹĖĨīĒĎġĚĨ~¡¨Ĩ
ĮAÔBŸcĿšĒħĚĭAĭŠ½yĿ
ÇĥĢĎ
ďŸĐ
æ …“ĬĕęĻÄĮī0DģėčIJģÄėĪĭĸē
īŢŅŖŎšĨĹļħĒĻĖĮ#ĬěļħĕĹ
ğčġĭyĮ8£¥BŸĬĶ͇™“BŸĬĶØ
ģĩ¹ĔĹļĻĎġĚĨŵųĿšĒĢÔAž–]9
ĭĨčÄĭU_YĬßľĻÔAĭk°ĩč}
ÔAĭŠ½
‘ĿÇēĎ
ďuĐ
æ ŋŨłŗŕŎŕĭp§ 15 wĭÂáŢťōŒšĖĹŶ
ŴŲĿeĜčAffymetrix GeneChip ATHůĨ‘E
ĜčÔAž–œūŏĿXĢĎj'ĜĢƒĮٙƒč
ÄĭM)H¦\ķbQěĬßľĻÔA as1 ‹oƒč
as2 ‹oƒčAS1 ў–ƒčAS2 ў–ƒĨčġĭ
œūŏĿŇŤōŏťũňőūŦ FuzzyART ĨĜĢĎ
ďu%į³‚ĐĮĝĵĬ PCaP1 ĭ T-DNA i=›
ƒĿÊĜĢόĬĚĭ=›ƒĩٙƒĿšĒħÛL
ōŔŧō—ĬĸĻȖ5ĿÇĥĢĎÎPĭÛLł
ńũ²`ĿĶĦ MS 74ĬHĜħÜĕĸįÝėÑIJ
ĢĮ‹ĭ274ĿÊĜ腓Ŀp§Ĝħ 2 Ė
Ĺ 4 ÐÞWĬ…“4Õĭ™ØÚĿ‘EĜĢĎġĭ
³‚č܋ōŔŧōĬĮ¢<ƒĮº\ĿgĥĢėčÝ
ĭÑč‹ĭĪĤĹĭōŔŧōĬHĜħĶTIJĻĚĩė
¤/ěļĢĎěĹĬ„7zĭFRĿåĵĢFàō
ŔŧōĬHĞĻȖ5ĭĶÇĥĢĎġĭ³‚čٙ
ƒĩ¢<ƒĭåFà•_Ĩĭ…“ĭÞĬ´ŸĬ
|^īNėĹļĢĎIJĢ PCaP1 ŜŨţūŏū::GUS
ĿiĜĢƒĿÊĜč$ÃŃťŋŏūĨđĻ flg22
ĿĔĢĩĚĽč:OÕĨãÅī PCaP1 ž–;?ė
ĹļĢĎĭĚĩĖĹčPCaP1 ėĚļĹĭōŔŧōĬ
[ªĜħŋňŕŦÒĿfēAĨđĻ(½\ė¤/
ěļĢĎ
ď³‚Đ
ĿXħĒĻ as2 ÔAĬděļħĒĻÔA
űĭēĤŰė,ĝŇŤōŏĬäěļčÓĬäě
ļħĒĻĚĩė ľĖĥĢĎ{ĬčŠ½
‘ĿÇēĢĵ
ĬčĞĨĬ ĿXĕĺčÄĭU_YĬßľĥħĒ
ĻÔAĭijĨŇŤōŏĿ`ĜčġĚĬŠ½} ĭÔ
AĿ ĺhĺčŠ½
‘ĿÇĔĻqÀ FuzzyART Ķ
`ĜĢĎ
x„s~}z}+u|t…E{…€
C-19
v \b_]a_Y iDHJ1%W
cR!KCŠ) W Š
C-21
4F
ˆU†;N‰
ďŸĐŋŨłŗŕŎŕĭ±¼¿ĬK3ĞĻt
ŅŐń
ũ ³ + ŏ ũ ř Ň ñĊúòüúìæ è
æ
ćăüĉĄüëĄĀĄýĈüąĀæüĉĉĆþĂüĊĀÿæþþ ü ĊĂĆąëýĂąÿĂąāæćć ĈĆĊĀĂąæìéæ
ĮŁŠŘ× ííð Ĩˆ`ěļŮõăċ ĩ øČĉ ĭ¶.Úė­
îðçĩ>ĘŮäĞĻv ŏũřŇĮīĒĎ¿ÌÎâ
6ĭīĒŏũřŇĨđĻĬĶĖĖľĹğٱ¼¿ĬC
EŸĬ³+ĞĻĩĒē”ZĿĶĦϙ—ŸŠ½Įy
ĨđĻĎ~¡¨ĨĮ™"BŸŠ½yĭ˜ĩĜħŮ
ĚĭAĭ¿³+‰SĭyĿŸĩĜĢĎ
ďu%į³‚Đù ĭ õăČ ĬŠťōŔłŦ8ė³+ĞĻ
ĩm‘ĜŮĚĭ õăČ Ŀ ñăü Ĭ·nĜĢ úòüúì ĭ ò Ĭ õôú ĿÆ+ěĠħž–ěĠĻĩŮ~€Ů±¼¿Ĭ†
ěļĻ úòüúì ė±¼ĬGěļĢĎIJĢŮúòüúì
ĭ þóùñ Ŀ.Ĵ’±¼¸¬Ĭ îö늝ōŐũ×
Ŀ!Ĕħ&[ěĠĻĩĚĭ û÷ Į úòüúì Ĭ'ĺIJļĢĎ
ĚļĹĮ úòüúì ėŠťōŔłŦ"ěļĻĚĩĿlŸĬ
yĜħĒĻĎěĹĬŞōśŀŐŌŦłŘŋŔūŦťũ×ĩĭ
³+ĶĜĢĭĨŮġĭ±ĿĜĢĎå®RĬ
«ÊĜĢťʼnũŚŕũŔ úòüúì ĿsĩĜħٜ\ĭ
¿Ĭ2E"ĜĢťũ¾ĩĭšĿĜĢĩĚ
ĽŮú÷èîêðéúí ĩ ú÷èîêïêðéúî ĬHĞĻ”›Ÿ³+ėijĹ
ļĢĎĚļĹĭ ĖĹٱ¼¿ĭKaŸīÕİ
ĭ³+ė
‘ěļŮĖĦŋňŕŦÒAĩĜħĭŠ
½ėm‘ěļĢĎæ
x„s~}z}iLi&*'O
-iflhv‚y{ƒ…wq<ef+
r„‡|iS?
c#dV2$dV$d
"Bd ,d>=d.
9dˆP†(<;8P‰
x„s~}z}iLi?;hTp
o OhnoGg
`^\ i'30i!jmk YXW "B YXW Q ZXW W
V2$ YX[XW , YX[XW .9 YX[XW W
>=7
ZXW c>= YX[ˆY P†
/8stXWZ †:XW[ P†(;‰
ďŸĐ 婅“ĬĕĒħÄķÁĭ™0DĮč»ŬÈÉŭč8ÕÕč@uĩĒēĦĭ
ĬŽĥħž™Ū"ĞĻĎIJĢč-»ŬÈÉŭĭU
`ĬĮčA RNA ėØīV ĿĮĢĜħĒĻĎŋ
Ũ ł ŗ ŕ Ŏ ŕ ĭ ASYMMETRIC LEAVES1 (AS1) ASYMMETRIC LEAVES2 (AS2)ÔAĮčĦĭU
`ĞıħĬßĜč-ŬÈŭ"ĬßľĥħĒĻĎ~¡
¨ĨĮčAS1 ĩ AS2 ÔAėĪĭĸēīŠˆĨ-"Ĭ
ßľĥħĒĻĖĿyĹĖĬĞĻĚĩĿŸĩĜĢĎ
ďuĐæ as1čas2 =›čAS1čAS2 ў–čٙ
5ĖĹ RNA ĿeĜčşłŇŨŁŧłčreal-time
PCR čA RNA ĭŘŊũĿÇĥĢĎ
ď³‚ĐşłŇŨŁŧłĭ³‚čas1čas2 =›Ĭ
ĕĒħž–ė;!ĜčAS2 ў–ĬĕĒħž–ė
JĞĻÔAĩĜħčŢťōŒšĭµgĬßľĻ class
1 KNOX ĭv ÔAĬ!ĔħčrĭÔAėe
ěļĢĎěĹĬčreal-time PCR ĬĸĺčAS1 AS2
ĮčÄĭ»ŬÉŭ"ÔAĭž–dĬßľĥħĒ
ĻĚĩė¤/ěļĢĎěĹĬ AS2 ĭž–ËI¬ĿšĒħ
ž–ĜĢĩĚĽč0Dĭ»ŬÉŭ"Ĭßľĺčńū
ņŋũ[ª\ĭ1AĨđĻ ETTIN(ETT)ĭž–d
ė č Ë I W r z Þ Ĭ † ě ļ Ģ Ď ETT Į
ta-siRNA ĬĸĻYĿēęħĒĻĚĩėľĖĥħĒ
ĻÔAĨđĻĎAS1AS2 ÔAĮč»ŬÉŭ"Ĭß
ľĻ ETT ĭž–dĿÎĜħč-ŬÈŭ"ĬĖĖľĥ
ħĒĻĩ¹ĔĹļĻĎ
- 54 -
C-22
‰“ˆšƒ˜P>{DI
oncogene 6b |‰ “›zDId
#{RJz/l€w
uQOG£ v'F£ vh&£v
O\9 rv=S sva! s vo
£
jtMK$vr - jŸ[V
$vs jtMb$
•–‚Œ^{7"†šŠX‘™žŒ—
 ziySW
D-2
é
6b §Xl‰a—Ÿ)0M>/9
J+FO8GA(2,N3 T-DNA ªhmg
$§Xl#‰—›’~žY˜
%$Ž‹$§Xlru
s©'S$6>1—›TŽ‹$
DKHN'‡_ 6>1—›^¢'[
¦$"%${‘•6b ‰—›$^lœ'z$$
x…¨ƒ Two-hybrid …!# 6b UZŒ
$6>16N?/'v–cn®“«
UZŒfl^lŠt'|6b
rwY DNA E*/M)L*|'¡
™}(1)®^l'cn¬NtSIP1, NtSIP2,
NtSIP3­VeNtSIP3 @3:N H3 'id$(2) 6b 6N?/@3:N
H3 @3:NODPK;O;G*N™b
6b =/L-5PF€¥'Z$œ
#@3:NO2ICMN†tWQ
"
6b /ME7N€¥s©'S§Xl]L
BK'j`$š"%$(3) 6b rw2
M*=<4<‚q2M*=<4< RNA ”
LBK'E*/M)L*|!#„¤6b
rwY 1.5 \WQQy§Xl
10%1/1.5 WRˆp 10%
6b ‰k§Xl mRNA LBK
s©'S$&
!T
-P.2N£o§Xl$'id$
Lz}~›‡›–„’ ›—š
…‘‡‹œ ‘{xyo
uOo k p vYOo :6p v+o c
D-1
pp
vO=o .po
¡p bŸMLVvppT), Ÿ,¢o
ĉŸĊãĸļŪ«œä‹ZĶŧĿŧŚĺŔūŧŠŦ
ĻőĿŇŨūő(APEOn)ĥĆ&]ŠĆďĮĦË
ÃÇ ġ ėğ ;Û ģ šĖ IJğĒ Ĝćġĕ ijđ Ć
APEOn ĥƆLďĮĦË·1ģ@0ĘıX™”ģĮİ
‡Đē‹Zĵ£ĘĶŧĿŧŚĺŔūŧ(AP)§ħ
ɂZĖIJıĕġđkįĐģĢĞĜ摵įĥĆh
Ĝģ APEOn ĵ AP ĨĠ=ƒŸģĘıÂĵË·1Đ
į!âėĜćrÂzĥĆyæ–\ĤÔČģĮİĆAPEOn
ĤģÔČđ¢ÈĖIJĜćĚĕĠƋZД
Ĥb­ĵŸġėğr ¦ĵCjėĜ±vƋ
ZДĵ'BėĜĤĠ5)Ęıć
ĉiˆĊļŀŎŧŚĺŔūŧŠŦĻőĿŇŨūő(OPEOn)ĵ
’¬ġėĜyæsĤĢı31ĵšČğĆrÂz
ģĮıèĵÅČĆrÂzģďĔı‹ZÐ
”ĵb­ėĜćBÛuĥĆľňŀũšőŁťŚķū
(GC-17A Ć SHIMADZU) Ć } { Ĥ ¢ È ĥ Ć
MALDI-MS(Voyager-DE PRO)ĵĚIJěIJšČĜć
ĉ±vĊrÂĥĆgyrB Õ?Ĥ64ÖĮİĆ P.
putida BSN22 zġ+(ėĜć}{ĥĆ1)OPEOn Ĥ
qØģĮı OPEO3 ĨĠĤĆ2)OPEO3 Đįc
OPEO1 ĵ™]Ć3)OPEO1 Đį OPEO1-ĽŧşŪØĵ
°›ė OP ĵ™]ĘıġČč 3 €áĤģĮİĆOP ĵ
™]ėğČı$ºZđ£,ĖIJĜćyæ–\ĵ9ĎĜ
èĤ±vĆrÂzĤ‹Zĥ¡ØÜģĮĞ
ğÐĖIJğČĜćĨĜĆ¡ØÜĥĆrÂzĤ8ģ
VåĵĎĢĐĞĜćĕĤ±vĐįƘ7Ĥyæs
ĤÔČđĆÂĤ8ĠĥĢēĆ׬‹Z§ĤZ
ģVåĵĎıĕġģĮİƔĤ™]ÍRđ
ÐĖIJıĕġđkįĐģĢĞĜćĕĤĕġĥƘ7.đ
‡ĐēA”ģĮı˜7„xRĵM%ėğČ
ı$ºZđċıĕġđ£,ĖIJĜć
é
,(<$@: 9- ?
% &%5 ,# )64 3, %" .
+7/ '
=8+0
!+ >2/ ;=
+*7
=+
1+
ĉŸĊŘŚķʼnňÂĥŜũŕĸļŐķŀňġėğĆĨĜĆ
ĚĤ8ģpĢļŦńªĥŜŨŕĸļŐķŀňġėğ
ģ‰ĖIJğČıćoÌĆ KįĥĆťŀőê êŘļū
ňŬúüõóé÷ÿĂąŮêŰ÷ĂĀüôĀŭďĮĦľťŀőê êŘļūň
Ŭ÷üõóé ÷ÿĂąŮêŰ÷ÿĂüôĀŭĵŦŪØĘı׬ťŀ
őêêŘļūňŞňŞŦťūŋŬúüõýŭđ¥ĈĤŘŚķʼn
ňÂĤÂģ@0ĘıĕġĵkįĐģėĜćĕIJįů
ªĥĆŗőŢŧŀļŦńªĭţŎŪ2ªÝĤ{]]Ġ
ċİĆŘŚķʼnňÂĥťŀőêêŘļŇōūŋďĮĦĻŪ
ŒêĄê êĶŊŎŧľťŀőŅŢœōūŋĵ‡ėğĆůª
ĵÑâėÂģ#ĪġdĖIJıćĚĕĠĆ^Ĉĥ
Õ?ĤŒģ@0Ęı ôõö őťŪňŠūŌūĵ
{]ĘıÕ?³ģ‰ėĆúüõì÷üõ Ĥ#İĩģ
àĴĞğČıĬĤġdėğuĵÅĞĜćé
ĉiˆĊ éùöûîïîñ zĮİrőťŪ
ňŠūŌūÕ?³ĵ!âėğ64Öĵ…BĘıġ
ģĆ4±&ŌŪŖŀŬ÷úêõýŭĵ þñ ŇňŐţĵš
Čğ;۞—ĖęĜć÷úêõý ġ¥ĈĤļŦńªġĤ±
&ĥ§ŽB“ÛŬøþöŭĵšČğƓAŸģ
ėĜćé
ĉ±vĊøþö ģĮı±&BģďČğĥĆúüõ ďĮĦ
÷üõ ĵėĜlģž“đ
EĖIJĆťŀőūňĵ>ī
ġĘıĚĤĤůªĭ!ªĤlģĥž“đįIJ
ĢĐĞĜć±&§Ž²Ĥu±vĐįĆ÷úêõý ĥŮ©
_Ĥ4±&ŅĸőĵĬĝĆúüõ ďĮĦ ÷üõ ģFĘı
ā đĚIJěIJ òñëíé ăû ďĮĦé îíëðé ăû ĠċıĕġĆĚ
Ĥ±&|SĥĻŪŌŧřūç2ĠċıĕġđkįĐġ
ĢĞĜćĨĜĆ4&Ĥ±nģ]ėĜćé
D-3
A]^P>7š” Ž{EZ@
8(5 qvu`2f qv'*£vB
0# r vm?%F rvHg rv=
1 qve qvOU sv<;# sv
C(n s o ¡ q jŸMbv ¤ 4
Ÿ_v¥g Ÿ3NMI¢o
ĉŸĊ®Â¹?ĤžÀĥĆ¹?¶“Zĵ`čÆJ{
ÎŬ¹?/pĤŝŜŎŒŁŦĽŪŬŃŧŐŏŀňŭJƁ
®¹½›tĤ:½Ć"ĦŃūőŌŪŖŀJŭĤ¾O
Ó¤ġ´ĎWıćÌPĆ¹?½»ÉġžÀġĤ
ßĤÙĢàÏZđ£,ĖIJĆTČ¿*đaĜIJğ
ČıćĚĕĠ^ĈĥĆwÁÂ
¹?ģĖIJĜ
hŦŖūŋ|ŌŪŖŀ YcsK Ĥ}ºuĵĩĜć
ĉiˆĊwÁ¹?U]lģďĔı ycsK Õ?Ĥ
uĆycsK ~gz¹?ĵšČĜƗ2ĤuŬžÀ
Y¨º"Ħ½»ĤBÛuŭĆ"Ħ¯ĩfĎĵ
šČĜ in vitro ģďĔıwÁÂ"ĦŊŨĹň YcsK Ĥ
׬AŸuĵÅĞĜć
ĉ±vĊŔūņŪśũŏőġ GFP Ä&ŌŪŖŀĵšČĜ
uĐįĆycsK Õ?đ K "Ħ GerE ģ@ėğ¹?
•Ÿģž—ĘıĕġĆ"Ħ YcsK đŃūőJħH0Ę
ıĕġđ£,ĖIJĜćĨĜĆ'Õ?~gģĮݹ?Ĥ
LêĶťœŪģY¨ĘıžÀºđ<ėĜć;¼Âģž
—ĖęĜ¯fĎĵšČĜ Zymography Ĥ±vĆYcsK
đŦŖūŋ‹ZĵpĘıĕġđ£,ĖIJĜĕġ Đ įĆ
^Ĉĥr׬ĵ LipC ġ+(Ęıĕġĵe-ė ĜŬJ.
Bac., 189, 2369ŭćĖįģĆ
¹?ĤÑ⻸ØÛ
ĵBÛėĜ±vĆڙz¹?ġ lipC ~gz¹?ģp[
ĢNđįIJĆLipC ģĮı¹?:½Ĥ»Éġ LêĶ
ťœŪģĮıžÀÞ>}{đDcģàÏėğČı$º
Zđ£,ĖIJĜćĨĜ^ĈĥĆŊŨĹň LipC ŞŤũŁ
đŦŖūŋ‹ZĵpĘıĕġĬėĜćĕIJįĤ±v
ĐįĆBacillus I®ÂłŔţģQē@ĖIJğČır×
¬Ĥ¹?žÀ}{ħĤàđĆGĢēġĬ Bacillus I
®ÂģmҟĢ—ÊĠċıġ´ĎįIJĜć
- 55 -
D-4
X^YU]ZE./?QU_W^
PGTS%>Q!9
M#<; 1N)- 1N* 2NL
6FA 1N(1& 1
cBb.4 1N2D 2d
µ{¶± IGuqѲÏ²‡/Ð pH ½A¦IÙA
âĄçĄIËØuŒÄÝÁ̽˾ݳÆÐ pH J=IϪÄÝ
ˆÖѲE. coli ÎͤЇ‘Ëa½Ÿ×ÛÞʸÝ
½²âÿø¦z¥‘Ë·Ý Corynebacterium glutamicum ËÑ
,%½Î¸³'²#‘Ï»ÀÝAâąçĄIt-ËÐuŒ
ЈÖÐ[à{ÌÃʲÐd—à“Èdz
µZl¶± .ycÐuŒÏ»ÀÝ pH 7IѲ\;*)àw
¸Ç:2*)»ÚÒm*¯Ë˜Ôdz*)Ð pH Ѳ€´
ÐùóüáĈàw¸Ê˜WÃdz–¢6ÐïĂóõèćê
ĆĈöćëÙïĈìćðÑ8lÏDÈʓÈdz
µ‰b¶± M´ÑϲC. glutamicum ¨uc¼ÛăćòĀ.y
ÏÚÜAâąçĄIÐ:2*)ËuŒË¾Î¿ÎÈÇ.yc
à0VEÃÊ,%ÃÇĉH19 > 3 ] œ1Ċ³ÁÞÛ.
ycÐ0¿ÑIËѨucÌ#‚ÏuŒÃǽ²pH9
à›ºÝâąçĄIt-ËѨucÚܒøuŒà~
ÃdzDÈʲÁÞÛ.ycÑâąçĄIONIϪßÝgŽ
½hUÃÇcË·Ý̋ºÛÞdz_‘ÐíøĀăäýăĄ¼Û
âąçĄIKIà'FÂÅÝ DNA YÐR†àÖdz
ÆЉb²!.yc¼Û– DNA Y½EÂÞdzïĈ
ìćðЉb²ÁÞÛÐÏÑgŽ{ÏyÎÝÌS8ÂÞÝ
€´Ð¢6½$ÕÞʸdzÁЉb¼Û²_‘Ðâąç
ĄIONIЈÖÑċÉËÑο²VÐgŽ½ªßÈÊ
¸ÝÁ̽~&ÂÞdz
D-5
Tsujimura, Kenji Kano
Division of Applied Life Sciences, Graduate
School of Agriculture, Kyoto University
µPurpose¶In previous studies, it has been proved that some kinds
of bacteria can utilize endogenous mediator for electron transfer to
carbon electrode during substrate oxidation. This metabolism in
microbe should be regulated by controlling the rate of electron
transfer out of cell by adjusting the electrode potential. In this
study, P. freudenreichii ET-3 was utilized to verify this purpose.
µMethods¶ P. freudenreichii ET-3 and glucose were used as a
biocatalyst and a substrate (electron donor), respectively. All
electrochemical experiments were carried out in a flow-type
electrolysis cell filled with a carbon/graphite-felt electrode and the
growth medium of P. freudenreichii ET-3. Amperometry was
performed at 37 oC under anaerobic conditions. The profiles of
end products were analyzed for the electrochemical growth
medium under steady state conditions at given applied potentials.
µ Results¶ After seeding bacteria into the electrolysis cell, the
system produced an oxidation current in the presence of glucose
when positive potentials were applied. This means that the
microbial cells donate the electrons to the electrode during the
glucose oxidation without artificial mediator. At a low applied
potential of -260 mV vs. Ag/AgCl, lactate was the dominant
end-product and reached 18 mM, however it decreased to 5 mM at
a positive potential of 500 mV, in which formate became the
dominant one. The concentration of propionate which was one of
the typical end products also decreased when the potentials
changed from -260 to 500 mV. It was considered that electrode at
high applied potentials can work as the electron acceptor for
microbial cells, which leads to the change in the end-product
profile from that obtained under normal anaerobic conditions.
X^YU]ZE./?QE80P
GTS%>Q!9
M$"@ 1NK 1N* 2NL
6FA 1N(1& 1
cBb.4 1N2D 2d
µ{¶± âÿø¦z¥‘ Corynebacterium glutamicum Ñz¥
`ÌÃÊ3iIÐt-àjÄݳÁÐÇײO2 Ñâÿø¦
Ðuvsà< ÄݧÎ(ÐċÉÌÎÈʸݳM´
ÑϲC. glutamicum ½:2*)ËîĆöĈàCL˾Ý
O2 o?ЫxÑ 0.5%Ï·ÝÁÌà,%Ãdzüò_
‘Ð O2 wÏÍÐÚ¹ÎgŽ½ªßÈʸݼ²ÆЇÑ
[Û¼Ëθ³'²_‘Ð O2 wϪßÝ¢6ÐR†
à{ÏÐd—à“Èdz
µZl¶± .ycÐuŒÏ»Àݦ…7IѲ\;*)à
w¸²Q̹*¯ĉ°ži`ĊÌ®Š*¯ĉži`ĊÐ 2
`˘Ôdz–¢6ÐïĂóõèćêĆĈöćëÙïĈ
ìćðÑ8lÏDÈʓÈdz
µ‰b¶± M´ÑϲC. glutamicum ¨uc¼ÛăćòĀ.y
ÏÚÜ O2ĉ0.5% O2Ċt-ËÐ:2*)ËuŒË¾Î¿Î
ÈÇ.ycà0VEÃÊ,%ÃÇĉH19 > 3 ] œ1
Ċ³ÁÞÛ.ycÐuŒrIàm*¯Ë˜Ôdz.yc
Ð0¿ÑQ̹*¯ËѨucÌ#‚ÏuŒÃǽ²®Š*
¯ËѨucÚܒøuŒà~ÃdzDÈʲÁÞÛ.
ycѦ…ÐwϪßÝgŽ½UÎßÞÇcË·Ý̋
ºÛÞdz_‘ÐíøĀăäýăĄ¼Û¦…jIà'FÂÅ
Ý DNA YÐR†àÖdzÆЉb²!.yc¼Û–
DNA Y½EÂÞdzïĈìćðЉb²ÁÞÛÐÏÑ
gŽ{ÏyÎÝÌS8ÂÞÝV€Ð¢6½$ÕÞʸdz
D-6
Electrochemical
regulation
of
metabolism
in
Propionibacterium
freudenreichii ET-3
M Yung-Fu Wang, Masaki Masuda, Seiya
D-7
E?O\`[VaE?Q
JPR
S:=I5QC
M1N,'3N#+N7
cHBd
µ{¶GuqpX­kѲGuq½^gqÐ
™à“¹¬
ÏvÖÂÞÝ£à­iå÷ąéĈÏ.TÃÊÜÄ
Á̽˾ݕŠË·Ý³'Ñ
”{Î5iI‘ÐÉË
·Ý¦‘ Lactococcus lactis à4ÌÃÊGuqpX­k
Ð+}{Î|à“ÈdzëąîĈðà+
ÌÃÊ5i{Ï
*¯ÃÇ̾²¦‘Ñ NADH ¼ÛЭ69ÌÃÊûą
úć¦àwò¦àuLÄݳ_|Ëч/­6
9ÌÃÊ­eàw¸²¡BέàÃÊ*¯ÄÝÁÌ
˲NADH ¼Û­eÓЭ6à@¾šÁÄÁÌà{Ì
ÃdzÕDz’©Ð­6 āôãåĈñĈàuLÄÝÁ̽
, % Â Þ Ê ¸ Ý þ Ć û æ ć ¦ ‘ Propionibacterium
freudenreichii ET-3 ÌÐn"*¯à“¹ÁÌ˲s{έ6
H„ÐfƒàPÃdz
µZl¶黒鉛化処理したカーボンフェルトを作用電極とし
て用い、ポテンシオスタットで電極の電位を制御し、
37℃、嫌気条件下で乳酸菌、プロピオン酸菌の培養、お
よび両者の混合培養を行った。また、電極への電子移動
を電流として測定した。
µ‰b¶電極電位を一定に保った条件で乳酸菌を培養した
ところ、電流が観察され、生成物の HPLC 分析では、乳
酸生成量の減少と酢酸の生成がみられた。このことから、
乳酸菌内の NADH から電極への電子移動が起こったと考
えられる。また、電子移動の効率を高める目的で培地に
少量のメディエーターを添加したところ、より大きな電
流が得られ、乳酸の減少と酢酸の増加がより顕著に表れ
た。次に、乳酸菌とプロピオン酸菌の混合培養を行った
結果、電流値の増加が見られたため、プロピオン酸菌の
生成したメディエーターにより、電極への電子移動が促
進される可能性が示唆された。
- 56 -
\> zvw
} okmn †‚A,{)d,h
D-8
ê™ëNAD Ĥĸ Ŕįċ NAD ĊđěōŒÓ,ù Ą
NADP ě’2aûėĊĉLùĄçNAD(H)ĤĸŔįċ
NAD Ć NADH Ċ l ě ō Œ Ó , û ė è Ò ƒ
Saccharomyces cerevisiae ĉċç3 ăĊ NAD(H)ĤĸŔ
į Utr1pŕ¦³ĉO9ŖçPos5pŕŅĶĨŒķōĝĉO
9Ŗ ç.č Yef1p ŕ O9 ^nŖ ò D9 ûė èĐĀ ç
NAD(H)ĤĸŔįĊ 3 Ô?—zŕutr1yef1pos5Ŗċ¶
^ěûèuœŸąċçNADH ĤĸŔį‡^ěøĈ
íAµ¸•w NAD ĤĸŔįŕYfjBŖě”íĄç¦³Ċ
’²ĆŅĶĨŒķōĝŕMitŖĊ´ĉçNADH ĤĸŔį‡
^ò\àąìėñćîñěnĕñĉûė÷ĆěđĀè
êl†ëUTR1 Ć yfjB ěçþĘÿĘ POS5 ĊŁŐňŔı
Ŕç.č POS5 ĊŁŐňŔıŔĆ Pos5p ĊgG Mit ōŔ
IJŔÑ#ĊˆĉăĈíāĤŇ ŌŁŌĭŅķěÀù
Āè÷ĘĕĊĤŇŌŁŌĭŅķě”íĄçutr1yef1pos5 ěJ
ĆùĀŁŌĭŅķœīʼnijĿōŒĦě¼í禳Ċ’²^
Ć pos5 Ċ½:Ċ¿^ěKùĀèĐĀçgG Mit
ōŔIJŔÑ#Ċ
)ĉĔė Utr1p Ć YfjB Ċ Mit ĎĊÆ
ÈěHûėĀĒĉç҃¦³ě Mit –"Ʀ³–
"ĉ"–ùç1–"ĉðõė NAD ĤĸŔį‡^ě‹
GùĀèøĕĉçUtr1p Ć YfjB Ċˆĉ GFP ě»2øý
ĀıŒĽĥě¦³ą˜øý禳ěºâ[Ø
ąKùĀè
ê¨yëŁŌĭŅķœīʼnijĿōŒĦĔĖ禳Ċ’²Ć Mit
Ċ´ĉçNADH ĤĸŔį‡^ò\àąċĈí÷Ćò
6øĘĀèĐĀç"–HãĔĖçgG Mit ōŔIJŔÑ
#ě
)ùĀ Utr1p Ć YfjB ò Mit ĎÆÈøĘçgG
Mit ōŔIJŔÑ#ě
)ùĄíĈí Utr1p Ć YfjB òç
Mit ĎÆÈøĘĈí÷Ćěû¨yòYĕĘĀè
D-9
D-10
t h u@]&u6H&
bŽX‘
ê™ëP. methanolica ċŇıĻŔŎÃĊ×Ò¤ĝŎ
ĨŔŎĢĤīIJŗį(AOD)ěĝĞİĪĞņĆùĄdû
ėèuĝĞİĪĞņċ 2 žĊĩŀŊĹijĶòŌŒIJņĉ 8
ÖĎ2ûė÷ĆĉĔĖVaøĘçĩŀŊĹijĶěĨ
Ŕķûė AOD ÏCċĉŇıĻŔŎ(MeOH)ąU(
ĉÁNøĘėòçþĊ˜ċ—Ĉė$ZěîõĄíėè
béċçÏCŁŐňŔı엞ıŒĽĥ˜£ĉ
”íė÷Ćąç-ĉ—žıŒĽĥěA֘øýėā
õąĈôç\ĉ]úĄ 2 žĊıŒĽĥěéĉ˜
$Zøýė÷Ćò0´ąìėĆ°ïĄíėèþ÷ąçuœ
Ÿ ċ 2 ž Ċ AOD Ł Ő ň Ŕ ı ě ] ” ù Ā k P.
methanolica —žıŒĽĥ˜£Ċژě™Ćûėè
ê¨yë!·ÒƒĊ PHO5 ěŏŃŔıĆùçuÏCò
ĨŔķûėÓ^ĿġĭĿĜıŔį(AP)Ċ‡^ĉĔĖ 2 ž
Ċ AOD ŁŐňŔı(PMOD1 çPMOD2)Ċ˜$ZĉăíĄ
ùĀèAP ċ PMOD1 ĊiÑĊēĆçMeOH ĊđĈĕ
üĦōĮŐŔŎ(Gly)ĉĔĂĄēU(ĉ˜ùĀèlç
PMOD2 ĉĔė˜ċ Gly ąFĉc$øĘĀòçGly ċ
MeOH ĉĔė PMOD2 ˜ ěc $ù Ĉñ Ă Āè Đ Ā ç
MeOH ŒSĉLûė˜] ĉēP—òđĕĘç
MeOH ąċ PMOD1 òçäŒSąċ PMOD2 Ċ˜ò
iљąìĂĀèøĕĉçÓ¤ŒSò AOD ˜ĉðí
ĄÔąìĖçäÓ¤ŒSvą PMOD2 ċ PMOD1 ĔĖē
ċėñĉU혐ěùĀèĊ÷ĆñĕçPMOD1 ðĔ
č PMOD2 ċ—žıŒĽĥĊA֒“ĉðíĄç˜
ĭĴŔĬðĔ蘐ÖěŇıĻŔŎŠ)Öœosçøĕ
ĉċÓ¤©ÖĉĄÂ¡ąóė0´^òøĘĀè
W\>{O3!~'`xy}/
Y i
t .uHKSueBh bŽEX‘
ê™ë!·Òƒç«¹çīŋğĬŋğļĠĈćĊňĵŎ
’ě”íĀœŸòç9Ċ¯,ÏEœŸĉðí
ĄAóĈX'ěyĀùĄíėèqÇç"¾Òƒ
ŕSchizosaccharomyces pombeŖąēžě÷ïĄDøĘ
Ā¯,$Z7CĆþĊ*yòÐnøĘĀèbéċ
¯,ÏEœŸĉðíĄkĀĈšěYė÷Ćěe
ùç"¾ÒƒĊGQs’Dŕ§oM5Ŗěmøýė
kĀĈ7Cě3Gûė÷Ćě™ĆùĀè
êl†ë҃ĊM5ċ"¾M5ƧoM5òìĖç§o
M5ċ>‚GQsĉðõė’Dě§o™ĉ‹Gû
ė÷Ćąxąóėèbéċç§oM5ò›íĆøĘė
ĭĶŏĭ] ^ MAP ĤĸŔįřSty1 Ċ€hzě”íç
§oM5ěTÙøýė@ĨľŔjĩŁŏijĩŔÏC
ě|¥ùĀè
ê¨yë@ĨľŔjĩŁŏijĩŔÏCĊ|¥¨yç
%béòä‰É8`/^?—zĆùĄ3GùĀ hos2
?—zĊä‰É8`/^ě¿ûė DNA á;ò sty1
€hzĊ§oM5ěTÙøýė÷ĆòĚñĂĀèøĕĈ
ėxĊ¨yç÷Ċ DNA á;ĉċt3GĊ 80 ĝŅĻ
ÓñĕaėıŒĽĥěĨŔķûėÏCòD9ûė÷
Ćç÷ĊÏCòĨŔķûėıŒĽĥċĉ{ĉO9
ûė÷ĆçþùĄ÷ĊÏCĊÎ&˜ċ"¾ÒƒĊ
ՒzĊ§oM5ěēTÙøýçøĕĉÎÓ,„¤Ď
Ċ±^ēöė÷ĆòĚñĂĀè÷÷ąçbéċ÷Ċk
ĈÏCě ecl1+(extender of chronological lifespan)
Ć54ûė÷ĆĉùĀèĐĀç÷ĊÏCĆç@ôĊ’
žÛąM5ěTČûvĆùĄšĕĘĄíėģŐōŔ
$ÞĆĊÜēxùĀè¨yçՒzěģŐōŔ$Þ
ûėƧoM5òTčėĊĉLùçecl1+ ě䘐øý
ĀՒzĉģŐōŔ$Þě¼ĂĄē§oM5ĉAóĈ
?,òĈí÷ĆòĚñĂĀèæ
‹ƒŒ…Œ‰\> { t$4V 1uU65 2u NZ 2u
I 2u0$* 11 #a +GE
CM[u2 7X ECF:[‘
D-11
gT llkkpjqrsh Pz|}
(‡„…€{QRJ8
t f< 1D’u^ 2“u"9 ’uU c’(’bEXŽ
EC=;u“_?%ŽˆŠL)
ê™ë¢Ž¸ CCAAT-box ¨27CŕHap 2Ŗċ
“}ÔĈÒ¤ÏCěBĒĆûė~éĈÏC
Ċ ě$Zûė÷ĆònĕñĉĈĂĄíėèÇRçå
¸ċħĻņÑ#ò…GøĘçħĻņőĞķąĊœŸò
0´ĆĈĂĀèbéċ Hap 2ĉĔĖ $ZøĘė
ÏCěª¬™ĉ3GùçHap 2ĉĔėå¸
$ZĺijĶőŔĥĊě‘ûė÷Ćě™ĆùĀè
êl†.č¨yë $ZĊÏC­ěª¬™ĉ
xûėĀĒçHap 2ĩŀŊĹijĶĊ+ÝI:?
—zě”íĄ DNA ńĞĥŐĝŏĞxě¼ĂĀèþĊ
¨yç@jĊ®
ÜËÏCò c$øĘė÷Ćò
nĕñĆĈĂĀèå¸ħĻņĉ3GøĘĄíėĄĊ
ōłİŔńŎıŒĽĥŕRPŖċ Hap 2ĉĔĖ
c$øĘĄíĀèå¸ĉ)ïçÏE™xĉĘĀ
Aspergillus nidulans Ċ½™ĈŞŝÏCĊ˜ĉă
íĄēĻŔĪŒxě¼ĂĀĆ÷ęçHap 2ĉD
ùĀ c$òÅ÷ė÷Ćò"ñĖçĔĖp͙ĈÄ
ąìė÷ĆònĕñĆĈĂĀè÷ĘĕŞŝĊŁŐňŔıÑ
#ĉċ CCAAT Ñ#ěrûėēĊĆrøĈíēĊl
òìĖçHap 2ĉĔėc$ċŁŐňŔıá;ĎĊ
fĊ¨2ĉĔėēĊąĈôçÛf™ĈēĊąìė÷Ćò
6øĘĀè÷Ċ0´^ě|ûėĀĒĉ罙Ĉ
íôăñĊ RP ŁŐňŔıĉ lacZ ÏCě»2ùĄ A.
nidulans ĉNùçin vivo ĉðõė CCAAT Ñ#Ċ
´ě x ù Ā èþ Ċ¨ yç _ Ê ĖŁ Őň Ŕ ı Ċ
CCAAT Ñ#ċ RP Ċ c$ĉfÜùĄíĈí
÷ĆòøĘĀèŁŐňŔıĊDÑ#ě¦ĉÂ
ďėĆçĄĊ RP ŁŐňŔıĉÊûėŘ=<ĊÑ#
ŕśşŚŚŜśŜŚŜŖòD9ùĄíė÷ĆònĕñĆĈĂ
Āè9ç÷ĊÑ#òŞŝÏCĊ˜ĉïėWßĉ
ÜùĄ¦ĈxěÌĒĄíėè
- 57 -
D-12
¹¤¯¼pJK-UG_ „~
› ‹ˆ‡Š†ˆ‡{
Ž†Œ‰Ž‹†ŠŒ{|‚…ƒ…}Cšœ\ZpW/1
÷
č¨ĎgČīęĸĮĥĩ Mortierella alpina 1S-4 ,ĬğĪÕ
TD¥…Ļð€ĦěĠĊļŮŃŖųãĻīĜıĦĝķ0¯Īõ
Yò7ÉÅã ¡Ļ@6ěĤĖĠċĮĠ'm¨Ĩ[
t–Ļè¦ěĊIƯĻÑđęĦĥÉÅã¾fĪuDĻM
žěĤĖĠċ]‚ M.alpina 1S-4 ĩēĘķPŢńŏŵºĥ
īĊàIæĻ¢ĐĤsÇIĩ[tŢńŏŵĻiġ
İęĦĥ[tĻÑĢĤĖĠĕĊ8wĠĩ
Agrobacterium tumefaciens Ļ¢ĐĠàIT–ĩĴĶÉÅ
ã¾fĪuDĻįĠĪĥ@6ĝķċ
čx–ĎPĦěĤ]‚ĪPŢńŏŵºĩēĘķĿŮʼnŰ
“bD¥…Ļ¢ĐĊśľŗůŵŢńŏŵĪ T-DNA ï=ĩå
…£‚Ī ura5 àI¦ž¢łŌŒŕēĴĬÞ#¦žĻ
¨ĦěĠ΅£‚Ī3 àI¦žłŌŒŕĻŏųŔũĩp
ěĠ[tŢńŏŵpBIG3ura53 ĻŠµěĠċŢńŏ
ŵĻŀűńŕŲŦűŵʼnŭųĩĴĶĊA. tumefaciens C58C1 …ĩ
TěĊMortierella alpina 1S-4 …Ī[tĻÑĐĊÉÅ
ã¾fĪƒĻÑĢĠċ÷
čÀ„Ď]‚ĩĨĐKLbĻ­ĝĊ[tĪ.^ĩf%
ěĠċĮĠğĸĵĪÉÅãƒĔĵŤŋŕ…Ħī~eĨVĻ­
ĝĊ 3 àIĪÞ#¦žĩÚ9ĝķŀľņŇţųŏŀųã
ĪаĻ¬ÔěĠċÀ„ĴĶ]‚ĪàIæĩĴķ[
t–ĩDĺķĊATMT –ĩĴķ±ijĔĨĥĪĴĶKL
ěĠÞ#¦žºĪŠµĩf%ěĠċ
D-13
D-14
’%`4“MDh“&(x“>f^
B“+Á“F@3{ ¿ ti½,LJ
“ m* t½iÀ÷
Oe.IžL”—y=[-oV
›HN­§¡¼{
’M+ “` T“ A
Y!
¿ t½)À“9c¿ t½)“
½s27/ª¼¬¾À“8
;3“qQv¿ t½JiÀ“
?5“MD¿$l]KÀ
č¨ĎĎâ¼Ī—bĻ3ĚĞķĠıĪŏųŜńU
J¨h–ĪEėīĊÁtĪ¯ñij¾į1ĺĞĕËF
ĨĠıĊEFĨ{éĻ`Ħĝķî&¨ĨIJĪĕE
Đċ«²ĥīĊ⼗bĪ3ĩêĺķŽ?ÁtĪ
¾į1ĺĞĻc@ŸĩĴĢĤŰŵŰĦěĤkěĊĚ
ĵĩõ—bĨâ¼Ļ&¨ĩŔňľųĝķw
h–Ī
è¦ĻoěĠċ
č x – Ď  « ² ĥ ī Ċ 2-deoxyribose-5-phosphate
aldolase (DERA)Ħ?ĦĪ
¢ĕÃĒĵĸķ 4 á
(73, 76, 238, 239 )ĩēĐĤĊļŨŚãĪD¥ DNA
ŮľŠŮůĻŋńůŵŘųŅěĠċÀ„^ĵĸĠ 40 ĪD
¥ĩēĘķŽ?ÁtĪ¾į1ĺĞĻ›Ÿ(J¨Ĩ
oŒĭĦDtěĊªØc@Ÿh–Ī 1 ģĥ ďķ
Fuzzy Neural Network (FNN)Ļ¢ĐĤĊ¾į1ĺĞŰ
ŵŰĪr½ĻÑĢĠċ
čÀ„ĎFNN ĩĴķƒĪÀ„Ċ73, 76, 238 ĩēĐ
ĤĊ—bĩQĝķäĨŰŵŰĕ^ĵĸĊğĪŰŵ
Űĩ]ĐĊMô¨ĩīŋńůŵŘųŅĚĸĨĔĢĠ 12 Ī
D¥â¼ĻwĠĩ1fěĠĦęĹĊ12 11 ĪD¥
ĕå …Īõ—b(3 )Ļ­ěĠċ}ĩĊ
īĜıĪŋńůŵŘųŅĴĶIJõ—bĪD¥ĕSĚ
ĸĊh–Ī~&bĕ­ĚĸĠċĚĵĩĊIūŔůų
ŅŴʼnŨŬűŵʼnŭųĩĴĶĊ?Ħâ¼Ī´ŠÜĪ
ĔĵIJÃSĻÑĢĠċ
²¡£º´Ÿ¡°º¾žN˜•—º·´
¹³¼kJK šr
–PS
’M'd 1“:zE 1,2{ ¿1 w { i{ ,
J“2 w ½jR#0b #t½X
²¡£¦¡¢¼©À
č¨Ďˆ›”Ī¸ÒU®ĥīĊ·”Éĩ4ĮĸķÍ
¼ij̒Ļì+ĝķĠıĩãb§:ĕ¢Đĵĸķċě
ĔěĊğĪ5©È$ĕĝķĦ”ɺZ‡›ŶZ§
:ŷĦěĤX üûŹĕqĚĸķċ«²NĥīĊ
”ÉĻÙ(ĝķ ÷Ă楥÷üûĀāþ Ļ¢Đķ
ęĦĩĴĶĊZ§:ĩŽ¤ĝķˆ›”ĔĵĊůťşŮŞų
ŶŞŏŨų ăŸŷĪ ¡ĻÑĐĊ~›(Ī/ÈbĻ‰Ó
ěĤĐķċ«²ĥīĊļŰŃŰ(!Ļ¢ĐĤŮųŐũ
ĩ³D¥ĪÕ¦ĻÑĐĊ×njëO›ĩÄb
Ļ~ĝķD¥…ĻŋńůŵŘųŅěĊůťşŮŞųõ ¡
…Ļœ^ĝķęĦĻ¨ĦěĠċĮĠĊœ^ěĠõ ¡
D¥…ĪšŲœŁŵũƒĩĴĶ (J¨bĻ‰Ó
ĝķċ÷
čx–Ďľŏņųãī ĪůťşŮŞų1fĩê
ĝķŅůŁŃʼnŰã¿Īâ¼ľŎńŀųãůļŵō
ĻëOĝķ›ĦªĵĸķċęĸĻ¢ěĤĊĆøŪőŰ
øĆĉøŘŕŲøĆøŘŕŲŎŅļŘŊųĩĴĢĤ³D¥
ŸěĠ΅Ļľŏņųã4~RG>;ĩBWěĊľŏņ
ųãÄb…Ļœ^ěĠċůťşŮŞųīöÍĪ›ĥ
ďĶĊņŲŘŵĪÍĪ™˜ĻoŒĦěĤD¥…Ļßě
Ġċœ^ěĠD¥…ĪšŲœŁŵũƒĻÑĐĊŏųŜ
ń¦žĻå <…Ħ‘ÛěĠċ÷
čÀ„Ďý÷ą ůļńŏŵĩēĐĤå …Ļ¢ĐĠA1Ċ»
¶Ĩϯ”Ļ¢ěĠ>óĥīĊůťşŮŞų™Yī
üùû÷Ĉúą ĥďķċxĊ8œ^ěĠD¥…ī2‹Ī>
óĥ ýùÿ÷Ĉúą Ħ ¡bī ý ĩyěĠċĮĠĊš
¼ĻZ§:ĦěĠ>óĥIJ2‹ĪÀ„Ļ­ěĠċ
\īĊD¥…ĩēĘķ×ĪD(ģĐĤƒĻÑĐĊ
}ĨķůťşŮŞųÞ# ¡…Īœ^Ļoĝċ÷
D-15
€‘~­£¤¨º·±¥»£¨¯›oV
/š6L™¶©¶µ¼®¸¬¾«›=
[<{
’
a“(qg"“nu“
&({ x“F@{ 3
¿ t½i½,JRÀ
č¨Ď2ĉ-ŔŁŃʼnůťřńűŁʼnŖŶdNSŷī PCR Ī|
,ĊàI•Īè¦Ċ†ãºjĿĽŰŋ!Īè¦ĩ
ĐíĪlFĕdĚĸĤĐķċgČīřńűŁʼnŖ
ºâ¼ÂĦ¹ºĻłŒšůųŅĚĞĠŧŰőŋœ
Œšâ¼–ĩĴķĊŅŰņŵŋĊļŌŕļŰŔŝŖĊ†ã
C?Ļ*vĦĝķ dNS 1f–Īè¦ĻįĤĐķċ
«²ĥīçâ¼ĦĨķŤŋŤţųŕũŏŵōŶPPMaseŷ
ĩêěĊůųã(1›Äbâ¼Īè¦ĻįĠċ
čx–Ď dNS ¡šŲŌŋīĊŜųâĪ ATP ºĻ¢ĝķŅŰņŵŋĔĵĪşŰńŕŵŋ 1,6-ůų
ãŶFDPŷĪÕTĊŔŁŃʼnůťļŰŖŮŵōĩĴķ FDP
ĦļŌŕļŰŔŝŖĔĵĪ 2-ŔŁŃʼnůťŵŋ 5-ůųã
ŶDR5PŷĪ1fĊPPMase ēĴĬřńűŁʼnŖŤŋŤůŮ
ŵōĩĴķ DR5P Ħ†ãC?ĔĵĪ dNS 1fĊĪ 3 ŋ
œŒšĔĵĨķċęĪ ¡šŲŌŋĩēĐĤĊšŲŌŋ
)ĩĤ" ĝķ FDP ĨħĪůųã(1›ī PPMase aĩëO¨ĩ¢ĝķċğęĥgČīĊdNS ¡ĩ~
¢ Ĩ ů ų ã ( 1 › Ä b PPMase ¡ Î Ļ r ½ ě Ċ
Bacillus sphaericus AKU229 … Ļ ^ Ġ ċ Ě ĵ ĩ B.
sphaericus £‚ PPMaseŶBacillus PPMaseŷàIĻF
ÊÎĩńŲŵŘųŅěĊE. coli £‚ PPMaseŶE. coli
PPMaseŷĦĪÈ‘ÛĻÑĨĢĠċ
čÀ„Ď Bacillus PPMase ĪFÊÎĥĪ¦žºĻ¬´
ě Ġ ċ Į Ġ Ċ Bacillus PPMase ĕ ę ĸ Į ĥ ĩ g Č ĕ
PPMase HĦěĤ¢ĐĤĐĠ E. coli PPMase ĴĶIJõ
Đůųã(1›ÄbĻ­ĝęĦĻzĵĔĩěĠċĚĵĩĊ
ŅŰņŵŋĔĵ_ ›ÖÒěĠ DR5PŶFDP ĨħĪůų
ã(1 ›Ļ 4~ĝķ ŷ Ļ ?Ħ ě Ġ- aĩē ĐĤ Ċ
Bacillus PPMase ¦žFÊÎĻ PPMase HĦěĠA
1ĊE. coli PPMase ¦žFÊÎĻ¢ĐķĴĶIJ&¨ĩ
dNS 1fĕÝÑěĠċ
- 58 -
fD)X_M5”œ“‚›€
{}~1;B[)|s
D-16
ub=*v84/:v>Zv ž#¡v4d ž#v
k.2ŠŒŸ¡
Đ³đĊ _§ Ł©ēĦ §¨ıčVšV8ī,
aĘîàğč,aŒŜŚŨĸ´ÌīęĽĝĬėĻč(I
,aŨŷŔŒijİa©Ę[ĞľĪēĽĎ­’b=
īı~œF-’ÁőŒŜůĘ~'īĒĽĬÑĕĻ
ľĽĘč_§ Ę~œFįOğĪÓbŁoĩĝĬĘ
÷ĬĮĽĎµºīıč GőŲŪŷŸÿíñG
įĺĽ~œFÓbŰňŠœůijİ'„Ł‡ãğĦĎ
Đw•đĊ ~œFįs\İñG±£ƒįĺļč
~œFÓbįÿġĽñGÐİmŹÓb…İ
dŁpğĪęĦρµºīıčñG±£ƒī
JV³įĉ±£ğĦñGÐįÅ×İŒŞŶŒa½į
ÿġĽ GőŲŪŷŸĘBĚĞľĦĝĬėĻč
GőŲŪŷŸÿíñGŁCÚÝįPğĦĎĝľĻ
İőŲŪŷŸP…Łč~œFŁ÷TğĦMD<:
ī 30Čč24h <ćğčŎŷŠźZd¢įĺļ~œFÓ
bŁ
ğĦĎ
ĐȄđĊ ‰ā¦?ī§ÔġĽčçEŸb.ÅÝ
Pyrococcus horikoshii OT3 ª‚ŨŶŦņŵŝŃŸñ
GP…įĖēĪč~œFÓbİ2ʶäĞľ
ĦĎ~œF˜& 3 zþ\İÅ×ũʼnŏŸXŁ›
JğĦĬĝĿčŨŶŦņŵŝŃŸñGPįĺĽ~
œF-ļĶùʙQğĦĎ|įčőŲŪŷŸ—bİ
ğĦŨŶŦņŵŝŃŸ N €čĖĺIJ C €ŽuA¬Ł
©ēĪ~œFÓbŁ
ğĦȄčÓbİ2ı
¶äĞľĢčøb…İŨŶŦņŵŝŃŸĉ±£…İĶ
ÓbĘ2ğĦĎİĝĬėĻčŨŶŦņŵŝŃŸİ
GőŲŪŷŸ—bįĺļč~œFÓbĘ2ğĦĬ
ÑĕĻľĽĎ
D-17
‡›Œ˜h„›–…ˆ™Ÿ‹|‘
ƒ“‚—Ž€†‰7zcHy| t
3pN%Œ’†|OG7
D-18
6"\v-Ln¢u9i?( ^žmžqE¡
Đ³đĉ¼§ ª‚İŋŵŗŮŸöŝňŵūʼnőųź
ŕŻGADżıŽi#b¸Çï īĒĽċ-łŮšô
öŻGABAżİ0dŁnĔõÃīĒĽž¹ąİ¬ĮĽ
ñG¨ īĒĽłńŖŦņźůİH9ĘyĻėįĞ
ľĪĖļŽÙĮĭīıŽ1Å×įwİłńŖŦņź
ůĘ1zį±£ġĽĝĬĺļŽS9bŹ—b#^ĮĭB
Ěİ®5ĘjĜėěĻľĪēĽžYµºīıŽłńŖŦ
ņźůþİ1bŽńŸŞŷŸĬŅʼnŖŸİÎÿŽ
»ŠìīİŅʼnŖŸòĮĭ݃ŁŢńŇńŸ
ŦņŭŜŃŊŒg•Ł©ēĪàĨĦžĵĦŽGAD ıÀR
°İÜU¯k+ŗŸţŊīĒļŽŗŸţŊĬğĪ
ݬV±£İ~žįÿğĪ–ĞľĪēĽžÖī
ıŽŒŨųńőŸŋ¬VįĺĽ GAD25 ݱ£Ę>3Ğ
ľĪēĽĘŽĤİ
İ>3ıĵħĮĞľĪēĮēž
6Žß¤įĖěĽ GAD ±£İƒŁàĨĦİīŽĤİ
Ȅĸ0ŀģĪ>3ġĽž
Đw•đŢńŇńŸŦņŭŜŃŊŒƒıŽWeb īý
ĞľĪēĽśźŵŁ©ēĪŽōšůƒÈ„Ł=įğĪ
àĨĦžŤŞª‚İߤėĻŽ*¤Ł-ļğŽWestern
blotŽRT-PCR įĺļ GAD ݱ£ŁƒğĦž
ĐȄŹÑNđGAD ı 16 İŅʼnŖŸĺļŠdĞľŽŅʼnŖ
Ÿ 1ſ3 İ1bıēžłńŖŦņźůþīńŸŞŷŸ
İq¾fıHĞľĪēĦž€†ßīıŽ30 Ĭ 80
KDa İŢŸşĘ GAD65C €Ą;ŁäåġĽkįĺļ
Western blot ī¶äĞľĦžGAD65/67C €äåkī
ı¶äīęĢŽRT-PCR ƒİȄŽGAD65C €¡¬
³kİŅťŞźŨĄ;ı@WĞľĦĘŽGAD65/67
Ą;ı@WīęĮėĨĦžŅʼnŖŸ 15 Ĭ 16 İ?«į$
ÒİŅťŞźŨĘÎġĽĝĬĺļŽ±£ŗŸţŊİ C
€Ą;ıŽŅʼnŖŸ 16 ʎuğĪēĽ/ØbŽĩĵļŽ
ÆÍ¡¬³ŒŨųńőŸŋ¬VŁ·4ġĽž
lKQj•”|•”“
‚—Ž€†‰{}~@)s
u
`Vv
e0vL'v
>Z #RUT¡v
4d #RUTv
k.2ŠŒŸ¡v6$<
¡
Đ³đ‹ďĮØ³ŪŨřşİrÄįĖěĽ}Cİ
7Ăıč20 ¹ąİłŮšöİÆĶ0ŀģvĘüûŪŨ
řşĹăDłŮšöİ"©įaĠĪÛCĬĮļčKĈ
³ĮrÄĘ/ØīĒĽīĒĽĎĝİĺĔĮă'¢³
ĮrÄīı³İØŁoĨĦŪŨřşŁ]ĻľĽ¶
¢ĘăVįēĎĝİĦķčKĈŝźŗŁc>¥h
áīƒġĽĝĬīĆé³į'¢(ġĽháʓķĻ
ľĪēĽĎµºīıčx8©Łoĩ§ŪŨř
şīĒĽ Angiotensin II (AngII)įÈ0ğčĤݧ—b
ŁĀLġĽŪŨřş(VVIVIY)ŁįčŪŨřşłŶńĬ
c>¥ƒİg•Ł©ēĪØbĘĺļ2ġĽ
ĺĔĮŪŨřşİrÄŁàĨĦĎ
Đw•đŪŨřşłŶńŁ©ēĪčVVIVIY ó!Łį
120 ¹ąİŪŨřşųńŧųŴŁŒŊŴźŠŸŋğčĤİ
ȄŁ=į 1 =Ît'„İĉēłŮšöŁËϳį
ÆĶ0ŀģĦŝŐńŸųŸŘůųńŧųŴź3360 ó!Ł
ĞĻįŒŊŴźŠŸŋğĦĎĤİ\čĤİȄŁèĵĕĪ
Ang II È0ó!Ðİ¡`Ł Fuzzy Neural Network Ł©
ēĪc>ƒğčŵźŵmğčŵźŵį”ĨĦŪŨ
řşŁĞĻį 256 ¹ą0dğč³İØbŁoĨĦŪ
ŨřşİH9¢İ2Ł¶äğĦĎ
ĐȄđȄč6mer ŁËÏġĽ 6400 ¹ąİó!İ
č 16000 İ 1 İŏńœİŒŊŴźŠŸŋŁàĔħě
ī VVIVIY İ Ang II È0ŪŨřşĘ 60 ]
ĻľĦĎĵĦč*ĮĽųŸŘůųńŧųŴėĻİrÄį‘
ĴĪčFNN įĺĽŒŊŴźŠŸŋwúİv6ݏ
ıčŒŊŴźŠŸŋ'¢ŁCWį2ġĽ'„ĘĒĨ
ĦĎ
D-19
CX]aP+WKwx
Burkholderia cepacia M5š’Ÿ‹|
FN)|,
uLn&v!rAv
` 1 v
iSo mIgv1 JYR¡
ĐÕ{Ź³đBurkholderia cepacia KWI-56 …ª‚İŴţźŕ
ıӟbĹÓ~œFbįľĪēĽĦķ¨ˆ"©Ę[
Ğ ľ Ľ õ à ī Ē Ľ Ę č I — b ( 0 ī Ē Ľ 2-phenyl
propionic acid ester įOğĪı) Į&’ —bĖĺIJ
IðlbŁ·ĞĮēĎĤĝīµºīıčŴţźŕİA¬
ųńŧųŴźŁŠ¿ğč2-phenyl propionic acid ester įOġĽ
ĉē&’ —bĮĻIJįIðlbŁoğĦA¬Ŵţ
źŕŁ]ĽĝĬŁĶĦĎ
Đw•ŹÈ„đ$įeďıč G PCR •ĬžÅ×Þ²
0dÁŁÆĶ0ŀģĪA¬Þ²ųńŧųŴźŁŠ¿ġĽő
Œ Ŝ ů č SIMPLEX Ż Single-Molecule-PCR-linked in vitro
expressionżŁý±ğĦĎĝİőŒŜůīŠ¿ğĦA¬ųńŧų
Ŵźıč§Å×Áīı±£İĂğēÞ²īĸêëį0d
īęĽčõ×bĮĭŁpŒĬğĪŒŊŴźŠŸŋīęĽ
¼İ¡`Ł~ġĽĎµºīıčŴţźŕĬOæ=İ0
ŠìűŝŵėĻčA¬PòŁ­’bŬŌŚŞİ 4 ¾
fİłŮšö=įÉļĶčĤľĥľŁ 9 ¹ąİ­’błŮ
šöīÁʳįÎtğĦA¬ųńŧųŴźŁ SIMPLEX įĺļ
Š¿ğĦĎâğĦųńŧųŴźŁ S-=įOġĽ —
bŁpŒĬğĪŒŊŴźŠŸŋŁàĨĦȄč S -įOğĪ
Į —bŁ·ġA¬ŴţźŕŁ]ĽĝĬįd%ğĦĎ
- 59 -
]ª¢¯œŽ’“U8¥©šž
˜¤•«§±PBS  PBS/A²
D-20
0E9'Š‰fW(aŠcJŠ0E
3Š±j&+ 7VUS
+j²
đ²Ē®%jţ ŮŐŕŖňšłŰũĩēĽ PBS Ī
PBS/A įĎńŐŗŰÉ8ĩħĬęĦĥŒïŀuħê
šłŰũĩēĽďğĘğĎPBS Ī PBS/A ĮńŐŗŰÉ8
įĎAŴ”¿ĭOBĠĽf®¦°…ĮÒ%õ
ÅůŝŵœĭĺĦĨTĭ&zĞľĽďƒµ½ĩį7
¼f®¦°…Įůŝŵœŀ¯ĔĨĎPBS Ī PBS/A Įš
łŰũĮ%Ñŀ’ëğĥďůŝŵœĮ§jĪ%ÑĪ
Įüŀ%NűŤŰĩ~ĻĘĭĠĽĝĪĩĎĝľĻšł
ŰũĮ§jĭ8Ħĥh¯—Ĺ¯dĮìîĬ%—
ŀŽÆĠĽĝĪŀ²Īğĥď
đ|—ĒŅůŵޖ1—ŀ¯ĔĨĎÄŻż¼ĄĮf®
¦°…ĮõÅůŝŵœĮ’˜jŷ2į unit/mLŸŀ•
ķĥďůųöGÊܚĭĝľĻõÅŀ9Į˜j¢\
ĭĬĽĺĕĭ ĞĢĎPBS/A šłŰũŀ™¡ĞĢĨĎ%
Ñŀ’ëğĥďPBS/A šłŰũįèfùL¹
0.001mgŀ¯ĔĨšłŰũĮ÷ùĮžXŀv
¹ùğĎPBS šłŰũĮ%ùį $ğĥ¤Åùŀ
TOC(¤ÅŸRÞÍ)ĭĺĦĨŸRğĥď
đɇĒŅůŵޖ1—ĩ’˜jŀŸRğĥɇĎõ
ÅĮ’˜jĮKWĪšłŰũĮ%î\ĪĮûĭį
üįĬĔĝĪę%ĘĦĥďÖ²:ĪğĨĎPBS/A
Įf®¦ůŝŵœĭĺĽ%jįĎÇØůŝŵœŽņ
şůŝŵœŽõ‘ůŝŵœĮāĩēĦĥď
%î\įĎõÅ¢\ęĔĂDĭėĔĨĎijĴ¢
\ĭ’ğĎõÅ¢\ĮĈĔĂDĩįijĴRĪĬ
ļĎĆ=¬æęĻľĥďĝľįĎõÅ%NĮšłŰũ
ÝĀıĮ<³ùĮĆ=ĮĥķĪÏĖĻľĽďĊ
ÇØůŝŵœŀ¯Ĕĥ TOCŷ¤ÅŸRÞÍŸĭ
ĺĽÉ‡ĎPBS/A šłŰũį PBS šłŰũĺļĸÄźżŹ
ĮĈĔî\ĩ%ĠĽĝĪę%ĘĦĥď¬BĎõÅ
ĮšłŰũÝĀıĮ<³ŀãIJĨĔĽďĊ
„†ƒ £¯›Ÿ•š¥¬–M”V‹Œ
„†ƒ#)oVGM{
D-22
‰HAr) ~{ 1*> ‚~{ cu% ~{
.B"' ~{ l\t  {|{ &q®U
i~{‚ p4&q®T{ }
đ²Ēƒµ½SĩįĎW/O ńŧŰŏŭų!ĩşŵő@
R1 PCR ţŮŃŧŵŀ¯ĔĨÚĬĕ%N PCRŷńŧ
Űŏŭų PCRŸĭĺļĎŧŃňŲşŵőĭ DNA ŮŃŢŮ
ůŵŀ@R1ĠĽqÛŀú±ğĎĝľŀ¯ĔĨŪŔŜŵ
Űç1jÇØ Paracoccus denitrifcans ŊŜũŮŃŢŮů
ŵĘĻĎP. denitrifcans °…Į#?N PhaR Į{É
8ĂDĮªeĭm.ğĨĔĽď
Ċ ƒµ½ĩįĎ嬯 Aspergillus nidulans Į#?N
ĩēĽ AmyR ŀ4ļĜĎÃĮ·¾ĪĪĸĭĎAmyR ę
áåĠĽ DNA ô'ŀ~ĻĘĭĠĽĝĪŀ²ĪğĨĔ
Ľď嬯 Aspergillus nidulans °…Į#âV?N
AmyR įĎAspergillus YĮŁŨŮŵœóNÎĮţŲ
ūŵŔŵĂDĭÉ8ğĎ#ŀ˜j1ĠĽď
đ|—ŴɇĒńŧŰŏŭų PCR ĭĺļĎŧŃňŲşŵő
ĭ DNA ŀ@R1ğĥďĭĎMalE Ŕʼnŀ
/ğĥ
AmyR1-411 ėĺİٍåğĥr MalE Ŕʼnrŀ/
ĖĥďĝĮ€Ď#?NĮáåĠĽ DNA ę@R1Ğľ
ĥşŵőĩįĎşŵő-DNA-#?N-ٍår
Į8ębmĞľĽďĝĮÙŀĠĽşŵő
8ŀ FACS ŀ¯ĔĨìîĭòsğĎAmyR ĮŔŵŊ
ŖŘô'ę¢ÌĞľĽĝĪŀ·áğĥď
¦ªkVvx8FS5 €€°
;{
D-21
D-23
0E9'®‰,a±j&7VU
S²ŠO s ®$ ‘ ± c eL
±C²²Šy@6t®?=Q±2Y²
đ²ĒŦůöįQĩľĥ¦jŀĸĦĨĔĽ ĥ
ķĎdĮ®%jŦůŧŵŷŠ¦ţŮŐŕŖňŸĪğĨ
ĮZEtKę‚cĞľĽďğĘğψêjęğěĵĥ
ÐÜwję^ĔĥķĎšłŰũĹŎŵŘĬīĮ%øĩ
Įh¯ĭÕĦĨĔĬĔ½ĩįĎŦůöĮê
1ĮĥķĮ6F,ŀŠ¦°…Į3yĘĻļ$ĠĝĪ
ŀ²Īğĥďdϛ+1ęliĞľĽąÁ>ăŀ
ÏkğĎÿ6ąjĮŠ¦–ÒĩēĽŞŧŎ–ŀ*¯ğ
ĥx,Įú±ŀ²Īğĥď
đ|—ĒŦůöĪ6F,Į jŀĈķĽĥķĭĎŅů
ŌöęÉ8ğĥŞŧŎ¶1–ŀŞŧŎ¶1–ĪŮňŕ
řĘĻ
Mŀ¯ĔĨ1P²|—ĩ8mğĥď8mğĥ
6F,(HyCaLa Īº)ŀŦůöĪœËğĎŢűųř
Į¦jĹ®%jŀ%†ğĥďĵĥĎHyCaLa ÔĮ
®%jĭħĔĨį BOD —ĭĺļ(Rğĥď
đɇĒŞŧŎ¶1–ĪŮňŕřĮœ8-8ŀIĖĽĝĪ
ĭĺļ[C%NùŷMwŸę 2,000 ĘĻ 5,000 Į HyCaLa
ŀ8mğĥďŢűųřĮ¦jį]_ļćĪŎŬŰŠ
ŵÜwćĭĺļŀÚĔĎģľĤľĮ%NùĮ
HyCaLa ŀ 20ž30Ŷ»\;ĶŢűųřŦůŧŵįİ
« ĭ ė Ĕ Ĩ 0 ‡ ę ēĽ ĝ Ī ę ĿĘ Ħ ĥ ď ĵ ĥ Ď õ Å
Protenase K ŀ¯Ĕĥ%jĮćɇĘĻĎHyCaLa
Įô8ùę JĔijī%ę ðĞľĽĝĪę ĿĘ Ħ
ĥďBOD —ĭ弮%ćĭėĔĨĎfÀ1ğĥ
HyCaLa į®%jŀĸħĝĪę·áĞľĥ½ĩ
8mğĥ6F,įĎŦůöĭíĮäjŀĖĽ
ĥķψêjĹîĹĘĬ®%jęgĬ%øĭŦů
öŀh¯ĠĽýĭ*¯ĞľĽĝĪę‚cĞľĽď
dw¥©›¨­z”V‹ŒŠD
-
…ˆ‡ <ª—­ š˜ª¯¡­™
MZ_{
‰m/ 1)³h 2)³`Rg 2)³K
!' 1,2)³[PN 1,2)
1)
j&q7VUS³ 2 ²j&+USIb
nXY^:
đ²Ē‰!5TĮůŇųř˜jĮ—įĎ®¦˜
jĪ¦­1P²jĮĭK)ĞľĽďnĐįύ
åű×ŀĞġvĘħůŁŰŔŃũĭ LXR ĪŋŁň
ŕŤŵŔĮÉ8ŴþĮ`^Īî\ŀŸRĩĚĽÝĀ
ţŮőūų ĉŀ*¯ğĨĎLXR ůŇųřŀ¦­1P²
jĮĀĘĻŐňůŵśųʼnĠĽp—ŀ·¾ĠĽĥķĭ
„‹àŀÚĦĥď
đ|—Ē ŸRĭį Biacore3000ŷBiacoreAB,Ċ Uppsala,Ċ
Sweden Ÿ ŀ ¯ Ĕ ĥ ď Ş Ř Į p160 Steroid Receptor
Coactivator Įťţŕřŷaa.676-700ŸŀşŅŕų1ğĥĸ
ĮŀŒųōŵŕŖţ SA ĭ@R1ğ Ďć18¦Ī
hLXRċ-LBDŷaa.207-447ŸĮœ8šŀ DMSO ęÈ¢
\ 5%ĪĬĽĺĕĭãßğĨŁŚŮŃŘĪğĨ/ğĥďU
¥ĭį}´ LXR ŁŌśŐŘĩēĽ T0901317ŷCayman
Chemical Ÿ ŀ ¯ Ĕ ĥ ď ŕ Ŗ ţ Į " ® ĭ į
0.5%SDS/10mM-NaOH ŀ 1 %û/ğĥďŮųśųʼn
Ê Ü š ĭ į 50mM-Tris-HCL(pH7.4), 150mM-NaCl,
1mM-EDTA, 0.005%Surfactant P20, 5%DMSO ŀ 0.22
Čm ĮšłŰŔŵĩ£ñğĎӓğĨ¯Ĕĥď
đɇĒ T0901317 į¢\O²ĭ LXR Ī SRC1 ťţ
ŕřĪĮ¯ŀH`ğĎģĮűŐŦųŐį 25čĩ
20 € û Q R ğ Ĩ e Ļ ľ Ľ ĝ Ī ę · á Ğ ľ ĥ ď
T0901317 2©ĩįűŐŦųŐŀ·áĠĽĝĪęĩĚĬ
ĘĦĥďĝľĻĮɇĘĻ Biacore3000 ę LXR ůŇųř
ĮŐňůŵśųʼnĭ*¯ĩĚĽĝĪę¸Ğľĥďŀé
ĵĖĎaµ½SĮoĠĽL¦°…Į18¦ŮŃŢ
Ůůŵŀƒ—ĭĨŐňůŵśųʼnğĥɇĎÄ 600 ōųţ
Ű 1 ōųţŰęĎ¯ùO²ĭ LXR Ī SRC1 ťţŕ
řĪĮ¯ŀH`ĠĽĝĪę·áĞľĥď
- 60 -
`L?v&{}u
ON$*Sj
…–œ„šx<)
p :P kŸ5a/ lŸiU kŸj
E-1
j j 3^ kŸ72" kj
k [Dd›@=!Ÿl [D››MTž
þ’ÿé 2ļŚŢĻŠĠť¢)¡¦ĝ+ĦįĮkĩ»Aĝ:
0ĎĮńŠōĹ
ęĀĭťŒ‹’pę­H
)Čʤ£
wÁıO[ĎĮŦČąČļŚŢĻŠ¤£O[ğ9ŖķŋŁŕ
ĝėāĘĠťnĔhĜĆ7āŦ\ýĠĉįĦęĝťijĹ
ņŋŅĴŠÚîøö÷ðñóðÙ õðõ÷ñïíöðÛęÐ>|ČēļŚŢĻ
ŠÚäÜåôòÛğ¤£O[¬ĆĎĮĉĚıhĬąĝČēŦo‘
¶ęĠť–G¼t†ËÚæìåۃ>ĝīĭťőŏľŠ‹ļŚ
ŢĻŠÚëÜåôòÛ
)Ě äÜåôò )ğ†—‚LĪŎŢĹ
O‰ı{¿ĎĮĉĚęť×ywÁğGąĬŒčĮ†;’
”ıRĮĉĚı’ĚČēŦÙ
þg}ÿŋşʼnś“ÆąĬJ}ĝīĭÉ'„Wú2ļŚŢĻŠı
`ČťđįĒį ëÜåôò Ě äÜåôò ıº¸ČēŦ(ļŚŢĻŠ"
9Ě
)ğ†<>WıºģĮēĨťõèÙ áÝÞ Ě õèÙ ãÝâ ę
æìå ƒ>ČēŦĦēťƒ>ğÓ§iÍğPÔıºģēŦÙ
æìå ƒ>pĝĄĈĮļŚŢĻŠ
)ğ×ywÁğOY
ı¼t2Ò9ÕTÌÚìçêÛĝīĭBČēŦÙ
þ¢rÿ"9‰YÚõèÙ áÝÞÛğ äÜåôò ğ†—j¤ĠľŠĺ
ŜŎŢĹÙ ÚááùåÛęĀĭťëÜåôò Ě®ČēŦäÜåôò )ğ
æìå j¤ÚõèÙãÝâÛęĠťà ėğŎŢĹĆ¹ĨĬįēğĝCČť
ëÜåôò )ęĠĝ ß ėğŎŢĹƖċįēŦċĬĝť
)ęğŎŢĹO‰ĝÕ²ĜÄāĆvċįēŦĴŠĸŘŐ
ŢľřŠiÍĠť×‚ğŎŢĹO‰ĝPÔı$ĥĎĉĚĆ
hĬąĝĜĖēŦĦē äÜåôò )Ġťú2ļŚŢĻŠğˆ
UęĀĮ¤£O[¬ğĆ ìçêÙ ĝīĭBċįēŦ
ğ¢rīĭťijĹņŋŅĴŠ‹ĠļŚŢĻŠ
)ĝ†<>
W6!ıĚĩĜĂ×ywÁ6!ıNć½ĉĎĚcBċįēŦ
E-2
A dipeptide YY derived from royal jelly
proteins inhibits the renin activity.
pAfroza Sultana1), A.H.M. Nurun Nabi2,
Uddin M. Nasir2, Hiroe Maruyama3,
Kazu-michi Suzuki3, Satoshi Mishima3,
and Fumiaki Suzuki,2.1) (1)United
Graduate School of Agric. Sci. and 2)Fac.
Appl. Biol. Sci., Gifu University,
3)
Nagaragawa Res. Ctr,
API Co. Ltd.)
Objective: Royal jelly has been recently reported to
posses the antihypertensive effect by the inhibition of
ACE in the spontaneously hypertensive rats (SHR).
Renin is the key enzyme in the renin angiotensin
system. In this study, we investigated the renin
inhibition of royal jelly protein and its derived
dipeptide YY.
Methods: A dipeptide YY was isolated from digestive
fraction of royal jelly protein fraction by HPLC. The
renin activity was measured using recombinant sheep
angiotensinogen at pH 7.0 under the standard assay
conditions.
Results and Conclusion: Inhibitory effects of renin
activity were observed by the protein fraction and
dipeptide YY. The Km value of the substrate;
angiotensinogen was 0.15 M and the Ki of YY was
10 M. Besides this, the dipeptide YY showed the
systolic blood pressure lowering ability after the oral
administration of it (10 mg/kg) in the SHR by
approximately 12 mmHg.
Therefore it can be assumed that the dipeptide YY
could be beneficial for the supplement of
anti-hypertension and prevention for its related
complications.
E-3
‘™—0RhVJKwst|˜‘š›
~šˆ‚š‡šK8*x]E>
pC/ žq;_ žq34X¡žqb
1-. ž ¡ž  ž c›d›Z›@=Y@
Aq¡ž(B@H›f@ž
þ’ÿŝŋŠšijŠĿĶňŠľŠţRAŤğk ‡ęĀĮij
ŠĿĶňŠľŠ II Ġûµš“Ÿ«5z/9ğÅ9‘Š
ıÂĎĮĉĚĆ4,ċįûRA ĚµšfŒĚğÎĆkÀ
~ċįĘāĮüo•˜Ġûŋşʼnśmª#صšĝĄ
ā Ę © ğ Î ı h Ď Į ē Ĩ ĝ û Ħ ď Hamburger
Hamilton StageţHHŤ17 ĝĄĈĮ#صšĝĄĈĮ RA 
w[/9ğ mRNA ğ:0ĄīġđįĬğŝŐŜıhĬąĝ
ĎĮĉĚı’ĚČēü
þg}ÿŋşʼnś&œ#ıJ}ĝČēĆĖĘ HH 17 Ħę#3
ÖČēüDq³€ğļŠʼnŞŢŜĚČĘĎĮĉĚı¨
ZČĘû#صšĝ PBS 100 μl ı€QċĬĝÓ§3ÖČ
ēü€Q 0.5 iÍąĬ 2.5 iÍĦęû0.5 iÍĊĚĝ#ص
šğħıb%Čēüb%ĽŠŏŜıŒŗĿŊĴŁČēğĕû
J}ĝČēĆā mRNA ı`ČûRT-śijŜńĴŕ PCR }ĝī
ĖĘ RAS w[/9ğ mRNA ı>ËČēü
þ¢rÿ#صšĝĄāĘûRA w[/9ĎĜİĕijŠ
ĿĶňŠľŌŢĻŠţAngNŤûŝŋŠûijŠĿĶňŠľŠ6d
ȞţACEŤûijŠĿĶňŠľŠ II ńĴŏ 1ţAT1Ť&@ûńĴ
ŏ 2ţAT2Ť&@ûţŏŞŤŝŋŠ&@ţPRRŤmRNA ğĎģ
ĘĆvĄīġ>Ëċįēü
đğęׅLĝ:0ČēğĆ AngNûACEûPRRû…
LĆ AT1ûAT2ûkĩ…LĆŝŋŠ mRNA ęĀĖēüƒ>
iÍĝĄĈĮ( mRNA Ëğ6 ĠûAngNûACE Ąīġ
PRR ĠlXĜ5ĦēĠFĆħĬįēügûŝŋŠû
AT1ûAT2 &@ĝėāĘğ6 ĠĤĚIJěĜąĖēü
īĭûHH 17 ğŋşʼnśmª#صšĝĄĈĮ RA 
w[/9ğ mRNA YĆBęćēü
E-4
nom ”Œ•–œ‹x’Žƒ€šwz
|'Wyx%ej
j
r9qC#Q(G+d›6
g›f6gqG+d›–“†
š‰A\,FIŠ)
þ’ÿ
VţcentrosomeŤĠ ‡Ÿ«ğŸ«E.=ęĀ
ĭû·mĝĄāĘ8Ÿ«Ģğs¯ğ1™Çğ
ēĨğ·VğĠēĬćıĎĮüÅ9^‡
p53 ĠVğ¸ı^’ĝº›ČĘāĮüDNA ğ
ĞčįıIć]Ď DNA ʼnœĴŃŖŚŢł IûIIţtopo Iû
IIŤıŌŇĹŅĵŠċĐĮĉĚĝīĮV¸ğPÔı
p53 xeŸ«šÊŒ2Ÿ«ıŽāĘºtČēü
þg}ÿ
p53(+/+)Ě p53(-/-)ğŔĵŀ¥£°Ÿ«ţMEF cellsŤĢŔĵ
ŀ topo Iûtopo II ğ siRNA ŐĹńŢţpSUPERŤı
FuGENE 6 ıŽČĘ transfection Čēüpositive control
ĚČĘ 10 ğ 1 Ëğ GFP-C1 ŐĹńŢı*iĝ€Č
ēü48 iÍ3ÖQğŸ«ıs¯ČĘąĬ´Õ
TÌęBČēüđğÑĝ topo Iûtopo II ğ‘ŠËĠ
anti-topo Iûanti-topo II _ęûVĠ anti--tublin
_ęs¯Čʃ>ČēüŸ«uĝėāĘĠ DAPI ę
s¯Čēü
þ¢rÿ (+/+)
ţŧŤp53
MEF cells ĝėāĘ
p53(+/+) MEF cells Ġûđį­¾ĝVğJ¸Ġ
ĬįĜąĖēütopo I, topo II ĝīĮŌŇĹŅĵŠę
VğJ¸ĆĬįĜąĖēü
(-/-)
ţŨŤp53
MEF cells ĝėāĘ
p53(-/-) MEF cells Ġûđį­¾ĝVğJ¸Ć
±KĬįēütopo I, topo II ĝīĮŌŇĹŅĵŠęV
ğJ¸Ć5Čēü
þ¨Bÿ
p53 ĠV¸ıSšº›ČĘāĮĉĚƔĬįĘ
āĮĆûtopo WıÏ?ĎĮĉĚę DNA eıaćû
Ÿ«-mĆÃMĎĮĉĚęVğJ¸ıNć½
ĉĎ̨ăĬįĮü
- 61 -
}ƒ„Šˆ…„‡†‡ u– ~€} ¦ª¨©®ŸŒ¢¦
™ ¨©®Ÿr(I3”¤¢be!E
5I3z
E-5
`Kj# 1 ŒG 1,2ŒS.c 1,2
(1 Z4%s"­AwŒ2 Z4%s"­©™
¥œ™š¬Q%l6Y^ž)
Ĉ£ĉAcetogenin æħąŕŨŦĻń¨Ħ”Sũ”S
ƒ•ďijĔĶěÿÜÏPġĊĴąg_ı
žf$_Đ>3ĔĶĠċĵĆ-© Acetogenin æĢ
ęĦàķxˆ)J.dĕĠąDNA ŞŤŢţŪň
(pol)ąŐŞĻʼnŢţŪň (topo) ĦâM_ĢŗŐµÁ
?‹f$_ĥğċĠЂĕěĆ
ĈtĉAcetogenin æħąmucocin (1), jimenezin (2),
19-epi jimenezin (3), muconin (4), pyranicin (5),
pyragonicin
(6),
10-epi
pyragonicin
(7),
3-hydroxy-4-methyl-2-tetradecyl-4-butanolide (8)Ħ 8 •
ķ.dĕěĆpol Ģ topo âM_ħTĥ\ĞěĆŗ
Ő¢ÉŸµÁ (HL-60 cells) Ħ?‹ħ MTT ġ’K
ĕěĆ
Ĉ·ĉ
ā pol â M  _ ů Acetogenin æ 8 • Ħ Č ĝ
pyranicin (5)ĐwİXĒ6æš} pol ķâMĕěĆŭŬ
pol
H©Ħġħ polÿĥOėĵâMĐwİXĒą
IC50 ħ 2.3ĀM ġĊĞěĆ
Ă topo âM_ůpyranicin (5)ħŗ՚}Ħ topo I ĎIJ
Ĩ topo II ķâMĕěĆIC50 ħ 5.0ĀMą7.5ĀM ġĊ
ĞěĆ
ă ŗŐµÁ?‹f$_ůAcetogenin æĦµÁŒ
_ħ pol âM_Ģ/Ė0ķ§ĕą pyranicin (5)Đ
wİXĒâMĕěūLD50 = 9.4ĀMŬĆ
Ą pyranicin (5)Ħ HL-60 ĩĦZäůµÁ4yķ G2/M
yĎIJĨ G1 yġ‰ĔĘěĆ[3H]-thimidine Ħ,Ĵ
ĭķâMĕěēĢďij DNA .dķâMėĵēĢЧ7
ĔĶěĆDNA Ħs)ĐijĶěēĢďijĺŞŐŪńņ
ķÏPėĵĢ¼čijĶěĆ
ŭŬ
WgNTV¢©¬›«¡§£®Ÿ
¯‚‰„z{°–x23o–'z
E-7
‹bqŒ<=[;Œ=X#Œ
@S\CŒLD8ŒJt¯"sz
Pkz 2R#P]%°
ë
ø£ùë ŐţŨņŀťŊŠŒŪňì öô Ģ›íħąŊ
ŨŖĿĦŀťŊŠŨŠ=ĢąŤŅŨŠ=Ĭěħ²ĺ
ŠŨĢķx·.ŦŜťġ€‡ėĵÛ³řĹŠŤŪġąê
­(•ĥħŮğĦĺĻʼnŃĻšĐI:ėĵĆöô ħŊŨŖ
ĿĦ–KĦŀťŊŠŨŠ=ķÎÑĕĠ
G+^ķ
ßFėĵěįąęĦ4Ú!ĥħ%_ĐI:ėĵĢ
¼čijĶĵĆećħēĶĬġĥąřĹŪŅl§;ŝśŌ
őţĻŚţŤķ™ċąöôðū¶¹;Ŭı óúûþüýë÷õõõūɑ
9¬ ÷õõõ 8HŬęĶĚĶĥê+^_ķ§ėąÅ×=
Ú!ķ/Kėĵ„´°ķ¦«ĕĠċĵūŭŬĆöôï ħ
öôñîöôò ĢĥˤµÁĥI:ĕąµÁ…ÕŊŨŖ
Ŀ»ķ€‡Ý.ėĵĥIJĴąË¤Ħ)Ydĥá
ĕĠċĵĆēĶijĦĺĻʼnŃĻšàĦ[& hħv
ġĊĴąęĶĚĶĐEĮ=Ú!ĥáėĵa>ħzĜ
ĤċĆ{¥ªġħąöôï Ħê+^_=Ú!Ħ/Kķ
£ĢĕěĆøø tũ ·ù ëïð Š=ĦţŨŋšŝśŌőķ
l§ĕěřĹŪŅķŀťŊŠŨŠ==Ģĕąöôŭ
ĥIJĵŘľŌŨ†Ñ²ĺŠŨĦ,Ĵĭ+^ķÊĞ
ěĆĺŘŅŨ5_ķ#™ĕĠ+^ĕěřĹŪŅķ®Ì
ĕąCÄÇĥbĔĘĠ?UėĵĢċČÖĦpķº
ĴÔĕąØ"ĕěřĹŪŅĦl§ėĵŝśŌőÚ!ķŽ
KĕěĆęĦ·ąBrĦÚ!ĥKĦ%_ĐÎ
įijĶěĆöôï ĢĦ+^_ķėĵěįąęĶijĦŝ
śŌőÚ!ķ1Į¶mčŊŨŖĿķÌĕą+^_ķ
~ĕěĆȆÑĬěħĺĻʼnŐŪś†Ñĕě²ĺ
ŠŨĦ,Ĵĭ+^ĥIJĴą
ĦĺĻʼnŃĻšİ1įĠ=
ĢĕĠĦ+^_ķ„ÍĕěĆęĦ·ąīĢĸģĦÚ
!Đ öôï ĥOĕĠêċ–_Ģ+^_ķ§ĕěƘ:
ğķØ"ĕą-ĺŠŔ܊=ķĺţœŨĥAmĕěA
ķÌĕĠ+^_ĦA)ķ~ĕĠċĵĆë
(1) Sugimura et al. J. Biol. Chem. 281, 17699 (2006)
C. ŰŶŲųŴűŵŷ et al. (2007) Lett. Drug. Design Discov. 4, 239-245.
¢©¬›«¡§£®Ÿ—Mbe“–
MOV(–0•1“Ž˜z
z
E-6
‹HiCŒS9$Œ<=[;Œ@
S\CŒLD8ŒJtz "s­P
k­2R#P]%z
­BTH;–›jË·EPT?<RBM
GV@Ñ[X TGÒ)9R>7N68T]|­'
BTH;Í'b’ºoÑ6ALJCFºoÒ(„
‹4z"(„¤-œÀ4wj1(
Ë·lˆ)IE#)ğcr-®ÁÆ®„‹&%
x…&¨p¦É'ÎY"12*#Œ
)
ODRX´¨¢Ñ‰µÂÒ4©"¸¿'
1¢§­&_'"TG ^‡'Î31$
4‘/'"Zq)i¢¸¿4É
$"¢§­&_4Yuo'"TG '
.1–›lˆ_^‡'ÎY1nÀ‰'!
"˜Çž”É$")IE¾ª“
(W®¶¸¿— 4©¢§­_)t
Я#v¸¿'"9MAQ4©
"_!1$'.0Å *Ô²(«&
1Ã`#™ÈD:?EPT4©"_4Y
†'^‡Å32¸¿4£«­'kd
1ž4°³(#TG (Ïf(
g'.1h•4˜Ç*56A=6N(
¹»s TGÑTG2Ò(+¼SKR#¬¦Ž
e21Ê\{}~‚a—4š³(¸¿4©
uo(¢§­_'1^‡4€
"¬¦Že—' TG2 Ê\{4a2}~‚
a—4š³(_^‡À4˜Ç
º•U
½€¢§­_4m¸¿(^‡¥)TG (
Ïf4 g1$#’Š'¡ƒ*TG2
¬¦Že—'",_^‡y/2¬¦
Že—'Ê\{4a2TG2 (¬¦Ìq‡
¸¿—#)¢§­_'1^‡¥q‡
"2/(º•/TG ¸¿(¢§­_
/(^‡'ÎY1$±2
ÑÓÒWada et al. FEBS J. 274 , 2766 (2007)
E-8
xfdv7•’
R‘˜ | a+Um#–>z
‹:q&c 1Œ)?cp 2Œ-&h 2Œ
=_ 2Œ=D/ 3Œ"qFP 3 ŒB
,y 1Œ *9/ 2 ¯1 n"­2RP
MŒ2 "s­Pk%Œ3 "s­°
Ĉ£ĉ¯QŸķ2ĔĤċşļņ SM/J °¸Ģ A/J °¸ď
ijĔĶě SMXA-5 °¸ħ¯QŸķ¡ ĕąēĦŸ
cħêÿçn,ĥIJĴ?`ĔĶĵĆećħą
SMXA-5 Ħ 2 œÆĥêÿçn,ġ™ėĵ
A/J š}Ħ¯QŸÙHW T2dm2sa ķ„ĕąēĦÙ
HWķ1Į A/J š}Ħ 2 œÆå<ū± 120MbŬ
ķ SM/J ĥPĕěŁŨŅĽœōĿ°¸Đ¯QŸķ2ė
ĵēĢķvijďĥĕĠđě (1)Ć{¥ªġħąT2dm2sa Ħ
ÒÙHĦ/KķjĕĠąT2dm2sa ĦI:å<ķ
ãRėĵēĢķ£ĢĕěĆ
ĈtĉŁŨŅĽœōĿ°¸Ħ A/J š}Æå<ķs
)ĕěİĦķxėĵłŚŁŨŅĽœōĿ°¸ķ 7 ©æ
ĕěĆēĦČĝą2 °¸ūR1AąR2AŬķ™ċĠêÃ
¿çn,ġĦ¯QŸYķ SM/J ĢÓ„ÍĕěĆ
{¥ªġħąşļņ/@ĦqoĥIJĵ˘;ĩĦZä
ķDĒĕą˜_ĦĊĵŏŪŊķ]ijĶĵèÀ|ķ¦
«ėĵěįĥą*—èÀĥIJĵLé°ķk™ĕěĆ
Ĉ·ĉR1AąR2A łŚŁŨŅĽœōĿ°¸ġħĢİĥ
SM/J ĥĪĠą¾“VĦuąÃ¿¶¹ÝÞĦ?'
ķÎįąR2A ġħ½¯ÂĦİNĔĶěĆēĶij
ĦēĢIJĴąR1A ĦiğŇŨŐŧŢĺĦ± 5.6Mb ĦP
å<ĥħ¾“ĥáėĵÙHĐI:ĕąR2A Ħi
ğŎŧŢĺĦ± 26Mb Ħ A/J š}å<ĥħ¾“ũ¯Q
ŸĥáėĵÙHĐI:ėĵēĢЧĔĶą2 œÆ
ĥħrĦÒÙHĐI:ėĵēĢĐvijďĢĤ
ĞěĆ
(1)Kobayashi,M.,et al., Diabetologia, 49:486-495 (2006)
- 62 -
J‡}Y
”cŒko“/‘
•:ŠŽ
E-9
…v5K 1·hXw 2·U 3·r
] 3·y 2·P$+ 1,2·dVS 1,2
µ1 €*ˆ<\[Y·2 €*-[YOp
†_bf@·3 °®ž‚QI6¶
E-11
§›¦¢¨—¥’”A`
\“
.‘•Ÿ²˜ ²˜ª™ D2 ž­±¦
£¤ loop B T‹(”L|%,
)3,ƒ2=;NCW
David B. Sattelle* E]7µ{*ˆ³
z³<[*›£œ¡¬š´¥*¶
[¥]÷ğ‚Æě÷çĠ«÷¹ÅĞĩĬ÷,&ě÷Ê
¹ÅĞĩĬ÷PXğőŠŤłĞĩėęÓ³ďĭęąĬĀ
é»S÷´ú£Ġÿ«÷¹Åiğ9ĞĩĬßğ
÷,&Ċ$0Ě÷çĊ‘JđĬĀ«÷¹Åğ!İ
íBđĬ—ĤĖĠ÷ʹÅğ!İÝđĬ—
Ġ÷´ú£ğìĨh.ĞU(ÆĚĄĬĀYāĠ
}äëܗğ«÷¹Åě÷ʹÅğ!ĞFđĬ
íBİ~ÑĐĖĀĔğ¼zÿ«÷¹Å!İíB
đĬ}äÒH!)—İ
ĐĖğĚ7-đĬĀ
[j]«÷¹Å!ÒH0<(ODF/RANKL)ğ=2
Ě ÿ «÷ ¹ ÅĞ ! đĬ RAW264 ¹ Å |% ġ
M-CSF =VřĴł÷øžx¹Å(BMM)İ5õĐÿ
«÷¹Åğ!řťĸťĚĄĬã©äÄVäŘłŕı
ņťńV(TRAP)ğ“@ě{ÉĞĩīÿ«÷¹ÅĢğ
!İĐ ĖĀVğTĪĭĖ!)—ĞFĐ ęĠ
BMM ě÷ʹÅěğ=5õĞĩĬ«÷¹Å!
%ġŔʼnŋPXĞFđĬİ~ÑĐĖĀĤĖ MC3T3ý
E1 ¹Åݝąę÷ʹÅğ!ĞFđĬİIJŢ
ĸšŘłŕıņťńŦALPŧVğ“@ě{ÉĞĩī
ĐĖĀ
[¼z]}äëܗ 116 ¯ĞĘąęłĻšťōŤļĐĖ
¼zÿAra AMP ěĔğÒHĠ 10üg/ml Ě RAW264
¹Å%ġ BMM ğ«÷¹Å!İíBĐĖĀĤ Ė
8-(1-Decyn-1-yl) cyclic AMP ħ 15üg/ml Ě RAW264
¹Å%ġ BMM ğ«÷¹Å!İíBĐĖĀďĪĞ
=5õĞĩĬ«÷¹Å!%ġŔʼnŋPXĞFđĬ
İ~ÑĐĖěĎĮÿĎĭĪ!)—Ġ÷ʹÅğ
!řťĸťĚĄĬ ALP VĞĠQòēĒĞ TRAP 
VĞFĐęğĥ”M=¥ĝíBİ­ĐĖĀĎĭĪ!
)—ĠŔʼnŋPXİ[ĐĖĎěĉĪÿ÷,&[—
ěĐę÷´ú£ìzħĄĬěÃćĪĭĬĀ
Ă¥ăŎķōĽňŏijŌ·†ÍijŚŇĻţŗšŌ(IMI)
ĠÿmÍōĽňŤVIJŃňŢĽšŤ'C(nAChR)Ğ
FĐęà^¥ĞIJľōłŋİ¤fđĬĀįĭįĭ
ĠĎĭĤĚĞÿĎğĩĆĝ IMI ğà^¥VĞFĐęm
Í nAChRĿŖŝōʼnŋĚĠ
loop C 1)ÿĈĩġ loop B
2)
ĉĪ N vĞĉčęğó4 ĊDđĬĎěİoĪĉĞ
ĐęąĬĀ/ÿŀŞĴŁŞĴőĶ D2 ĿŖŝōʼnŋİF
ÖěĐęÿĔğ N vĉĪ loop B ĤĚğêĚ IMI ěğ
à^¥ĞDđĬÛ0<ĞĘąęÓģĖ
ğĚ7-đĬĀ
ĂjăœşĽ Ŭ ĿŖŝōʼnŋğ N vĉĪ loop B Ĥ
Ěğó4ě loop C ó4Ğ=2đĬļŢņŚŤä„6
İÿĔĭĕĭ D2 ĿŖŝōʼnŋěŗţšŤ„6Ğ*p
ĞÁeĐĖĺŜŠĿŖŝōʼnŋİĽťŌđĬ cDNA İ
XĐĖĀw cDNA İœşĽ2 ĿŖŝōʼnŋİĽťŌđĬ
cDNA ěěħĞIJŕšĸŊŜĹĶŢ#‡¹Åğ}ĞřijĻ
ţij ŤŁĵĻŀŞ ŤđĬĎěĞĩīÿĺŜ Š- ŐijŖ šʼnŌ
nAChR ݤšďēĖĀĺŜŠ-ŐijŖšʼnŌ nAChR ğIJŃ
ňŢĽšŤĈĩġ IMI ĞFđĬU²ĠÿÈð
1@
ݝąęðŠœ›>¥Ğ“ĐĖĀ
Ă¼zăœşĽ 4 ĿŖŝōʼnŋğ N vĞbĐĖŀŞ
ĴŁŞĴőĶ D2 ĿŖŝōʼnŋğó4İ…î¥Ğ¨¿
ĐĖěĎĮÿĄĬ…îİ8ĞĐę ĺŜŠ-ŐijŖšʼnŌ
nAChR ğ IMI ĞFđĬ'CğU²ĊôËĞ:!Đ
ĖĀĎğ¼zĉĪÿD2 ĿŖŝōʼnŋğ N vó4Ě
IMI ěğà^¥ĞëįĬó4İâ¥ĝĊĪ
ħ˜@đĬĎěĊĚċĖĀ
mt ”ko
~‰i„”ul”FŽ
sj75!9 Dn,
]> 1 BD" 114 2r]
1C?Ž µ*ˆ[#1 2*ˆ
qe2 a5*³xb¶
©—«´ž´¯–’^R”\
H
E-10
Ă ¥ă ¹ Å ĞĠ s Wĝ ç ğ Þï ķ š ľ ¶ (Free
oligosaccharide; FOS) Ċ=2ĐęąĬĀIÅëÜ
ĞĈčĬ Peptide:N-glycanase (PNGase) ĝĜĞĩė
ę œ X ď ĭ Ĭ FOS Ġ ÿ ¹ Å Ğ Ĉ ą ę
endo--N-acetylglucosaminidase
(ENGase)
Ĩ ÿ
-mannosidase ĞĩėęďĭĖSÿšŅŅťśĞØ
ÚďĭĬěÃćĪĭęąĬĀĔğ¹ĝyİÏĆĖĦ
Ğÿ¾Í C. elegans ğ FOS ĞĘąęÿĔğÔ»ğ
oİĥĖĀ
ĂjăC. elegans ĩī FOS İ_µÐSÿŔšŁŢIJŚ
ŏ!Ğĩėę΀ÕĐÿHPLC ĞĩĬïµÐĈĩġ
MS yİÏėĖĀĤĖ¹ÅĞ+ĤĭĬņŤŒĻç
OĖīğ FOS Ġ HPLC ğŔ ťĻ ñ°ĩī‹ĦĖĀ
PNGase VĠ dansyl !ĐĖ sialylglycopeptide (SGP)
İ6ěĐęÏėĖĀ
Ă¼zăC. elegans ğæœ|ĩī_ĐĖ FOS ĠùřŤ
ŏťł3ğÞï¶èĚĄīÿávĞ GlcNAc İ 2
„6sđĬ FOS-GN2 ěÿGlcNAc İ 1 „6sđĬ
FOS-GN1 Ċ Ĕ ĭ ĕ ĭ ¸ 6% ÿ 94% + Ĥ ĭ ę ą Ė Ā
ENGase ƒg| eng-1(tm1208) ĩī_ĐĖ FOS Ġÿ
GN2 Ċ GN1 ĩīħ;Č=2ĐÿGN2 ĉĪ GN1 Ģğ:e
Ğ ENGase Ċ ë đ Ĭ Ď ě Ċ ­ ď ĭ Ė Ā Ĥ Ė ÿ
eng-1(tm1208) Ğ+ĤĭĬ FOS çĠÿæœ|Љģ
¸ 3 ğ 1 ®M‘JĐęąĖĎěĉĪÿGN2 ğÌ°Ğĩ
ėę PNGase ĊíBďĭĬğĚĠĝąĉěcEĐĖĀĐ
ĉĐÿGN1 ě GN2 ĞĘąę in vitro Ěğ PNGase íB
zİ~ĐĖěĎĮÿGN1 ě GN2 ğíBğ®MĞL
Ġ
ĪĭĝĉėĖĎěĉĪÿFOS ğ‘JĠ PNGase ğí
BĞĩĬħğĚĠĝąěÃćĪĭĖĀ
1) Shimomura et al., Neurosci. Lett. 363, 195-198 (2004).
2) Shimomura et al., Neurosci. Lett. 385,168-272 (2005).
E-12
M',sgsK8&
0GZµ€*-Ž <\[Y-€¶
Ă¥ăYāĠÿǺÀğĥݘ¡¥Ğ’đĬĖ
ĦĞ Magunetic Cationic liposomeŦMCLŧĞĩĬ’–Œ
İÏėęċĖĀĎğ MCL İǺÀĞKZ¥ĞŽ
Đÿ ¬Ÿİ•GđĬĎěĞĩīÿǘ¡¥ĝ’
–ŒĊ(ÆěĝĬĀYāĠĎğ’–ŒĞĈąęÿ
]Ç¢ĊÒHďĭęąĬĎěЧĐĖĀĎĭĞ
Ġÿ’–ŒĞĩėꤜđĬ–ŀŞʼnĻņŤŒĻ
70(HSP70)ĊČëįėęąĬĀĔĎĚÿ]$d­¹Å
ğĚrħ]$d­ĊNČÿĤĖ HSP70 Ğĩėę
ĔğXĊÒHďĭĬěąįĭęąĬ™¹ÅŦDCŧ
ĞĩĬ¢Œě’–ŒÿqйÅV¢İV!
đĬĚåĝ IL-2 ݝĐÿĔğzĞĘąęª±
İÏėĖĀ
ĂjăǹÅěĐęřĴłŜŠŏťř¹Å B16F0 ݝ
ąÿAö —Ġ C57/BL6J řĴłİąĖĀĎğ¹Åİ
¦ĞŽGĐę`řĴłİÐĐÿÇğRĊ¸
7ŭŭĞĝėĖ…îĚÿMCL ĞĩĬ’–Œİ 43þĚ 3
lêÿ24 pêˆĚÏėĖĀĤĖÿ’–ŒğÂlĞu
X DCŦ2.0û106cells/headŧİÇâKZĞ\Đÿ
qĞĔğ 1 lSĞ IL-2 İKZĞ\ĐĖĀĔğ\ç
Ġ 4.0üg/head ĚĄėĖĀĔğSÿÇğÙ¿ÿřĴł
ğœ=têğ“@İÏėęĔğzİÓģĖĀ
Ă¼z㒖ŒğĥÿDC ĞĩĬ¢ŒğĥĚĠ?
ĝÇğÙ¿Ġ×ĎĪĝĉėĖĀĐĉĐÿ’–ŒŨ
DC ŒİkđĎěĞĩīÿ8 " 2 "Ě$¤Çğ?
Ù¿ĞXĐĖĀĎĭĪğÙ¿řĴłğū"ũ"Ě
ŪMğ Rechallenge ĞĈąęħÇİa½ĐĖĀĤĖÿ
a½İÏįĝĉėĖřĴłĞĘąęħÿœ=liĊ
ĞnĐĖĀĤĖÿ’–ŒŨDC ŒŨIL-2 ĚĠÿ
4 " 2 "Ě$¤Çğ?Ù¿ĞXĐĖĀ
- 63 -
> @ ; s o p w matrix
metalloproteinase-3 MMP-3‘ \!t
LO:?V6
E-13
m3< nF0n$Qn
#5BWn'EDAW‘
ģ¢Ĥ‹’ŀŌŎÏMıŐŏŴƍŬŢƅũŝŧƋųŝī
‹’„ŀĩįŏ³½€œc!ijŏİĽłŌĭ¥ōŐĻ
ĦŏġaĢł‹’ŀŌŎÏMıŐŏÛCœ DNA Ũũ
ŹŀŌŎ·º¢ŀtIJĠĶŁƑĺļĥŏ MMP-3 ŀ‡
IJĠĶŁåH"œšijŏİĽļ‹’„%uŁ>
Vœ fIJ ĸġ a Ģī á ¡IJ ĸ ¾ ]¨ ] Z® C
(MCL)œÂÜŀŁňN7ıĵĠž¨œ‘Lijŏ
‹’†ļłÂÜŁňœ$‹ļĬĠƒƓĝŇļ$’
ijŏİĽļ£ÅĠĿľļEŀÔ¸ļĬŏġr¦
«ļłİŁ‹’j†œšĦĠMMP-3 åH"œšij
ŏİĽļ³½€Žī×ıŐŏİĽœmōĪŀIJĸġ
ģj†ĤĞƎin vitroƏſŗţƁƆűƍſ³½œ 6well dish ŀ
:îIJĠMMP-3 åHƎN-isobutyl-N-(4-methoxyphenylsulfonyl)glycyl hydroxamic acidƏœ 0,1.3,4,8ĜM/well
ŁTļŠ$XĠ42ĝŁ^‹|ļ 60,75,90 Ł‹’
˜œËĹĸġ2 lXĠ™³½iœŒFIJĠMMP-3 å
H"Ł%uœyÍIJĸġğƎin vivoƏſŗţ B16 ƁƆűƍ
ſ³½œƁţŁ C57BL/6J ſŗţŀ‡LIJĸ£Ƃūƈ
ļyÍIJĸġMCL œÂÜŀ‡LIJĠ„¢ŀłĥŇ
Ŏ%uīĦ 43ĝĠ30 ⣋’†œËĹĸġ‹’
ƑnâXŊIJĭł 24 nâXŀ MMP-3 åH"œÄÁ
ŀ‡IJĸġİŐōœ 3 lâËĦĠµÙœJIJĸġ
ģ¶uĤĞ‹’˜nâŀãŒōĴ MMP-3 åH"œ
Š$ijŏİĽļTD¢ŀ™³½iīIJĠ
MMP-3 åH"ī³½€œTD¢ŀÏMIJĻĦŏ
İĽīŒĪĹĸġğÕP 43ĝŁ‹’„ļłĠŅņ
ĻŁſŗţļ˜XijĮŀÂī>‚IJĠ° 30 lļ
€IJĻĦĸġIJĪIJĠMMP-3 åH"œšijŏİĽļ
˜ 30 lXļŊ° 4 #ŁſŗţļÂī§ÎıŐĴÔ
¸IJĻĦĸġŎŁſŗţļŊÂŁ>‚npĠ>‚
ÖTĽŊŀØĭĠU2%uīōŐĸġ
E-14
E-15
ģ¢ĤŴŬĽŅņ/{ĿşűƀŤũŬœoijŏťŸƆŷŕ
ũŢƄœšĦĸƁŧŽƊƍƀŢƋŭƊƍƀ¦«Ł,¾]
œgŏbBʼnĽIJĻƐ6•ŔūŕžšŖŬŚŖƋĽIJĻ¥
ōŐŏťŸƆŷŕũŢƄŔūŕžŰŝŨƋƎěûČĐĕĔƏċþăû
ŁŝƊƍůƋŞĽ¡–ƌ¾tœňĸġð
ð
ģj†ĤŴŬĩŌŃſŗţŔūŕžŰŝŨƋ ċþăû Ýœ
ĊĉĐĘ ĽIJĻ üĂûćĈð ėčĉĖċď œËĦƐťŸƆŷŕũŢƄ/
ÛCŁ/FœňĸġŴũŬIJĸÝœŀ”ŸŹƆ
ŖſƍœIJƐĆĈòĄýĆ ŀŌŎ>QXƐ4&“Û
C¡–źŝŧƍŀŝƊƍůƋŞIJƐ:îŁ4&“
³½ŀMIJĸġ³½ˆƐ:î:8œ ćþćòĄûĀÿ
ŀŌŎœXƐŘŶŬƍŹŧŞŀKijŏ”ŸdœšĦ
ĻŗŘţŧƋŸƊũŬtœËĹĸġ-´¹ŀĩįŏ¡
–ł ĆĈòĄýĆ †ŀŌŎGkIJĸġð
ð
ģ¶uĤŴŬĩŌŃſŗţŔūŕžŰŝŨƋŀKIJĻĶŐ
ķŐ ÷ùóøñƐ÷úóöñŁ/]œ©ij ěûČĐĕĔðċþăû œŝƊ
ƍůƋŞIJĸġŠƆƍşƋ{ŭƁŖƋƐýôą ŭƁŖƋŀ$
ĨƐ@àW`ŀ[
ĿŢţŪŖƋ;ŊDıŐĻ
ĦĸġÇ1‰ĦİĽŀƐěûČĐĕĔ ł¿¼³½ļŁ¡–ī
ÎʼnōŐĴƐÀƐ—Ɛïx¬Ɛ»ÆļŁ¡–īëÉ
ļĥĹĸġ4&“³½ļ¡–ıĵŏĽ:8ŀ…
ıŐƐſŗţƐŴŬŁ=.Ľ/{ŀŢţŪŖƋ;œIJ
ĻàƐàƐ@àœW`ijŏİĽīmōĪĽĿ
Ĺĸġ
@}Š{…{t g 2X7
(xRqw"
t+K
m8%)Nn&*n[3.n^_
anSnG-(]UŽb
DA)
ģ¢ĤCŢƃŻƊƋļĥŏ’ŢƅũŝŧƋųŝƎHeat
Shock Protein, HSPƏłĠÓRĠ™äY¯ŀKijŏ(
æŢŞŮƈŋŝƊţŹƉťƋŪƍŢƅƋĽĦĹĸ Ð
­¾œŊĺİĽī<0ıŐĻĩŎĠ@¾ĿŧƋųŝ
Ľ IJ Ļ ‡ ı Ő Ļ Ħ ŏ ġ r ¦ « ļ ł Ġ lymphoid
neoplasm P388D1 ³½ī HSP70 Ł C qŭƁŖƋœ
įŏĽĦħİĽœmōĪŀijŏĽĽŊŀĠ³½ŀD7
ijŏ HSP +Iœg²ijŏİĽœ¢ĽIJĸġ
ģj†ƌ¶uĤſŗţ³½›sŁ HSP72(MO-HSP72)
œŵřŨƋ'IJĠP388D1 ³½ĽŁ¶.œ SAv-FITC ŀ
ŌŏâhʆŁŷƊƍšŖŬƁƍŧƍļÐńĸĽİőĠ
ŵřŨƋ' MO-HSP72 ł P388D1 ³½ŀKIJĻí3¢
Ŀ¶.]œ©IJĸġŇĸĠİŁ¶.łé}ÑŁ
MO-HSP72 D7ļedıŐŏİĽĪōĠ”Ÿ¢Ŀ¶
.ļĥŏİĽīŒĪĹĸġP388D1 Ł³½ÌêœŹƊŪ
Ŕƍťļ˜IJĠMO-HSP72 ĽŁ¶.œtIJĸĽİ
őĠÞ±àĽ *\nâŀ DIJ Ļ¶.īIJĸĸ
ʼnĠP388D1 ³½Ł HSP +IłŧƋųŝ]ļĥ
ŏİĽī©5ıŐĸġ
HSP70 ł)w™“Īōw™“ŇļQSĭD7IJĠ
™“ªŀŌŎ C qŭƁŖƋŁÝŀ@{]īōŐ
ŏġİŁŀ¤IJĻĠſŗţ
?ŁżŗƉƋŦŗĠß
ÈĠAÃțsŁ 3 ªŁ HSP ŀĺĦĻ P388D1 ³½Ľ
Ł¶.œÐńĸĽİőĠw™“ƎſŗţƌżŗƉƋŦŗƏ
›sŁ HSP ł¶.IJĸīĠ)w™“ƎßÈƌAÃÈƏ
›sŁ HSP ł¶.IJĿĪĹĸġĶİļĠHSP70 Ł¶.
]ŁÚœ šIJĻĠ*\]v~" Sulfo-SBED ŀ
Ōŏ P388D1 ³½Ł HSP +IŁƆźƈ'œƒÒIJ
ĸġĶŁ¶uĠMO-HSP72 œƇśƋŭĽIJĻšĦĸ=.
ļłĠßțsŁ HSP70(LA-DnaK)Ł=.Ľƒń
ĻĠ65kDa ÓŁ 1 ĺŁŲƋŭĽ 200kDa Ł 4 ĺŁ
ŲƋŭŀOīōŐĸġ
~‡‹†z}‰y‚zˆ„{€ lhjf
t{Œƒ|rHCovu9P4
m[/Y’FM’Jc ,’I
%’Fc =’`1 Z
]ŽDT‘
E-16
~‡‹†z}‰ kfideclhjf t{Œƒ
|rALOsopwHC
mFM’[/Y’Jc ,’I
%’Fc =’`1 Z
]ŽDT‘
ģ¢ĤŴŬĽŅņ/{ĿşűƀŤũŬœoijŏťŸƆŷŕ
ũŢƄœšĦĸƁŧŽƊƍƀŢƋŭƊƍƀ¦«Ł,¾]
œgŏbBʼnĽIJĻƐ_•ŔūŕžšŖŬŚŖƋĽIJĻ¥
ōŐŏ ťŸ Ɔŷ ŕũŢƄ ĄûāòôƎĕđĉėĒĐēĔĎčēð ĉċĘĐęĉĘĔĖð
ĐēďĐĊĐĘĔĖòôƏƎěĄûāòôƏċþăû ŁŝƊƍůƋŞĽ¡–ƌ
¾tœňĸġð
ð
ģj†ĤŴŬĩŌŃſŗţ Ąûāòôċþăû Ýœ ĊĉĐĘ ĽIJĻ
üĂûćĈð ėčĉĖċď œËĦƐťŸƆŷŕũŢƄ/ÛCŁ
/FœňĸġŴũŬIJĸÝœŀ”ŸŹƆŖſƍœ
IJƐĆĈòĄýĆ ŀŌŎ>QXƐ4&“ÛC¡–
źŝŧƍŀŝƊƍůƋŞIJƐ:îŁ4&“³½ŀ
MIJĸġ³½ˆƐ:î:8œ ćþćòĄûĀÿ ŀŌŎ
œXƐŘŶŬƍŹŧŞŀKijŏ”ŸdœšĦĻŗŘ
ţŧƋŸƊũŬtœËĹĸġ-´¹ŀĩįŏ¡–ł
ĆĈòĄýĆ †ŀŌŎGkIJĸġð
ð
ģ ¶ u Ĥ Ŵ Ŭ ĩ Ō Ń ſ ŗ ţ ð Ąûāòô ŀ K IJ Ļ Ķ Ő ķ Ő
õøóõñƐõöó÷ñŁ/]œ©ij ěĄûāòôð ċþăû œ»Æ›
s ċþăû ŹƍƈŌŎŝƊƍůƋŞIJĸġă qŀł9
¢ĿŢŞŮƈÝœoIJƐďĚČĖĔĕďĉĘďĚð ĕđĔĘ ųŧƍƋ
łƐŴŬƐſŗţ ð Ąûāòô Ľ éPŀìIJĻĦĸġŇ ĸ
ěĄûāòô ÛCłƐŴŬƐſŗţ/{ƔĺŁŘŜŦƋŌŎz
`ıŐƐ¿¼´¹ŀĩįŏ¡–łçŌŎèŁjīëÉ
ļĥĹĸġ4&“³½ļ¡–ıĵŏĽ:8ŀ…
ıŐƐŘŶŬƍŹŧŞŀKijŏ”ŸdŀŌŎŢƋŞƈ
ŲƋŭĽIJĻyıŐĸġ
- 64 -
E-17
Š‹‚@7=C1+]*}
RPKQ|~w&e
q%_U 1 ‘# 2‘d/ 11
^c?V‘2 I<Š‹‚F
H„Œ…Ž
ü«ý+ıőŝĸĜàã̏Vė¢Æčī‡›ĝŧ
ĩĂĜoŁʼnşŁŒ‰įĀĖÿīĘÂĀĩĬīú
wŧÄE*ċĒÉŽÀėĝŧ•h亳ěĨīä*
ŁʼnşŁăÉżÇĜŒÈįZĄÙĈčĈĘă­ĩ
ĬĖÿīúĐĈė
9lûĝŧĈĬĩ‡›Ăĩ,íţ¸
ÔĊĬĒoä*k ě¬ċŧÉżÇĜ *ěP
čī(ƒįzĩĂěčīĈĘį«ĘċĒú
üw“ýÉżÇĜśňŞĘċĖŗĴŁ 3T3-L1 ¼Çį
¤ÿŧ *×Q{ĨĪ+ıőŝĸ-£‡›ě¥čī
1³oä*k į³ûĜšYė–'ċĒúhÉÅ
ĜÏ´åĘıňIJŖľijʼnĸijšťAdiponectinŧResistinŦ
Ĝ©žţ ’åį *Ĝp‹ĘċŧĐĬđĬ Oil red O
ěĨī„ÍŧŝıŞńijř PCR āĨĞĴĶŁńšŒŠņʼn
“ěĨĪJåċĒú
ü¾ƒýØĠĒŪ³Ĝoä*k
Ĝėŧ
Hydroxytyrosol āĨĞ Resveratorl ă 3T3-L1 ¼ÇĜÉ
żÇğĜ *įëLċŧhÉÅĜÏ´įôÎě
m"čīĈĘăzĩĂĘĚĔĒúk ě”ċĖĊĩ
ě
¼ěˆÕċĒĘĈĭŧ *×Q`Ũxŧũxě
āÿĖŧ–'ċ Ēåě HċĖ Adiponectin āĨĞ
Resistin Ĝ©žāĨĞ=õ=;ğĜ ’åă—Rċ
ĒúĢĒ PPAR ħ aP2ťFABP4ŦĜ©žĦ¤åH«ě
m"ĊĬĒú
‰‡ESDKQ opgjh }T ZG
|uv€ˆƒ†Œ]bX=}A
6|xtyf
E-18
q B.(rM-Yr2$r
0
JrB^c ?V
ü«ý[®µKėĝù™hŐńŘš B ÁěTčīŋ
ļŅšäāĨĞĐĜêß*2›Ĝv¢ ¤ùÐ
¤Ĝt»į«ĘċĒ®µįSèċĖĄĒúĐĜ
¡ĘċĖùŏʼnªÑ§¼Ç HL-60 įò·ŸŠ¼ÇğĘ
*į×Qčī*2›Ĝˆ»įÒĔĒĘĈĭùŋļŅš
ıŘŊùijŃŋļŅšäùŋļŅšıŘŊ N-ķĹĿŊă
*×Q¤į±čĈĘăzĩĂĘĚĔĒúž:ùgh#
ö÷hªÑ§Ĝ‘ěāÿĖùªÑ§¼Çį *×
Q č ī Ő ń Ř š A Ô $ ė þ ī ATRA ť all-trans
retinoic-acidŦăËXĜž@ė¤ĊĬùEĄĚ(ƒį
ćĖÿīúĐĜwėùşŅŌijšä¨ÁĜ©¨
ħùATRA ÃhªÑ§ăþīĈĘħù©Ĝ0Èhă
øÿĈĘă8óĘĚĔĖāĪùATRA ĜšYįćĖn
ċù‘(ƒįþćīĈĘħùĜÐ$ĘĜ¤ěĨ
Ī(ƒįþćīĈĘă‘Ĝž@ěāÿĖeĘĊĬĖ
ÿīúĐĈė®µėĝù *×QÈį|čīŋļŅš
äêß*2›ėþīŋļŅšıŘŊùijŃŋļŅšäě
”ċùATRA ĘĜ¤(ƒěĕÿĖˆÕįÒĔĒú
üw“Ę¾ƒýŏʼnªÑ§¼Ç HL-60 =õċùATRA ,
 ùŋļŅšäêß*2›, ùĢĒŖŀŇ
IJŒļšʼnŠŤŞĘċĖōŞœŠä ùşŁŢĵŜʼnŠŤ
Ş ùāĨĞĐĬĩĘ ATRA Ĝ¤ ť24 {éù
ĢĒĝ 48 {éŦįÒÿùUôdæė¼ÇĜ\jD
*ĜOāĨмÇBm"(ƒįˆÕčī Ēĥ
MTT ıņłijįÒĔĒúĐĜ¾ƒùœěùATRA ĘijŃ
ŋļŅšäĘĜ¤ ěĨīBm"ă°ÖĊĬù
ĐĬĩěĨī¤(ƒă}_ĊĬĒúĊĩě¼ÇB
m"ăÖĥĩĬĒ€ěāÿĖùőŠŤľijʼnŚŤńŤ
į¤ÿĖ¼Ç *{ě©žčīÓîŗŤĸŤCD11b
Ĝ©žěĕÿĖ‚ċĒúĐĜ¾ƒùATRA , ěŽĠùœě ATRA ĘijŃŋļŅšä¤ Ĝ@2
ěāÿĖ©žĜB'ăÖĥĩĬĒú
‰‡ESDKQ HL-60 }9s{T
ZG|uv€KQ NADH `}
|xty
E-19
qM-YrB.(r!$>Nr
0
JrBf ^c ?V
ü«ý[®µKĜĈĬĢėĜˆÕěāÿĖùŏʼnªÑ
§¼Ç HL-60 ěPċĖŋļŅšıŘŊĚęăò·ŸŠ
¼ÇğĜ *į×QčīĈĘįċĖĄĒúĒēgh
#ö÷hªÑ§Ĝ‘ěāÿĖù¿Ȇ(ƒį
qćĖÿī ATRA (all-trans retinoic acid)ěĨī HL-60
Ĝ *×Qà²ĘŽÚčīĘùijŃŋļŅšäĝŏʼnÓ
îo- CD38 Ĝ©žăşŔŞĚĩĞěńšŎĺ
şŔŞėĜyăÖĥĩĬīăùŋļŅšıŘŊāĨĞ
ŋļŅšıŘŊ N-ķĹĿŊėĝÖĥĩĬĚÿě¬
ċùlûĝ ùŋļŅ šı ŘŊěĨī *×QŒ‰ĝ ù
ATRA Ęĝ¶ċĒù!ĜŒ‰ăH:čīĜėĝĚÿ
ĂĘiJčīěÌĔĒú¼ÇBğĜ]ïįˆÕčī
ìùW“ėþī MTT ıņłijĝùĐĜáěĕÿĖ
ĝùNADH åįĘĩĀĖÿīĘĜ?6Ħþīăùĉądå
ĜD*ĜĒĥùa“ĜĕėþīâºľijĺŝšĻ“
ěĨīlûĜ‚ěāÿĖĦùĐĜD*ĝrĀăĒĂ
ĔĒú¼ÇĜ NAD/NADH ŽĜD)ăù¼ÇijŔ
šʼněāĨġč]ïă?6ĊĬĕĕþīĈĘĂĩĦù
9ĝù *×Qà²ěāĆī¼Ç NADH åĜD)
ěœě¬čīĈĘĘċùĜˆÕįÒĔĒú
üw“Ę¾ƒýŏʼnªÑ§¼Ç HL-60 ěPċĖùATRA
āĨĞŋļŅšıŘŊįFĥĘčī1³êß*2›įù
Šû̀ěĖ ċùMTT ıņłijěĨī¼ÇB
ğĜ]ïįˆÕċĒĘĈĭù¼Ç *ěāĆīŘʼnļšŊ
ŝıĜ^&į±7čīěÌĔĒúĊĩěv NADH ıņ
łijěĕÿĖĦ3ŠĜ €ěĖ‚įÒĔĒúĐ
Ĝ¾ƒùATRA ėĝEĄĚD*ăÖĥĩĬĎùŋļŅ
šıŘŊėĝy4ăÖĥĩĬùijŃŋļŅšäėĝ
Ýě—R4ăÖĥĩĬĒúĈĬĩĜ¾ƒįçģĖù
ě NAD į>Ęčī³ûĜ¢*I/fěêčī
ńšŎĺÁťPARP, SIRT1ŦĘĜêßhěĕÿĖ¬
ċù‚ċĒ¾ƒěĕÿĖĦþĮďĖ?6čīú
E-20
klmki z klmni |€R,:8
}4f
f
q3"[)r_ra"O;\r!
5Lr7BcWf 'A?
ü«ýABCA1 Ę ABCG1 ĝŗĺŠőİŤŀį5Ĥ~†¼Ç
ėà%ĜÉįsčī ABC ńšŎĺėþīúABCA1 ă
ıŖŝŖńšŎĺ A-I(apoA-I)ěļşŁŇŠŤŞĘŕŁőİŅ
ŀŞļŝš(PC)įsċù¢ČĒøMYŝŖńšŎĺťHDLŦ
ě ABCG1 ăĊĩěļşŁŇŠŤŞùŁőIJšĽŘĶŝš(SM)ù
PC įsčīú¼ÇÊěĝŁőIJšĽÉĘļşŁŇŠŤŞ
ěNĤŜőʼnăH:čīăùABCA1 Ę ABCG1 ěĨĔĖÛÜĊ
ĬīļşŁŇŠŤŞĜñ<ĝzĩĂěĚĔĖÿĚÿúĐĈėù
ÉsĜ GŒ‰ĘÊÉŜőʼn‰ÞĜêįzĩĂěč
īĈĘį«ĘċĒú
üw“ýSM 2kěeðĚ CERTťceramide transfer proteinŦ
ĜD¦ěĨĪ¼Ç SM åăċĒ CHO-K1 ¼Ç¥Ĝ
LY-A ¼ÇĘùĐĜŒÈ9c… LY-A/CERT ¼ÇùCERT à
%©ž¼Çě ABCA .ĝ ABCG1 į©žĊďùÉs•
hį˜JċĒú
ü¾ƒý LY-A ¼ÇĜ SM åĝùSM 5|=;ė=õčīĘ
LY-A/CERT ¼ÇĜ¹ 60%ěċùŜőʼnĜ¯CěĨĪŌš
ŜőʼnĜļşŁŇŠŤŞă LY-A ¼ÇěāÿĖB'ċĒúĈĜ
€ LY-A ¼ Ç Ă ĩ Ĝ ABCA1 ě Ĩ ī É s ĝ
LY-A/CERT ¼ÇěŽĠĖB'ċĒwùABCG1 ěĨīÉ
sĝ—RċĒúCHO-K1 ¼Çě CERT įà%©žù.ĝ
u SM į– 'ċ¼Ç SM åă B'ċĒ € ėĝù
ABCA1 ěĨīÉsĝ—RċùABCG1 ěĨīÉsĝ
B'ċĒúĢĒùABCA1 .ĝ ABCG1 Ĝ©žĝùŌšŜőʼnĜ
ļşŁŇŠŤŞåįB'ĊďīĈĘă ĂĔĒúĈĬĩĜ¾ƒ
ĨĪùÉʼnŜšŁŖŤńŤăÉsįċĖÊÉ¡Aį
DĀīwùʼnŜšŁŖŤńŤăH:čī@ėþīÊĜÉ
¡AăÉʼnŜšŁŖŤńŤĜŒÈį"bčīĈĘă±7Ċ
ĬĒú
- 65 -
E-21
€ˆExz}|:Z&X¡‹œ
„
y_^wH2vt
r=l V msal W ms+,l 3 msl
j<l nsFgl ms?Ll 0 ml
Ÿml i I c 4K I Osnl
fIb ڏۼLØķĘŁİčńĞĄr„ž©õô÷ž©âØ
exosome ÜĈÝø microvesicle ó6ùĉĈ¯I©ċxé
ĈæóâeĆáöçĉíÙæĉĆøØľŃ«¯ó¯ģŃĭĘ
áĆoYçĉñàć،àąú‡ÉTöàÝñØÅ
õsªċ\Þæóâ“çĉñÝĈÙ¦ĆøØķĐğ®
ž©lâ exosome p÷¯I©ċxèñÝĈæóØķ
ĐğvöØexosome óFNâÒéĈģŃĭĘŇľ
Ń«1â@8éĈæóċeĆáöèñÝĈ
[Nakatani H. et al. Biochem J, 2006]Ùi‘•òøØ(õ
Æċ¹µ/ªõĐĝvċˆÝñØvöàåĈ¯I
©÷ģŃĭʟYċ¹üĈæóċóèíÙ
ÚcyÛbÕõĐĝvċÀUÍéĈæóòدI©‰
ċÍèØçĆöĝļœFN&ûÀUÍöąć‰
èíÙ0‰ö4ÿĉĈģŃĭĘċØ«¨†ģŃĭĘ
Ņx¯I©ģŃĭĘ MFG-E8Øàąú«¨†ƒ
‹ģŃĭĘ butyrophilinņöGéĈĺīĘŁńĩĿ[ċ
ˆÝíŒıŁĦħyØàąúÆjċˆÝí PMF y
öąćjèíÙ
Ú kیıŁĦħy÷ kØMFG-E8 ÷įńĘFNø
1.14 g/ml òØbutyrophilin ÷ 1.17 g/ml óø‹õïñàćØ
Đĝvöø«¨†óø‹õĈ exosome p¯I©â4
ÿĉñ ÝĈ æóⓠ7 çĉíÙÿíØ Æ j ċˆ Ý í
PMF yąćØĽĘħİđľŃØĽĘħİēľŃ/PP3ØMFG-E8 à
ąúŒęŁıľŃóÝïí؇ÉTöȾéĈģŃĭ
ĘâØFN 1.08-1.14 g/ml ÷‰önçĉíÙæĉĆ
÷ káĆØĐĝvöøb
¯I©ŇģŃĭĘ1
â4ÿĉñàćØæĉĆâØ®àąú{'˜÷‡
ÉTöÈéĈæóâ“7çĉíÙ
E-22
‚“–†ŽS n Ž—œyR
Bd
5ž’x%u| pqo UH5y
@
r;esA/Ms6-]s?
Ds+,3sFgs?L0Ÿ
iIc4KIO ڏÛæĉÿòöØÖ*ĎŀĿĚŃòÜĈĔĵĸěď
ĨŅOMņöGéĈX¦²} IgE [÷>ÂøØĐĠĽ
OM ó÷K-VWċ“çõÝæóâeĆáöèñãíÙæ
÷K-VWċ ˆèíjöąćØĪłħľ OM Ēįħ
ńIJø—ʼnĨĹďŃöÌèñàćØì÷òă Asn88-Pro93
ŅD2L2 Ð9ņâ%õĒįħńIJÐ9òÜĈæóâ“7ç
ĉñÝĈÙi‘•òøØĐĠĽ OM ÷— 2 ĨĹďŃċ:ió
èñØĒįħńIJ÷@8â“7çĉí D2L2 Ð9÷ĀċĪ
łħľ OM ö£`èíėĹĽ— 2 ĨĹďŃċaö¾
èíŸ`ß[+ŅD2L2nņċ¹µèØĒįħńIJ÷£
ĄFNâ IgE [ó÷ 1ªö,þéPÏċjèíÙ
Úcy,ú kÛ>­±òŽ…çë͛µèí0”ėĹ
Ľ OM øØħľIJĝŃÊDzWàąú S-S 1÷£áĆ
–o½ċ]èñÝĈó_BçĉíÙ2 ¡÷ķĐğ
ŅDBA/2ØNC/NgaņáĆSĆĉí OM ƒ‹ IgE [ó÷
-VWċ ELISA yöąć¹üí kؗ 2 ĨĹďŃċĒįħ
ńIJóèñ·ºéĈöàÝñ D2L21, 2, 3, 6, 9, 12 ó
÷ÔÝ-VWâ“çĉíÙÿíØRBL-2H3 ž©ċˆÝí
¬Ñš¸Hª÷jöąćØD2L2n öðÝñ n=6 ò¬Ñšċ¸HéĈ3âĆĉíÙæĉöGèØĐĠĽ
OM ÷ D2L2 Ð9÷ĀċĪłħľ OM ö£`èíŸ`ßė
ĹĽ[+öðÝñøØIgE [ó÷-VWöKâÜ
ćØýóČô-VèõÝăÜïíÙæĉĆ÷ kąćØæ
÷ĒįħńIJÐ9û÷ IgE [ 1öø— 1 ĨĹďŃàą
ú— 3 ĨĹďŃâPÏċßñÝĈ/ªWâ“7çĉíÙ
Siglec-9 x{|•„›‘~ž‰y
‡ƒœJI_T
l
E-23
r)l 9>s#\l $Ps*'l es
,l `sk,l l
Ÿi.IGCY.! l
ڏÛSiglec øöŒ÷ž©´Îöƒ‹öŽ
…èñÝĈŀĘĥŃò؜Çhö#çĉñÝĈĝĎ
ĿÄċ·ºéĈÙì÷=äøž©ĨĹďŃö
Immunoreceptor tyrosine-based inhibitory motifŅITIMņ
ó6ùĉĈZ!W÷ĥŁĝŃĺĥńİċăðÙì÷ĥŁ
ĝŃt:âľŃÄ'ċ.åĈóØĥŁĝŃĴğİčģńĢ
ŅSHP-1ØSHP-2ņâľĘĿńħçĉ؞©û÷ĝęĩ
Ŀċ¹™éĈó÷;5âÜĈÙi‘•òøØö)†
òŽ…éĈ Siglec-9 ö‚ċOñØg-V÷¸
HöÅõ TLR öGèñô÷ąÞöˆéĈ÷áċ
jèíÙ
ÚcyÛÿêØķĐğķĘŁİčńĞpž©l RAW264
öÁ?HèØĮħ Siglec-9 ċABöŽ…çë힩
lċr–èØCÓöˆÝíÙTLR2 ÷ľĖŃĨòÜĈij
IJĥĨęľĕŃŅPGNņØàąú TLR4 ÷ľĖŃĨòÜĈľ
ĶĶľĜĦĕĽďĨŅLPSņòž©ċ"€èØxçĉĈ0
”ĜďħĕďŃ÷Ž…ÆċľĎĿģďĸ RT-PCR ,ú
ELISA òBÆèíÙ
Ú kÛěŃħŁńĿ÷ž©löuüØSiglec-9 Ž…l
òø TLR ÷"€ò¸HçĉĈ0”WĜďħĕďŃ
ŅTNF-ØIL-6ņ÷Ž…âZ!çĉíÙÿíØSiglec-9 ÷
ITIM Â÷ĥŁĝŃt:ċİđĪĿĎĽĪŃö£`è
í<‹ċŽ…éĈž©lòøØSiglec-9 ÷Z!$k
â Ć ĉ õ á ï í Ù ç Ć ö Ø Siglec-9 Ž … l ò ø Ø
Siglec-9 ó SHP-1ØSHP-2 âwéĈæóⒷçĉ
íÙ
ąćØSiglec-9 ø ITIM ÷ĥŁĝŃĺĥńİöą
ćg-VòxçĉĈĜďħĕďŃċZ!éĈæ
óâ“çĉØì÷$kø SHP-1ØSHP-2 ċéĈ/ªW
â¥ßĆĉíÙ
E-24
…™††™Œ†ŽšŠ’‹žw75
”˜†ž–yK
r*8sh+[1s"[sk
,Ÿ(l .!NQO ڏÛĶľěńĸ¤Á?øØĝļĐĞļĐĬĒ÷ĴĹĔ
ĵĦĘğÁ?¤÷Ð9ƒ‹õŽ…ĭģńŃ÷¢]
öÅõÁ?óèñ2BçĉíÙĶľěńĸ1ø
ö ʼn ” ö Ò ç ĉ ñ à ć Ø Polycomb repressive
complex ň Ņ PRC1 ņ ó Polycomb repressive complex ʼn
ŅPRC2ņâÜĈÙæ÷Þî PRC1 1ö4ÿĉĈ Pc2
øØĹĥĿ'ĮğħŃö 1éĈĘŁĺĨĹďŃċfèñ
àćØPRC2 ÷ĜıĻĪĦħ Ezh2 öąïñĹĥĿ'çĉ
íĮğħŃ H3 ÷ 27 Š÷ľĞŃt:ŅH3K27ņö 1é
ĈæóâòãĈÙi‘•øæ÷ Pc2 ómŀġIJģńòÜ
ĈęĿěěĿĥěďĨŀġIJģń(GR)÷ˆċeĆ
áöéĈæóċóèñÝĈÙ×
ÚcyÛPc2 ó GR ÷ˆċeĆáöéĈíĂöØi
‘•òø GST-pulldown yóQwyċˆÝíÙÿ
íØPc2 ÷ GR qÁ?û÷ˆċn¶éĈíĂ
öØsiRNA yóĘŁķĥьwyċˆÝíÙ×
Ú kÛIn vivo ó in vitro ò÷ GR ó Pc2 ÷ 1ċŒ
wËyó GST-pull down assay ċˆÝñjèØæ÷ʼn
ð÷ģŃĭĘâ^ 1éĈæóċèíÙÿíØ
ĽĦħ÷M°§ž©öàÝñ RNAi öąć Pc2 ċīĦĘĤ
ĐŃéĈóØYèí§ž©ò÷ĀŽ…èØGR öąïñ
Ĵ Ŀ ĺ Ń @  ö â z W ' ç ĉ Ĉ tryptophan
oxygenaseŅTOņÁ?÷Ž…ÆâdéĈæóâĊá
ïíÙ§ž©öàÝñØPc2 ÷Ž…Æø'â¿āö
RÝ~Jèñ³ä÷òØGR öąĈ'ƒ‹Á?
Ž…!TöØPc2 â|äÈèñÝĈæóâ“7çĉ
íÙæĉĆ÷ káĆØm.EâĶľěńĸ÷bí
õqóõćSĈ/ªWâ“çĉØ'ƒ‹öŽ…
éĈÁ?âféĈ!TĹĕĪĠĸ÷eöðõâĈ
ó¥ßĆĉĈÙ
×
- 66 -
日本農芸化学会
2007 年度（平成 19 年度）関西・中部支部合同大会
御寄贈会社名
本大会の開催に当たり下記 4 社より御芳志を頂きました。
この場をかりて篤くお礼申し上げます。
株式会社ミツカン
グループ本社
アピ株式会社
株式会社
ポッカコーポレーション
愛知県酒造組合連合会
（順序不同）
2007 年度日本農芸化学会
実行委員長：小林
総
関西・中部支部合同大会実行委員会
猛（中部大学 応用生物学部）
務：森山龍一（中部大学 応用生物学部）
〒487-8501 愛知県春日井市松本町 1200
中部大学応用生物学部
TEL & FAX: 0568-51-6084（総務）
日本農芸化学会中部支部
〒464-8601 名古屋市千種区不老町
名古屋大学大学院生命農学研究科内
支部長：前島正義
庶務幹事：小田裕昭
Tel. 052-789-4124, Fax: 052-789-5050（庶務幹事）
http://www.agr.nagoya-u.ac.jp/~jsbba/
日本農芸化学会関西支部
〒606-8502 京都市左京区北白川追分町
京都大学大学院生命科学研究科内
支部長：山本憲二
庶務幹事：中川好秋
TEL: 075-753-6117, FAX: 075-753-6123（庶務幹事）
http://jsbba-kansai.kir.jp/